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1.1 Proteins 
From a polymer chemistry point of view natural proteins are a remarkable 
achievement. Nature has complete control over the molecular weight, polydispersity, 
amino acid (monomer) composition and the three dimensional folding of a protein. This 
level of control surpasses anything that can be accomplished using current polymer 
chemistry techniques. The subtle folding pattern, predetermined by the primary amino 
acid sequence, enables proteins to attain specific functionality and bioactivity, e.g. by 
exposure of small peptide recognition elements, with the rest of the protein responsible 
for either stabilizing this small sequence, or maintaining a specific environment around 
the bioactive sequence. 
One class of proteins which are of special interest to materials scientists are 
structural proteins. Structural proteins, together with polysaccharides such as cellulose 
and chitin, are responsible for the introduction of mechanical properties into plants and 
animals1. Protein-based natural building materials often have unique combinations of 
properties. For instance spider silk, often described as nature’s high performance fibre, 
has an unusual combination of elasticity and strength. In fact, spider silk is comparable in 
strength and toughness with high tenacity nylon, and, when comparing strength per 
kilogram, even outperforms steel.2 This is especially remarkable for a polymer which 
consists entirely of amino acids. What makes structural proteins totally unique is that they 
are produced in water under physiological conditions, unlike man made polymers with 
similar properties, which are produced under much harsher conditions. The specific 
properties of structural proteins can also be attributed to their three dimensional folding 
pattern. Unlike functional proteins such as enzymes, the secondary structure of structural 
proteins is often determined by short amino acid sequences which are repeated 
throughout the protein.3  
 
1.2 Peptide-polymer hybrid materials 
Recently there is a growing interest in creating materials with biologically 
interesting functionalities.4-6 The inclusion of short functional peptides or even entire 
proteins into synthetic polymers has been shown to be an effective way to introduce 
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biological functionalities into hybrid materials.7 This has led to an increasing amount of 
polymer chemists looking for new methods to create peptide-polymer hybrid materials.8,9 
There are a number of applications in which it is advantageous to use hybrid 
materials. Proteins and peptides are easily denatured by proteases, heat and adverse 
solvent conditions, and when they are introduced into the body they can sometimes 
generate negative (immune) responses. The use of a peptide polymer-hybrid material can 
help to reduce these problems. A polymer coupled to a protein can shield the protein from 
any unwanted interactions. Including only the active part of a protein in a polymer and 
removing the rest of the protein could also help to reduce any undesired biological 
response. Thus by preparing peptide polymer hybrid materials it is possible to use 
functional proteins or peptides throughout a wider range of applications and 
conditions.10,11  
Peptide-polymer hybrid materials can also be used to more efficiently prepare 
(biologically) active coatings. When an active peptide or protein is included in a coating 
using only physisorption, leaching can easily occur. This leads to a lowered surface 
activity and it creates the possibility of a negative biological response to the free peptide. 
Anchoring the desired peptide or protein to the surface or coating chemically, by creating 
a peptide-polymer hybrid material, stops this leaching process, therefore removing any 
unwanted biological side effects and increasing the active lifetime of the coating or 
surface.12   
Another advantage to using peptide-polymer hybrid materials is that multiple 
functionalities can be included in the same polymer chain, or can be brought together in 
the same aggregate. This can be done by creating (block) copolymers of different peptide 
sequences or by connecting different proteins to polymer chains to create large 
amphiphiles which can self assemble, creating functional aggregates.13 
 
1.3 Protein-polymer conjugates 
One of the most commonly used methods for the creation of a protein-polymer 
hybrid material is to couple a protein directly to a polymer, using existing functionalities 
in the protein. One area where these types of protein polymer hybrid materials have found 
widespread use are the so called pegylated therapeutics. It has been shown that by 
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attaching a polyethylene glycol (PEG) chain to a free amine or cysteine within a peptide 
or protein14,15 the physicochemical properties change, the protein or peptide is shielded 
from the body’s immune response and the circulation time in the body is increased, 
allowing the administration of drugs that would otherwise be excreted too rapidly or 
would not survive in the body.16,17 Another application of peptide-polymer hybrid 
materials is in the area of tumour targeting. It was noted that the conjugation of a 
poly[styrene-co-(maleic anhydride)] to the anti tumour protein neocarzinostatin (Figure 
1.1), resulted in a tumour/blood ratio of over 2500, which was much higher than for the 
protein alone.10 This was caused by what is known as the enhanced permeability and 
retention effect (EPR effect) of tumours. This EPR effect is due to the enhanced vascular 
permeability of tumours when compared to healthy tissue, facilitating the uptake of larger 
molecules. Therefore, by using protein-polymer hybrid materials, the molecular weight of 
the agent can be increased, leading to a passive type of targeting.11  
 
 
 
Figure 1.1. Structural representation of the anti tumour agent (SMA)2NCS, a block 
copolymer of poly[styrene-co-(maleic anhydride)] coupled to the protein 
neocarzinostatin. By increasing the molecular weight of the protein, a passive form of 
tumour targeting occurs due to the increased vascular permeability associated with 
tumours.18  
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Polymer-protein hybrid materials also play an important role in the creation of 
well-defined, biologically active nano-structured materials, such as vesicles, micelles and 
rod like aggregates. There are several examples in which polymers have been coupled to 
proteins to create interesting supramolecular architectures. Nolte et al.19 showed it to be 
possible to synthesise a catalytically active giant amphiphile by coupling the enzyme 
CAL-B, via a free cysteine group, with maleimide functionalised polystyrene. Another 
giant amphiphile was synthesised by Maynard et al.20 by combining a disulfide 
functionalised poly(hydroxy ethyl methacrylate), pHEMA, with  bovine serum albumin 
(BSA).  
Interestingly it is not always necessary to connect the protein with the polymer 
using a covalent bond. It is also possible to use non-covalent methods such as cofactor 
reconstitution. This was demonstrated by Nolte and co workers, using two different 
proteins. In the first example amine terminated polystyrene was coupled with biotin via a 
PyBOP coupling. This was then recombined with the protein streptavidin to form giant 
amphiphiles which, when placed on an air water interface, assembled into a monolayer. 
Interestingly due to the fact that streptavidin has four binding sites the monolayer could 
then be further reacted with a biotinylated ferri-protoporphyrin  XI conjugate. Ferri-
protoporphyrin XI is a cofactor for horse radish peroxidase (HRP), which was then added 
to the monolayer to create a catalytically active surface. 18 In a second example ferri-
protoporphyrin XI was coupled to amine terminated polystyrene, again via a standard 
PyBOP coupling. The cofactor was then reconstituted with the HRP to form a giant 
amphiphile (Figure 1.2). The addition of a THF solution of the giant amphiphile to water, 
resulted in the formation of catalytically active vesicles which could be characterised 
with electron microscopy.21,22    
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Figure 1.2. Computer generated model of a HRP-polystyrene-based giant amphiphile.22 
 
The above approaches only make use of commercially available proteins. This 
limits the types of proteins which can be used and the functionalities which are available 
for polymer modification. To have more control over the sequence and increase the 
different types of proteins which can be used researchers have turned to protein 
engineering. By using protein engineering it is possible to synthesise exactly the protein 
which is desired,23 to introduce functionalities, such as cysteines, at points in the protein 
where the activity is not affected and to introduce alternative functionalities to thiols and 
amines.  
Protein engineering has been used to create tailor made analogues of a wide range of 
proteins such as silk24, elastin25, and collagen 26, all based on artificial genes. Even block 
copolymers built up out of two different types of structural proteins such as silk and 
elastin have been successfully developed27,28. The absolute control over the genes that 
encode for the proteins readily allows the introduction of different functionalities which 
can be attached to synthetic polymers. Kopecek et al29-31 used this methodology to 
produce the peptide sequence (VSSLESK)n containing a histidine tag at the end. The 
hydrophobic interaction between the side groups of the valines and leucines in the 
sequence causes the protein to assume a helical or coil type structure. These hydrophobic 
interactions then cause several coils to further aggregate to form so called coiled coils. 
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This coiled coil aggregation can be disrupted by temperature, pH and solvent. A 
copolymer of poly[N-(2-hydroxy-propyl) methacrylamide-co-(N’,N”-
dicarboxymethylaminopropyl)methacrylamide], (p[HPMA-co-DAMA]) with 
iminotriactetate groups in the side chain was then synthesised using free radical 
polymerisation chemistry. The side groups of this copolymer formed non covalent Ni 
mediated complexes with the terminal histidine residues of the coiled coil protein. Via 
this approach a series of well defined, temperature responsive hydrogels for use in drug 
delivery applications were produced (Figure 1.3). 
  
 
 
Figure 1.3. Structural representation of the hybrid hydrogel of poly(HMPA-co-DAMA) 
connected to a His-tagged coiled coil via a Ni2+ complex.30 
 
Another approach was recently developed by Smeenk et al.32 A combination of 
protein engineering and polymer modification was used to create a series of silk based 
block copolymers. Spider silk consists of two major domains, a β-sheet crystalline 
domain, which gives strength to the protein, and a less well defined amorphous domain, 
which introduces elasticity and toughness. Smeenk and co-workers produced a β-sheet 
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forming protein using protein engineering and then coupled this to an amorphous 
synthetic polymer (poly ethylene glycol). The β-sheet elements folded in well-defined 
crystalline domains, which were separated by the presence of the amorphous synthetic 
polymers. Examination of this hybrid polymer coated on a surface, using atomic force 
microscopy (AFM), showed the presence of well defined fibres.  
There are several examples in which protein engineering has been used to 
introduce specific functionalities at different points in a protein via site directed 
mutagenesis, to facilitate the synthesis of peptide polymer hybrid materials. Stayton et 
al33 used protein engineering to create an N49C mutant streptavidin, in which the 
asparagine at position 49 was substituted for a cysteine. This mutant was then coupled via 
maleimide chemistry to poly-(N-isopropyl acryl amide) (pNiPAAM). pNiPAAM is 
known to undergo conformational changes upon heating or changing pH. By attaching 
pNiPAAM to streptavidin, Stayton and co workers were able to create a protein hybrid 
whose ligand binding efficiency could be controlled by temperature and pH.    
To increase the scope of protein engineering there is broad interest in 
incorporating unnatural amino acids into proteins.34 By including non natural amino acids 
changes can be made to the protein folding pattern and moieties which can facilitate post 
translational modification can be introduced. There are several ways to do this. One 
approach uses the possibility to overwrite stop (nonsense) codons with suppressor 
tRNAs. If these suppressor tRNAs are functionalised with unnatural amino acids, these 
artificial building blocks can then become incorporated site specifically into proteins.35 
This method has now been developed to a functional in vivo system, and recently Schultz 
et al. have shown this approach to be successful to modify a protein with a PEG chain via 
[2+3] Huisgen cycloaddition.36 
An alternative method has been developed by Tirrell et al37-39 and involves the 
substitution of a natural amino acid with a close structural analogue. This method uses 
bacterial auxotrophs, which are bacteria that have lost the ability to produce one of the 
natural amino acids. These bacteria are dependent on the medium for their supply of this 
amino acid, therefore if an analogue is added to the medium it can be incorporated 
instead. The introduction of azido and acetylene analogues of methionine has also led to 
the presence of bio-orthogonal functional handles that allow further modification of the 
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proteins. However, this methodology has not yet been extended to the incorporation of 
synthetic polymers. 
Protein engineering is an elegant method with which to create peptide-polymer 
hybrid materials. There are several advantages to using protein engineering, such as 
complete control over the desired sequence, molecular weight and polydispersity, and the 
possibility to synthesise large molecular weight polypeptides and proteins with no 
deletions or mistakes in the sequence. However, there are several drawbacks which limit 
the use of protein engineering as a technique for creating materials. Protein engineering is 
a complex and difficult technique to use, which often requires long periods of time to 
optimise the production of one peptide sequence, and for every different sequence which 
is required a new DNA construct has to be synthesised. It is also difficult to produce 
peptides using protein engineering on a large scale.  
In order to make peptide polymer conjugates more accessible there is widespread 
interest in making peptide polymer hybrids using synthetic techniques.12,40 Totally 
synthetic peptide-polymer hybrid materials can generally be divided into two groups, 
main chain polymers, in which the desired peptide is included in the main chain of the 
polymer, and side chain polymers, in which the peptide moiety is positioned in the side 
chain of the  polymer.  
 
1.4 Peptide based main chain polymers from premade synthetic polymers 
There are several synthetic methods available for the synthesis of polypeptides. A 
widespread method for the preparation of homo polypeptides is α-amino acid N-
carboxyanhydride (NCA) polymerisation. There are many examples of using NCA 
polymerisation to create peptide-polymer hybrid materials, one of the first reports is by 
Gallot and co workers. 41-44 A diblock copolymers of polystyrene or polybutadiene with 
poly(γ-benzyl-L-glutamate) and poly(ε-benzyloxycarbonyl-L-lysine) was prepared. These 
structures were made using an amine end functionalised polystyrene as a macro initiator 
for the NCA polymerisation of the desired amino acid. It was observed that these block 
copolymers formed lamellar structures in solution and in the dry state the peptide chains 
folded and arranged in a hexagonal array on a surface (Figure 1.4). It was later found that 
in the lamellar structure the peptides assumed an α-helical conformation.45  Klok and 
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coworkers have taken this work further and shown that smaller morphologies, in the 
range of nanometers can be obtained using diblock oligomers in place of block 
copolymers.46.  
 
 
 
Figure 1.4. Electron micrograph of the lamellar structure of a diblock copolymer 
composed of polybutadiene (Mn = 26.2 kDa) and poly(γ-benzyl-L-glutamate) (Mn=12.6 
kDa). Polybutadiene, dark stripes; polypeptide, white stripe.47 
 
Klok et al. also reported the synthesis of water soluble stimuli responsive vesicles 
from peptide based diblock copolymers. A block copolymer of polybutadiene and 
poly(glutamic acid) (PB-b-PGA) was prepared using an amine functionalized 
polybutadiene as a macro initiator for the polymerisation of the N-carboxy anhydride of 
glutamic acid. These block copolymers formed vesicles whose size could be controlled 
by altering the pH of the solution.48  
A similar PB-b-PGA block copolymer was prepared by Schlaad and co-workers49 
who found that depending on the relative block lengths of peptide to synthetic polymer, 
either spherical micelles (radius 16 nm) or large vesicular aggregates (radius 70-90 nm) 
were formed. 
Sogah and co workers.50,51 prepared polyalanine via NCA polymerisation, which 
was subsequently coupled, via a simple amide coupling, to a polyethylene glycol chain to 
create polyalanine containing multiblock copolymers. According to IR spectroscopy and 
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solid state 13C-NMR measurements the poly alanine blocks assembled into β-sheets, 
mimicking the secondary structure of silk (Figure 1.5).52   
 
Ala
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N x
5 n
x
O
X = 4 and 6 n = 13  
 
Figure 1.5. Generic structure of designed silk-inspired segmented multiblock copolymers 
in which the amorphous segments are replaced by flexible nonpeptide blocks51. 
 
An advantage of NCA polymerisation is that it is possible to synthesise reasonably 
high molecular weight poly amino acids. With the advent of Ni based living NCA 
polymerisations it is possible to have considerable control over the molecular weight and 
polydispersity,53,54 and the preparation of amino acid based block copolymers is made 
possible. This has been demonstrated by Deming and co workers55 who prepared block 
copolymers based on two different amino acids. They prepared well defined poly(γ-
benzyl-L-glutamate) using living NCA polymerisation, and then used the living ends to 
reinitiate the polymerisation of a second amino acid56 such as the NCA of Leucine, or 
racemic mixtures of L and D leucine. TEM and XRD studies showed interesting phase 
separation behaviour (Figure 1.6).  
From Structural Proteins to Synthetic Polymers 
 
 14
 
Figure 1.6. TEM bright field images of microtomed films cast in 
pentachloroethane.PBLG100 cut (a) parallel and (b) perpendicular to the film surface 
show isotropy of the bulk film. (c) PBLG80L20 and (d) PBLG75racL75 cut perpendicular 
to the film surface55 
 
The disadvantage to using NCA polymerisation is that there is virtually no control 
of the amino acid sequence. This technique has therefore shown its value for the 
construction of polypeptide based materials for which the primary amino acid sequence is 
not important for obtaining functionality or activity.53,56  
Another commonly used peptide preparation method is solid phase peptide 
chemistry.57,58 Kopecek and co workers59 used solid phase peptide chemistry to produce 
(VSSLESK)n, were n= 2,3,4 and 5, which was a similar sequence to the one they 
previously made using protein engineering. They then coupled this to a PEG chain via 
standard amide chemistry, and demonstrated that coiled coil association occurs. They 
showed that this coiled coil interaction was stabilized through conjugation with the PEG 
chain. Klok et al46,60 used a similar approach to produce a coiled coil peptide motif 
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(G(EAKLAEI)3Y) functionalized with a PEG chain. They demonstrated that the number 
of coiled coils within an aggregate decreased with increasing PEG chain length, due to 
steric interference by the PEG. Interestingly, the driving force behind the formation of 
these supramolecular aggregates is not hydrophobic interaction as with conventional 
phase separation in normal block copolymers, but is driven by the propensity of the 
peptide blocks to form well organised tertiary structures.     
Rosler used the same method to prepare β-strand peptide sequences based on 
lysine and leucine repeats. These peptides were coupled to poly ethylene glycol61 leading 
to architectures similar to those prepared by Sogah, however instead of preparing 
multiblock copolymers, triblock copolymers were produced. The secondary structure was 
investigated using infrared and X-ray scattering and confirmed that the peptide strands 
aggregated into β-sheets, leading to a well defined nanostructured material.   
Reynhout et al62 recently published a completely solid phase method for the 
synthesis of peptide based triblock copolymers. Amine functionalised polystyrene was 
first coupled to an aldehyde modified resin to give a styrene functionalised secondary 
amine, which could then be coupled to the first amino acid (Figure 1.7). Then the peptide 
sequence GANPNAAG, a known β-hairpin folding sequence was synthesised, using 
standard Fmoc peptide chemistry. After removing the final Fmoc group from the peptide, 
carboxylic acid functionalised polystyrene was coupled to the terminal amine. The 
aggregation behaviour of this amphiphilic block copolymer was investigated using 
electron microscopy, and spherical aggregates of around 250 nm in diameter were 
observed.  
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Figure 1.7. Totally solid phase approach to the synthesis of a peptide-polymer hybrid 
material.62 
 
The advantage of using solid phase synthesis to prepare the desired peptide is that 
it is possible to have complete control over the peptide sequence. The main disadvantage, 
however, is that there is a limit to the length of the peptide which can be made without 
introducing too many deletions.58,63 To overcome this limitation Kochendoerfer et al. 
have devised a novel approach. The Erythropoiesis protein, containing 166 residues, was 
produced by coupling shorter peptides via thioester-mediated native ligation. Before 
ligation some of the peptide building blocks were first conjugated to a PEG chain using 
oxime-forming ligation between an aminooxy group on the PEG chain and ketone 
bearing lysines in the peptide. It was demonstrated in-vitro that the biological activity of 
the protein improved due to the shielding effect of the PEG chains.  
 
1.5 Peptide based Main Chain Polymers via in situ polymerization  
Besides the possibility of coupling a premade polymer to the peptide moiety 
recent investigations have been directed towards synthesising the polymer directly from 
the peptide while on the resin, by using the peptide as an initiator. The development of 
Chapter 1 Introduction 
 
 17
new controlled/living polymerisation techniques has made this approach more feasible.64-
68 
 
1.5.1 Controlled/living polymerisations  
A living or controlled polymerisation is defined as a polymerisation in which no 
termination occurs. If the termination step of a polymerisation is removed the polymer 
will keep growing until there is no monomer left. If this is the case then the 
polymerisation should follow first order kinetics with respect to monomer conversion vs. 
time. Another useful feature is the fact that all the chains keep growing at the same rate. 
This means that the molecular weight of the polymer is determined by the monomer to 
initiator ratio, and that there is good control over the polydispersity.69   
Recently a series of new controlled/living polymerisation techniques have been 
developed. They are all based on free radical polymerisation and are therefore known as 
controlled radical polymerisations (CRP).69 The three most commonly used controlled 
radical polymerisation techniques are nitroxide mediated polymerisation (NMP, also 
known as stable free radical polymerisation, SFRP) reversible addition-fragmentation 
chain transfer polymerisation (RAFT), and atom transfer radical polymerisation (ATRP). 
Each technique follows the same basic principle, which is to reduce the amount of 
termination by reducing the concentration of radicals which are present during 
polymerisation. This is achieved by reversibly reacting the radical present at the end of 
the polymer chain with a radical trap, creating a dormant species which can be reactivated 
and continue polymerising.70 It is not possible to remove termination completely, 
therefore these polymerisations are actually pseudo living, and are normally referred to as 
controlled polymerisations.  
 
1.5.2 Nitroxide Mediated Polymerisation 
Nitroxide mediated polymerisation uses alkoxy amines as a reversible radical trap 
(Scheme 1.1).71,72 
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Scheme 1.1. The proposed mechanism of nitroxide mediated polymerisation. 
 
The advantage of NMP is that it can be performed in a wide variety of 
environments, and it is tolerant to a wide variety of functionalities. However, the draw 
back to using NMP is that initiators for NMP are cumbersome to synthesise, it is difficult 
to synthesise very low or very high molecular weights, 73,74 and the monomer range for 
NMP is slightly limited.70 
Becker et al65 functionalised a peptide, based on the protein transduction domain 
of the HIV protein TAT-1, with an NMP initiator while on the resin. This was then used 
to polymerise t-butyl acrylate, followed by methyl acrylate, to create a peptide 
functionalised block copolymer. In a second article the same approach was used to 
synthesise a peptidic polymer containing the peptide Tritrpticin, a 13 residue 
antimicrobial peptide.75 The polymerization of t-butyl acrylate was initiated, followed by 
styrene, which, after removal from the resin and hydrolysis of the t-butyl esters using 
TFA, resulted in a triblock copolymer which clearly formed micelles in solution. 
Interestingly the anti microbial activity of the peptide was enhanced relative to the free 
peptide and the detrimental side effects normally associated with antimicrobial peptides, 
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such as a high hemolytic activity, were reduced, highlighting the benefits of using peptide 
polymer hybrids in place of peptides alone.   
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Figure 1.8. The synthesis of a peptide polymer hybrid material from a tritrpticin loaded 
solid support via nitroxide mediated polymerisation75. 
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1.5.3 Atom transfer radical polymerisation 
ATRP is initiated by the homolytic cleavage of a carbon-halogen bond by a 
transition metal based catalyst. 69  As the polymerisation progresses the halogen atom 
transfers between the end of the growing polymer chain and the copper catalyst, leading 
to an equilibrium between growing polymer chains and halogen terminated dormant 
chains (Scheme 1.2).76 This equilibrium is shifted far to the right in favour of the dormant 
chains.  
 
I X Cn/L I XCn+1/L
Pn
Pn
Cn/L
XCtn+1/L
Initiation
Propagation
I
+ +
X
Chain equilibrium
Monomer M
Pn
+ M  
 
Scheme 1.2. Schematic representation of the mechanism for ATRP. 
 
Many different transition metals have been used as catalysts for ATRP, but the 
most widely used is copper.77 Normally in combination with the copper (I) species 
different amino based ligands are used, to improve the solubility and stability of the 
catalyst.78-80   
There is also a wide range of initiators for ATRP, but the most commonly used 
tend to be based on α-bromo esters. The addition of an α-bromo ester to the end of a 
molecule is a method which is commonly used to create a wide range of functional 
initiators.81 Rettig et al64 used this approach to develop a versatile method for the 
synthesis of a peptide-based main chain polymer. A peptide was prepared using solid 
phase synthesis techniques and then functionalised with an α-bromo amide. The peptide 
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was cleaved from the resin and used to initiate the polymerisation of n-butyl acrylate 
(nBA). The resulting polymers had narrow molecular weight distributions, with PDI of 
1.19, and that the architecture that was made was well defined.  
Mei et al67 used the same approach to produce a polymer containing the peptide 
sequence GRGDS. This time however the polymerisation was carried out on the solid 
support. The RGD peptide sequence is well known as an important cell adhesion 
sequence. This peptide-polymer hybrid material was then used as a support for the 
growth of mouse NIH-3T3 fibroblasts.  It was shown that the cells adhered better to the 
polymer containing the peptide than to the unfunctionalised control polymer. This 
highlights one of the many potential applications for protein-polymer hybrid materials.  
In a slightly different approach Deming et al66 used a combination of atom transfer 
and NCA polymerisation to produce the block copolymer poly[(methyl acrylate)-b-
poly(γ-benzyl-L-glutamate)]. An amine functionalised poly methyl acrylate was 
synthesised which could then be used to initiate the polymerisation of the N-
carboxyanhydride of benzyl glutamate.  
The disadvantage of ATRP is that it is not possible to polymerise in a controlled 
fashion some monomers. For instance acryl amides70 and some solvents lead to problems 
during polymerisation, for example it is possible to carry out ATRP in water, but the 
control over polymerisation is inadequate.82,83 The advantage of ATRP is its simplicity 
and the ease with which it can be used to create functional polymers.84-86  
 
1.6 Side chain polymers 
To increase binding or bioactivity it is useful to have multiple copies of a peptide 
in close proximity to each other. Including the peptide in the side chain of the polymer is 
one method which can be used to increase the number of peptide moieties per polymer 
chain.  
There are two ways which have been used to synthesise side chain polymers. The 
first is grafting, in which a polymer is synthesised with some form of functionality in the 
side chain, normally an activated ester moiety which can further react with a peptide. The 
most commonly used method for the polymerisation of monomers containing active 
esters is free radical polymerisation. Many activated acrylate esters in particular have 
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been polymerised in this manner87 (Table 1.1) for use in a wide variety of applications, 
from the preparation of polymer drug conjugates88,89 to supports for solid phase peptide 
synthesis.90,91 
Table 1.1. Activated acrylates (AOR represents CH2=CHCO-OR) reported for the 
synthesis of carboxyl-activated polymer intermediates. 
 
Monomer R 
AOBt 1-benzotriazole92 
AOSu N-Succinimide90,92 
AOPcp Pentachloro phenyl89 
AOTcp 2,4,5-Trichlorophenyl 90,92 
AONp 4-Nitrophenyl 
AOQu 8-Quinoline90 
AOPy 3-Pyridyl90 
AOCp 2-Carboxyphenyl90 
AOMcp 2-Methoxycarbonylphenyl90 
AOCl Chloride93 
 
However, although free radical polymerisations are simple to perform, they do not 
give good control over the polymer architecture being synthesised. Good control over the 
polymerisation is essential for both activity and to allow the synthesis of more complex 
architectures.    
To create better defined polymers for grafting peptides onto Godwin et al94 chose 
to use ATRP to polymerise N-hydroxy succinimide methyl acrylate. Glycine-glycine-β-
naphthylamide was coupled to the side chain of this polymer, creating a well defined 
peptide-polymer hybrid material in a straightforward manner. Later reversible addition-
fragmentation chain transfer (RAFT), was also used to polymerise monomers containing 
an activated ester moiety.95 Schilli and co workers not only polymerised N-hydroxy 
succinimide methyl acrylate but also a wider range of monomers, including 2-vinyl-4,4-
dimethyl-5-oxazolone (VO), diacetone acrylamide (DAA), N-isopropyl acrylamide 
(NIPAAm) and acrylic acid (AA). The conjugation of these polymers to model peptides 
was investigated. 
Theato et al96 also investigated the polymerisation of activated esters such as 
2,4,5-trichlorophenol acrylate and endo-N-hydroxy-5-norbornene-2,3-dicarboxyimide 
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acrylate using ATRP. By performing a coupling reaction with ammonia it was shown that 
the polymer side chains were still active. 
The major drawback to using this grafting approach is that it is not possible to 
achieve 100 % functionalisation, therefore there are always some unfunctionalised side 
chains on the polymer. To overcome this, another approach has been developed, in which 
the monomer already contains the peptide fragment of interest. Therefore, after 
polymerization every monomer unit is functionalised.97 The disadvantage of this method 
is that synthesising and polymerising peptide based monomers is not trivial, for reasons 
such as the occurrence of steric hindrance.   
A common method used to polymerise amino acid containing monomers is free 
radical polymerisation. Endo and co-workers synthesised several monomers based on 
leucyl-alanine and leucyl-alanylglycine moieties. Peptides were either directly 
functionalised with methacrylic acid to yield the methacryl amide derivative or peptides 
were coupled to hydroxy ethyl methacrylate (HEMA) to yield the methacrylate 
monomers with an ethyl spacer between the peptide and the polymerisation handle. The 
effect of these oligopeptide side chains on the free radical polymerisation of these 
monomers was investigated.98-100.  
Kopecek and co-workers101 also used free radical polymerisation chemistry to 
prepare polymer-drug conjugates as anti tumour agents. A copolymer of N-(2-
hydroxypropyl)-methacrylamide (HPMA), a biocompatible polymer, and a 
methacrylamide functionalised peptide, such as Gly-Phe-Leu-Gly, containing a p-
nitroaniline group on the carboxylic acid terminus was prepared. It was then possible to 
graft the anti cancer drug Doxorubicin onto the active ester of the peptide (Figure 1.9). 
The idea was to use enzymes present only at the tumour site for selective cleavage of this 
peptide linker, which resulted in targeted drug release. This is one of the first examples of 
a peptide-polymer hybrid material as a drug delivery agent. 
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Figure 1.9. Preparation of a polymer-drug conjugate from the copolymerisation of 
HPMA and a methacrylamide functionalised peptide based monomer.94 
 
Other techniques have also been used to polymerise peptide based monomers.  
Cornelissen et al102,103 prepared alanine based oligopeptides and introduced an isocyanide 
at the N-terminus. These were then polymerised using a Ni catalyst into β-helical poly 
isocyanopeptides with the dipeptides in the side chain. It was found that with alanines in 
the side chain the polymers formed rigid rods, which were revealed by AFM to have 
extremely long persistence lengths. This rigidity was caused by the formation of β-sheets 
by the alanines in the side chain. The self assembly behaviour of these block copolymers 
was investigated. It was found that the amphiphilic nature of these polymers causes them 
to aggregate into vesicles in mixtures of THF and water.104-106 
Gao and co-workers107 also prepared helical polymers by copolymerising 
acetylene functionalised D and L alanine with the achiral hexanoic acid N-
propargylamide and pivalic acid N-propargylamide (Figure 1.10), using a Ruthenium 
based catalytic cystem. They demonstrated that including as little as 12% of the chiral 
peptide based monomer in the polymer still resulted in a polymer with the same helix 
content as the peptide based homopolymer.    
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Figure 1.10. Acetylene functionalised peptides. Inclusion of only 12% of the chiral 
monomers L and D-1A into the polymerisation of achiral monomers 2 and 3 resulted in 
the same helix content as for the homopolymers of L and D-1A. 107 
 
The first example of the polymerisation of a peptide based monomer using a 
controlled polymerisation technique was published by Maynard and Grubbs.13 A series of 
norbornenes functionalised with cell adhesion proteins such as GRGDS was prepared and 
polymerised them using ROMP. The molecular weight distributions of the polymers 
produced were above 1.3, meaning that the polymerisation was not completely 
controlled. An investigation was performed into how the prepared polymers inhibited cell 
adhesion to fibronectin, a natural protein containing GRDGS, which can be taken as a 
measure of the binding affinity of the polymers to cells. By including the peptide 
sequence GRGDS in a polymer inhibition was increased when compared to the free 
peptide. It was proposed that the conjugation of the peptide to the polymer increased local 
concentration of peptide, therefore the number of peptide-cell interactions increased. This 
highlights the advantage of including the peptide in the side chain instead of the main 
chain of the polymer, as with the peptide in the side chain there is a higher concentration 
of peptide per polymer chain. Also by polymerising a functional monomer instead of 
using a grafting approach they were able to maximise the concentration of peptides on the 
polymer. 
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Figure 1.11. Synthesis of homo- and copolymers with pendent bioactive oligopeptides by 
ROMP.13 
 
This line of research was extended by including a second peptide PHSRN in a 
copolymer with GRGDS, with which they were able to increase the inhibition even 
further. PHSRN is a synergistic peptide which increases the binding potential of GRGDS 
in fibronectin. By conjugating both peptides to a polymer they are brought into close 
proximity, as is the case with fibronectin. Again this shows the advantage of using side 
chain polymers. It is possible to place two different peptides in the same polymer in 
higher concentrations than if they were simply included in the main chain. It also shows 
the advantage of using a peptide–polymer hybrid material instead of a natural protein.  
 
1.7 The aim of this thesis 
Although there are obvious advantages to producing peptide-polymer hybrids 
containing peptides in the side chain, there have been no examples of the polymerisation 
of peptide based monomers in a controlled way. This has inspired us to investigate if it is 
possible to polymerise a peptide based monomer with a higher level of control than was 
demonstrated by Maynard and co workers, and to use this improved control to prepare 
more complex architectures. To achieve this goal we have chosen to use ATRP. ATRP 
was chosen over RAFT and NMP as it is a robust technique, which is capable of 
polymerising a wide range of monomers, and can produce the widest range of end 
functional polymers. More importantly it is the most straightforward polymerisation 
methode to use as it is not necessary to synthesise any complex initiators or chain transfer 
agents.  
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This thesis describes the polymerisation of a variety of different peptide based 
monomers using ATRP. We chose to synthesise polymers based on peptides commonly 
found in structural proteins. As already mentioned, structural proteins often have unique 
properties, caused by the secondary architecture.1 This folding pattern can often be 
attributed to a simple repeating amino acid sequence. By including these simple peptides 
in the side chain of a polymer we have shown that it is possible to recreate some of the 
folding properties of structural proteins. Although ATRP has been used to polymerise a 
number of biologically interesting monomers this is the first time it has been used to 
polymerise peptide based monomers. 
In Chapter 2 the conditions necessary for the polymerisation of an amino acid 
based monomer using ATRP are investigated. These conditions were then used for the 
polymerisation of three monomers based on different parts of a β-hairpin. One of these 
monomers containing the sequence AGAG was applied in the synthesis of a synthetic silk 
mimetic, containing the peptides in the side chain of the polymer.108  
In Chapter 3 the preparation and polymerisation of an elastin based monomer, 
containing the sequence VPGVG, is described. An investigation into the secondary 
structure of the homopolymer revealed that the peptide moieties retain the characteristic 
transition from random coil to β-spiral found in linear oligomers of VPGVG.109 The 
inclusion of this elastin based polymer in an ABA type triblock copolymer with 
polyethylene glycol as the centre block, resulted in a synthetic polymer with a lower 
critical solution temperature (LCST).  
The physical parameters which affect the LSCT of the elastin based block triblock 
copolymer were studied and compared to linear polyVPGVG in Chapter 4. The 
aggregates that were formed above the LCST were probed using electron microscopy and 
light scattering techniques.     
In Chapter 5 a bifunctional peptide based initiator was synthesised. This was used 
to initiate the ATRP of MMA in order to create a triblock copolymers. Investigations 
with light scattering and electron microscopy revealed that this amphiphilic triblock 
copolymer formed vesicles, or polymersomes, in solution.  
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The preparation and polymerisation of two monomers based on two antimicrobial 
peptides, gramicidin S and KFFKFFKFFK is described in Chapter 6. This demonstrates 
the versatility of using ATRP to polymerise peptide based monomers. 
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2.1 Introduction 
Silks are an important class of naturally occurring structural proteins.1,2 There are 
many different types of silk, with many combinations of mechanical properties.3 One of 
the most extensively studied is dragline spider silk,4 which is considered to be nature’s 
high performance fibre, because of its remarkable combination of strength and toughness, 
which is comparable to high tenacity nylon and steel.5 Silk fibres attain their unique 
properties via the characteristic folding pattern of the protein.6-8 This secondary structure 
consists of two major parts, crystalline β-sheet domains which are interspersed 
throughout a less well defined glycine-rich helical part.9 There are also some indications 
of the presence of a third, weakly orientated domain (Figure 2.1).10  
 
 
Figure 2.1. Schematic representation of the secondary structure of silk. The arrows 
represent β-sheet forming sequences and the lines represent the less well defined glycine 
rich areas. 
 
The remarkable properties of this material make it of interest for a wide range of 
possible applications from bullet proof vests to tissue engineering,11,12 and drug 
delivery.13 This has inspired many research laboratories to investigate methods for either 
reproducing the silk protein using protein engineering or to incorporate elements of the 
silk peptide sequence into synthetic polymers. Using protein engineering, the major parts 
of silk proteins have been reproduced in a variety of ways, from expression in tobacco 
plants, potatoes,14 to mammalian cells.15  A major difficulty of this method is that in order 
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to introduce the correct mechanical properties the silk protein has to be spun into a fibre 
containing the appropriate secondary structure.16 A recently developed aqueous spinning 
process has shown this approach to be promising.17 A second line of research has been 
focused on reproducing the most prominent structural elements of silk, namely the β-
sheet folding pattern, using protein engineering.18 Recently within our group, this 
approach has been extended by modifying the β-sheet containing element with an 
amorphous PEG chain on both the N and the C termini. The resulting hybrid triblock 
copolymer contained elements of both the crystalline and the amorphous domains found 
in silk, and was shown to form well defined fibres.19  
A similar, totally synthetic procedure has been developed by Rathore and Sogah. 
They synthesised a tetra peptide, alanine-glycine-alanine-glycine, using solid phase 
peptide chemistry,18 and  two peptides containing either 4 or 6 repeats of alanine, made 
by oligomerising the N-carboxy anhydride of alanine.19 These specific sequences were 
chosen as they are  known β-sheet forming sequences commonly found in silk worm 
silk12 and dragline spider silk respectivly.10 These β-sheet forming peptides were then 
coupled to poly ethylene glycol (PEG) to form block copolymers with the β-sheets 
located in the main chain of the polymer. The ability to recreate the secondary structure 
of spider silk by coupling these crystalline β-sheet forming peptides with a less well 
defined, amorphous matrix, was demonstrated by the fact that the peptide sequences 
clearly formed crystalline domains within the PEG matrix.  
This chapter outlines the work that has been performed towards the development 
of an alternative, versatile method for the construction of well-defined polymer 
architectures that mimic the secondary β-sheet structure found in silk. Our aim was to use 
a similar approach to that of Sogah and co workers by synthesising a block copolymer 
containing a central block based on β-sheet forming peptides and two outer blocks 
consisting of an amorphous synthetic polymer. Our approach differs markedly from that 
of Sogah, however in that we intend to introduce the peptide sequences into the side 
chain of the polymer (Figure 2.2). With the approach used by Sogah the final product has 
to assemble intermolecularly in order to assume a β-sheet structure. The introduction of 
the peptides into the side chain of the block copolymer has the advantage that we can 
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obtain a higher level of control over the β-sheet domain, and assembly of the β-strands 
into a β-sheet is facilitated by the closer proximity of the strands. 
 
 
 
Figure 2.2. Schematic representation of the approach chosen to synthesise a polymer 
which mimics the secondary structure of spider silk. An ABA triblock copolymer is 
depicted in which β-sheet forming peptides are included in the side chain of the central B 
block and the two outer blocks consist of a non-crystalline polymer. R = β-sheet forming 
peptide 
 
To achieve this we haven chosen to synthesise a series of monomers based on 
peptide sequences representing parts of a β-hairpin, and to synthesise the desired triblock 
copolymer architecture using these monomers. For the polymerisation of these monomers 
we have chosen to use atom transfer radical polymerisation, ATRP, as a robust and easy 
to use polymerisation technique which gives a high level of control over the 
polymerisation process. 
 
2.2 Results and discussion.  
 The approach that was used for the construction of β-sheet containing ABA 
triblock copolymers using ATRP can be divided into four stages. First conditions for the 
controlled polymerisation of peptide based monomers by ATRP had to be developed 
because, to our knowledge, this had never been done before. Secondly a series of 
monomers containing a short β-sheet forming peptide sequence in the side chain had to 
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be synthesised. The third step was to polymerise these β-sheet based monomers using a 
bifunctional initiator. The resulting polymer could then be used to macro initiate a second 
monomer to give the desired ABA type block copolymer, with a crystalline β-sheet block 
in the middle and two amorphous A blocks on the outside. Finally the synthesised block 
copolymers were investigated to determine if any β-sheet character was present.   
 
2.2.1 Glutamic acid based monomers 
 To investigate the optimal conditions for ATRP of peptide-based monomers, we 
decided to explore the polymerization of a single amino acid. For this purpose a glutamic 
acid-based monomer, 1, was conveniently synthesized, using DCC to couple the free 
carboxylic acid of the glutamic acid with hydroxyl ethyl methacrylate (Scheme 2.1).  
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1  
 
Scheme 2.1. Synthesis of methacrylate-functionalized glutamic acid 1. 
 
Polymerisations were performed using CuCl/Bipy as a catalytic system, and the 
standard ATRP initiator, ethyl 2-bromo isobutyrate (EBIB) was used. The 
polymerisations were carried out in DMSO-d6, which is an unusual solvent for ATRP.20 
The reason for choosing DMSO as a solvent was to make sure the peptide monomer as 
well as the resulting polymer remained completely soluble during the polymerisation 
process. Due to the specific nature of the peptides chosen hydrogen bonding and β-sheet 
formation could be expected, therefore a polar hydrogen bond breaking solvent was 
required. ATRP has been performed in water, although control over polymerisation was 
limited.21DMF was discarded as a solvent as there is a possibility of forming aminyl 
radicals during the polymerisation. The best option therefore was DMSO, which was 
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already shown to be compatible with ATRP.20 Another benefit is that by using deuterated 
DMSO we could follow the polymerisation with NMR.  
 
 shows the polymerization results for monomer 1. In Figure 2.3 the semi 
logarithmic plots of monomer concentration versus time for the polymerizations of 1 are 
depicted. The plot shows that at 40°C the polymerisation proceeds in a controlled 
fashion. When we increased the temperature to 60°C the speed of polymerisation 
increased, however the start of the polymerisation appears to be les well controlled than 
at 40ºC. The gel permeation chromatography (GPC) results for polymers A and B (Table 
2.1), however, show narrow molecular weight distributions for both polymers.   
 
Table 2.1. Polymerization results for monomer 1. a)PDI and Mn are determined using size 
exclusion chromatography. 
 
Polymer Initiator Temp °C 
Time
/min [M]0/[I]0 
Conversion 
% 
Mn 
kg/mola 
Mn,th kg/ 
mol 
PDI 
(GPC)a 
A EBIB 40 120 20:1 60 8.7 7.5 1.11 
B EBIB 60 120 20:1 90 7.7 11.2 1.09 
 
 
 
 
Figure 2.3. Linear plot of ln[M]0/[M]n vs. time for the polymerization of 1 with EBIB 
initiator. Polymerization was performed at 40 and 60°C. 
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From this successful polymerisation of monomer 1, we have clearly shown that it 
is possible to polymerise an amino acid containing monomer in a controlled fashion via 
ATRP. We have established a set of conditions which are suitable for the polymerisation 
of amino acid based polymers, showing that by using slightly lower temperature we can 
obtain better control over the polymerisation, especially in polar solvents which are 
known to increase the rate of ATRP.22,23  
 
2.2.2 Synthesis of monomers based on β-sheet forming peptide sequences 
Having shown it to be possible to polymerise a single amino acid we decided to 
synthesise three longer monomers based on three different elements of a β-sheet (Figure 
2.4): A β-turn, a β-strand and an entire β-hairpin. 
 
 
 
Figure 2.4. The peptide sequences that were chosen to include in the side chain of the 
polymer were based on three different parts of a β-sheet: The turn, the β-strand and an 
entire hairpin 
 
The first sequence Glu-Gly-Ala-Gly-OH, was based on amino acids commonly 
found at the turn of a β-sheet.18 This peptide was synthesised using standard solid phase 
peptide chemistry (Scheme 2.2). After the peptide was removed from the resin the free 
carboxylic acid was functionalised with hydroxyl ethyl methacrylate (HEMA) via a DCC 
mediated coupling to give monomer 2. HEMA was chosen as a functional handle as the 
addition of the ethyl spacer would allow the peptide more flexibility in the side chain. 
β-hairpin 
β-strand 
β-turn 
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The protecting group on the N terminus of the peptide was retained to ensure that there 
was no interference by the amine group during polymerisation. 
  
Fmoc Glu Ala Gly Ala
OBzla
Fmoc Glu Ala Gly Ala
OBzl
OH
b
Fmoc Glu Ala Gly Ala
OBzl
O O
O2
H2N
c
 
 
Scheme 2.2. Synthesis of Fmoc-Glu(OBzl)-Gly-Ala-Gly-ethylmethacrylate, a) 4 cycles of 
solid phase peptide chemistry, i) Fmoc amino acid, HOBt, DiPCDI, DMF ii) Piperidine, 
DMF (except after the last Glu)  b)TFA 95%, water 5%, c) DCC, DMAP, HOBt, DMF, 
HEMA, 49%. 
 
The second peptide sequence which was chosen was based on the strand element 
of a β-sheet, Boc-Ala-Gly-Ala-Gly –OH. This peptide was relatively straightforward to 
make using conventional solution peptide chemistry as the dipeptide Ala-Gly could be 
made in a single step, divided into two parts, and then each part could be deprotected at 
either the N or the C terminus. The two dipeptides could then be coupled together to form 
the tetra peptide (Scheme 2.3). By using solution phase peptide chemistry we were able to 
synthesise larger quantities than normally possible using solid phase peptide chemistry. 
After the peptide was synthesised the carboxylic acid end was deprotected and 
functionalised using HEMA to give monomer 3.  
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Scheme 2.3. Synthesis of Boc-Ala-Gly-Ala-Gly-ethylmethacrylate, a) DCC, HOBt, DCM, 
98% b) 4M NaOH, MeOH, dioxane, 86%  c) EtOAc/2M HCl, quantitative d) DCC, 
HOBt, DCM, 56% e) 4M NaOH, MeOH, dioxane, quantitative f) DCC, DMAP, HOBt, 
DMF, HEMA, 40%. 
 
The third peptide sequence was based on an entire β-hairpin. The sequence 
AGAGKGAGAG was synthesised on the resin in the same way as the first EAG peptide. 
This time the final Fmoc group was removed from the peptide and replaced with an 
acetyl group. For this sequence a different method was used to introduce a functional 
handle. After cleavage from the resin the monomer handle was added to the lysine side 
chain using 2-isocyanatoethyl-methacrylate (Scheme 2.4). It was decided to introduce the 
functional handle at this position to allow the peptide as much flexibility as possible to 
form a β-sheet without interference from the polymer backbone.  
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Scheme 2.4. Synthesis of monomer 5, Ac-AGAGK(EMA)GAGAG-OH  a) 10 cycles of 
solid phase peptide chemistry i) Fmoc amino acid, HOBt, DiPCDI, DMF ii) piperidine 
DMF b) TFA: H2O 95:5  c) H2O, NaHCO3, 2-isocyanatoethyl-methacrylate, 32% yield. 
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2.2.3 Polymerisation of peptide based monomers  
Monomer 2 was polymerised at 60°C in DMSO-d6 with CuCl/Bipy as a catalyst 
and ethyl bromo isobutyrate (EBIB) as an initiator. During polymerisation the conversion 
was followed using 1H-NMR spectroscopy, and it was noticed that the peaks at 7.1-8.2 
ppm due to the amide and Fmoc groups were becoming broader, and that the conversion 
did not appear to be first order. It was thought that the Fmoc group was cleaved from the 
peptide under the polymerisation conditions used. This was confirmed by placing Fmoc 
Alanine into DMSO-d6 along with CuCl and Bipy and heating it to 60°C. Using NMR we 
could clearly see loss of the Fmoc group over time. It is possible that bipy in DMSO is a 
strong enough base to cleave the Fmoc from the peptide. Therefore when further peptide 
based monomers were prepared using solid phase peptide chemistry the Fmoc group was 
removed and replaced by an acetyl protecting group.  
 The polymerization of monomer 3 was again carried out in DMSO-d6 at 40ºC for 
75 minutes after which a conversion of 81% was reached. This time bifunctional initiator 
1,4-(2’-bromo-2’-methylpropionato)benzene (4) was used (Scheme 2.5) to prepare a 
telechelic polymer which could be used for the subsequent macro initiation of a second 
monomer, to obtain the desired ABA type block copolymers. This initiator is a standard 
bifunctional ATRP initiator which could be readily synthesised using literature 
procedures (Scheme 2.5).24   
 
HO OH Cl
O
Br
2
a O O
O
Br
O
Br
4  
Scheme 2.5. Synthesis of bifunctional initiator 1,4-(2’-bromo-2’-
methylpropionato)benzene a) THF, Et3N, 0 ºC, 67%. 
 
The plot of ln conversion vs. time (Figure 2.5) showed that the kinetics of this 
polymerisation were clearly first order, indicating a living polymerisation. This was 
further confirmed by the GPC data (Figure 2.6) which showed a PDI of 1.12. From this 
we can conclude that the ATRP of monomer 3 proceeded without much difficulty. 
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Figure 2.5. Plot of ln conversion against time for the polymerisation of monomer 3. 
Polymerised using bifunctional initiator 4 in DMSO-d6 at 40 ºC for 75 minutes, 81% 
conversion was observed. 
 
 
Figure 2.6. GPC trace for the polymerisation of monomer 3.The Mn was 6.5 kg/mol and 
the poly dispersity was 1.12, against polystyrene standards. Arrow represents increasing 
time, decreasing molecular weight. 
 
Finally we tried to polymerise monomer 5. The polymerisation was attempted in 
DMSO-d6 with EBIB as an initiator, using a variety of different conditions. However, the 
polymerisation continuously failed, either reaching no conversion or reaching 20-30% 
conversion before terminating (Table 2.2). In all cases no first order kinetics could be 
observed. 
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Table 2.2. Different conditions used for the polymerisation of monomer 5, with EBIB as 
an initiator and PMDETA as ligand (in a 1:1 ratio with copper catalyst). a)Copper 
Chloride and PMDETA premixed before addition to the monomer and initiator solution. 
b)Temperature was raised from 50 to 90°C after 4 hours as no conversion had been 
observed. 
 
Experiment Catalyst Temp (°C) 
Conc. 
(M) 
Time 
(h) 
Conversion 
(%) Controlled
1 CuCl 40 0.0625 46.5 26 No 
2 CuCl 50 0.0625 4 22 No 
3 CuCl 50 0.125 19 19 No 
4 CuCl 60 0.125 22 15 No 
5 CuCl 60 0.089 15 23 No 
6 CuBr 50 0.0625 141 30 No 
7 CuCl 90 0.125 2 1 No 
8 CuCla 50-90b 0.125 22 4 No 
 
The reason that this polymerisation did not proceed is not totally clear, but it was 
noted that before polymerisation the solution in the vessel was green instead of the 
expected blue. Initially this was ascribed to a small amount of air, left in or introduced 
into the schlenk vessel during the polymerisation, oxidising the copper catalyst. However, 
the polymerisation was repeated and the same phenomenon was observed. The same set 
up was furthermore used to successfully polymerise monomer 3. Another possibility is 
that there was some impurity left in the monomer which was oxidising the copper 
catalyst. However, the peptide was synthesised on the resin, and therefore most impurities 
should have been removed during the thorough washing procedures. After 
functionalisation the monomer was further purified by extraction to remove any final 
impurities.  
Another possible explanation could be that the hairpin monomer itself formed a 
complex with the copper catalyst, hindering the polymerisation process. This was thought 
unlikely as the ligand used, PMDETA, is known as a strongly binding ligand for 
copper.25 To investigate this possibility the copper catalyst was premixed with the ligand 
before addition to the monomer solution, however the polymerisation still did not work, 
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and the solution still turned green. A definite explanation for the failure of this 
polymerisation therefore cannot be given. It could of course be that there are limitations 
to the peptide sequences which can be polymerised.  
 
2.2.4 Synthesis of a peptide based ABA triblock copolymer 
- Macro initiation after work up 
 Of the three monomers which were synthesised, we showed it was possible to 
polymerise monomer 3, which was based on the sequence AGAG. We therefore decided 
to continue using this monomer to construct the desired ABA type block copolymer. Our 
aim was to reinitiate the polymerization of the second monomer, MMA, from the halogen 
moieties that should be present at both chain ends of the telechelic poly(Boc Ala-Gly-
Ala-Gly-ethyl methacrylate), 7 (Scheme 2.7). We chose to use pMMA as the amorphous 
block of our polymer to keep the back bone of the block copolymer consistent, which 
would facilitate macro initiation. Although pMMA has a higher Tg than can be expected 
from the silk matrix material, it was preferred over other polymers with lower Tg’s, such 
as polymethyl acrylate (pMA), or polymers with a higher degree of biocompatibility for 
this reason. 
In first instance the peptide-based polymer was worked up after polymerization by 
precipitating the polymer in a solution of EDTA in water, followed by washing with 
dichloromethane. The purified polymer was then used as macro initiator for ATRP of 
MMA. This process was again carried out in DMSO-d6 to ensure solubility of the macro 
initiator and the resulting block copolymer. To obtain the optimal conditions for macro 
initiation several experiments were performed, in which ligand, catalyst/initiator ratio and 
temperature were varied (Table 2.3) 
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Scheme 2.6. Schematic representation of the macroinitition of methyl methacrylate form a 
telechelic peptide based polymer. R = Peptide, eg Ala-Gly-Ala-Gly.  
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Table 2.3. Different polymerization conditions used for the macro initiation of MMA from 
poly Boc-Ala-Gly-Ala-Gly-ethylmethacrylate, (7). Bipy and PMDETA were both used as 
ligands in a 2:1 and 1:1 ratio with copper chloride respectively. 
 
Ligand Conv. (%) Time(h) 
Temp 
(°C) 
Conc. 
(M) I:Cu 
Mn 
(kg/mol)
Mn,th 
(kg/mol) PDI 1
st Order
bipy 56 4 50 0.5 1:8 11.9 13 1.29 no 
bipy 57 4 60 0.5 1:8 11.1 13 1.29 no 
bipy 64 2 70 0.5 1:8 11.5 13 1.26 no 
bipy 3 4 60 0.25 1:8 NA 10 NA no 
bipy 64 6 60 0.5 1:4 13.0 13 1.07 no 
bipy 16 24 60 0.5 1:8 NA 10 NA no 
PMDETA 50 4 50 0.5 1:8 N/A 11 N/A no 
PMDETA 77 23 60 0.5 1:4 7.0 13 1.3 no 
PMDETA 51 2.5 70 0.5 1:4 N/A 13 1.3 no 
PMDETA 73 15 80 0.5 1:8 Bimodal 13 bimodal yes 
 
Although in some cases livingness was observed, based on the kinetics of 
polymerization and GPC results, it is clear that the reproducibility of the reinitiating 
experiments was rather poor. The increase in polydispersity observed in many 
experiments, and in one case even the occurrence of a bimodal distribution, indicates that 
the polymerization does not initiate properly. As the ATRP of the peptide-based block 
was performed in a well controlled manner, it was thought that the loss of control during 
the second polymerization was due to partial removal of the halide end groups during the 
aqueous work up procedure. To test this hypothesis, the macro initiation was therefore 
performed in situ. 
  
- In situ macro initiation 
For the in situ macro initiation Boc-Ala-Gly-Ala-Gly-ethylmethacrylate, 3, was 
polymerized as before at 40ºC, using initiator 4 in DMSO-d6 with CuCl/Bipy as a 
catalyst. This time after 2 hours, when the polymerization had reached 71% conversion, 
an MMA solution in DMSO-d6 was added. This second polymerization reached 56% 
conversion after 3 hours. From the plots of ln conversion vs. time (Figure 2.7 and Figure 
2.8) it was observed that both polymerizations were living. The GPC data (Figure 2.8) 
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showed that the PDI was low and a mono-modal distribution was obtained for the tri 
block copolymer, indicating that both parts of the polymerization were controlled and that 
the in-situ macro initiation was successful. There is some discrepancy between the 
predicted Mn and the Mn observed with GPC. This is ascribed to the difference in 
hydrodynamic volume between our polymers and the polystyrene samples used to 
calibrate the GPC. However it is still clear that the polymerisation is controlled, which 
confirms the idea that the loss of control during the first macro initiation procedure is a 
result of the work up procedure. 
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Figure 2.7. Plot of ln conversion vs. time for the polymerization of monomer 3. This is 
the first part of the in-situ macro initiation of MMA from poly(Boc-Ala-Gly-Ala-Gly-
ethylmethacrylate). 
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Figure 2.8. Plot of ln conversion vs. time for the polymerization of MMA. This is the 
second part of the in-situ macro initiation of MMA from poly(Boc-Ala-Gly-Ala-Gly-
ethylmethacrylate). 
 
Table 2.4. Experimental data for the polymerization of Boc-Ala-Gly-Ala-Gly-
ethylmethacrylate (3) and the in situ macro initiation of MMA from poly(Boc-Ala-Gly-
Ala-Gly-ethylmethacrylate). Polymerization was performed at 40ºC. 
 
Monomer Time Conversion
Mn,th 
kg/mol
Mn 
kg/mol PDI 
3 2 hrs 71 % 7.3 4.6 1.17 
MMA 3 hrs 56 % 12.9 6.1 1.19 
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Figure 2.9. GPC trace for the in situ macro initiation of MMA from poly(Boc-Ala-Gly-
Ala-Gly-ethylmethacrylate)  A) the polymerization of monomer 3 B) the polymerization of 
MMA. Arrow represents increasing time, decreasing molecular weight. 
 
Using an in situ macro initiation procedure to build up our block copolymer has 
advantages and disadvantages. The main disadvantage is that it is not possible to reach 
100% conversion while maintaining a living ATRP polymerization, meaning that there 
will be some monomer 3 left after the addition of the second monomer MMA. This could 
result in some incorporation of monomer 3 into the A block of our desired block 
copolymer, which is was not possible to determine using either GPC or NMR. This 
however was expected not to have a pronounced influence on any β-sheet structure 
present in the final polymer. The main advantage is that there is no work up procedure, 
and therefore the loss of end groups and formation of dead chains can be minimized.  
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2.2.5 Secondary structure analysis of β-sheet containing triblock copolymer, 9 
In order to investigate whether the introduction of AGAG peptides leads to the 
formation of β-sheet elements in the triblock copolymer, secondary structure analysis had 
to be performed. One technique which is simple, reliable and not influenced by the 
presence of the polymer backbone is IR spectroscopy, which was used for the analysis of 
the prepared triblock copolymers. Other techniques such as CD spectroscopy, electron 
microscopy and AFM were also used. Unfortunately, CD spectroscopy was hampered 
because the polymers were not completely water soluble and gave scattering problems 
when measured in a film. AFM did show some non regular structures but nothing which 
indicated long range ordering.  
The different Ala-Gly-Ala-Gly containing structures were therefore characterized 
using FT-IR (ATR) (Figure 2.10) and the amide I and amide II values were compared to 
values reported in literature for β-sheet structures.26,27 First both the monomer and Boc 
protected polymer were analyzed. Both of these showed no indication of β-sheet 
formation, instead the amide I and amide II values were indicative of a random coil 
structure (Table 2.5). A possible explanation for the absence of β-sheet formation within 
the polymer could be the presence of the bulky Boc protective group at the N terminus of 
the tetra peptide moieties. This was therefore investigated by cleavage of this protective 
moiety. After removal of the Boc group by treatment with trifluoro acetic acid (TFA) a 
sharp shift in the amide I and amide II signals was observed, which were now indicative 
of an antiparallel β-sheet conformation. The suggestion that β-sheet formation was 
sterically hindered in case of the protected triblock copolymer was furthermore 
substantiated by the observation that when TFA was still present in the block copolymer 
as counter ion for the free amine groups β-sheet structures were also disrupted. Only after 
a thorough washing procedure was β-sheet folding observed.  
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Figure 2.10. IR spectra of the Amide I and amide II region for polyMMA-b- polyAla-Gly-
Ala-Gly-ethylmethacrylate-b-polyMMA. 
 
 
Table 2.5. IR values obtained for monomer 3 and the respective block copolymers before 
and after removal of the Boc protecting group and TFA salts. a) Standard IR values for 
the Amide I and II bands.26,27 
 
 
Compound Amide I/cm-1 Amide II/cm-1 
Random coila 1656 1535 
Antiparallel β-sheeta 1632(s)/1685(w) 1530 
BocAGAG-EMA (monomer) 1655 1526 
pMMA-b-pBocAGAG-EMA-b-pMMA 1662 1534 
pMMA-b-pAGAGMA-EMA.TFA-b-pMMA 1670 1545 
pMMA-b-pAGAGMA-EMA-b-pMMA 1624(s)/1683 1537 
 
 
2.3 Conclusion 
In this chapter we have successfully demonstrated for the first time that it is 
possible to introduce peptides into a synthetic polymer using ATRP. Three different 
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monomers were prepared based on three different elements of the β-sheet folding pattern. 
Although it was not possible to polymerise two of the monomers, due to interference of 
the protecting group for the turn based monomer and a still unexplained catalyst 
deactivation during the ATRP of the hairpin based monomer, we have gained a clear 
understanding of how to introduce a peptide sequence into the side chain of a polymer 
using ATRP.  
A method has also been established that allows construction of complex peptide 
containing architectures using a bifunctional ATRP initiator and in situ macro initiation.  
We have used this method to construct a polymer with a silk like secondary structure. 
This triblock copolymer contains a central crystalline block, based on β-sheet forming 
peptides, incorporated between two amorphous pMMA blocks. The β-sheet nature of the 
peptide based centre block has been confirmed using IR spectroscopy.   
 
2.4 Experimental 
 
2.4.1 General procedures 
1H and 13C-NMR spectra were measured on a 400 MHz Bruker Inova400 machine 
with a Varian probe.  
IR spectra were measured on an ATI Mattson Genesis Series FTIR.  
MALDI-TOF-MS spectra were measured on a Bruker Biflex III machine, with 
dihydroxybenzoic acid (DHB) as matrix. The samples were prepared by dissolving 2 mg 
of analyte in 1 mL THF, after which this solution was mixed in a 1:1 ratio with a solution 
of 10 mg DHB in 1mL H2O, containing 0.1% trifluoro acetic acid. This was then placed 
on a MALDI plate. 
GPC measurements were performed using a Shimadzu GPC with Shimadzu RI 
and UV/Vis detection, fitted with a Polymer Laboratories Plgel 5 µm mixed-D column, 
and a PL 5 µm Guard column (separation range from 500 to 300,000 molecular weight) 
using THF as mobile phase at 35°C. Polymer Laboratories polystyrene calibration kits 
were used. 
 
2.4.2 Reagents 
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CuCl (Aldrich, 97 %) was purified by washing with glacial acetic acid 3 times and 
once with diethyl ether.28 p-Alkoxybenzyl alcohol “Wang” resin (Bachem, 1.14mmol/g), 
9-fluorenylmethoxy carbamate protected Glycine (Fmoc Val-OH) (Bachem > 99%), 
Fmoc Glutamic acid (Fmoc Glu(OBzl)-OH) (Bachem > 99%) and Fmoc Alanine (Fmoc 
Pro-OH) (Bachem > 99%), Boc-Alanine-OH (Fluka 99%), HCl.NH2-Glycine-OEt (Fluka 
99%), Boc Glutamic acid(OtBu)-OH (Bachem, 99%), methyl methacrylate (Aldrich 
99%), methyl acrylate (Aldrich, 99%) hydroxyl ethyl methacrylate (HEMA Aldrich 97 
%), 2-bromo-isobutyric acid, (Aldrich 98%), 2-isocyanatoethyl-methacrylate (Aldrich 
98%), 2,2´-bipiridyl (Bipy) (Aldrich 99%), pentamethyl diethyl triamine (PMDETA) 
(Aldrich 98%), N, N-dicyclohexylcarbodiimide (DCC) (Fluka 99 %), N-
diisopropylcarbodiimide (DIPCDI) (Fluka≥ 98%), 4-dimethylaminopyridine (DMAP) 
(Across 99%), DMSO-d6  (Aldrich 99.9 %), N,N´-diisopropylethylamine (DIPEA) (Fluka 
99%), 1-hydroxybenzotriazole hydrate (HOBt) (Fluka ≥ 98%), trifluoro acetic acid (TFA)  
(Aldrich 98%), Potassium hydrogen sulfate (KHSO4) (Riedel-de Haën 99%), Sodium 
hydrogen carbonate (NaHCO3) (Merck 99.5%)  sodium sulfate anhydrous (Fluka 99%) 
and ethylene diamine tetra acetic acid tetra sodium salt hydrate (EDTA, Aldrich 98 %) 
were all used as received.  
Dichloromethane (DCM) and ethyl acetate (EtOAc) were distilled from calcium 
hydride, THF was distilled from sodium/benzophenone prior to use. Dimethylformamide 
(DMF) and isopropyl alcohol were used as received (J.T.Baker) 
 
2.4.3 Synthesis of Boc-Glu(OtBu)-ethyl methacrylate (1) 
Boc-Glu-(OtBu)-OH (1.52 g, 5 mmol) was dissolved in 30 mL EtOAc and 650 mg 
(5 mmol) hydroxy-ethyl-methacrylate (HEMA) was added. While stirring vigorously, 60 
mg (0.5 mmol) DMAP and 1.03g (5 mmol) DCC were added in quick succession; a white 
precipitate was formed. The reaction mixture was stirred for 24 h at room temperature. 
Dicyclohexylurea (DCU) was filtered off and weighed to determine if the reaction was 
complete. After evaporation of the solvent the crude product was obtained, which was 
purified by column chromatography using silica and 1% MeOH/CHCl3 as mobile phase. 
Glu-EMA was obtained in 73% yield.  
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1H-NMR (SO(CD3)2): δ 1.4 (C(CH3)3, 18H, s); 1.7 (NHCH(CH2CH2R)COOR, 2H, m); 
1.9 (C═CCH3, 3H, s); 2.2 (NHCH(CH2CH2R)COOR, 2H, t); 3.8-4.3 (NHCHRCOOR, 
O(CH2)2O, 5H);  5,7 and 6.0 (C=CH2, 2H, s);  7.2 (NH, 1H, d).  
13C-NMR (SO(CD3)2): δ 17.73, 26.00, 27.53, 27.95, 30.98, 52.54, 62.31, 66.31, 78.02, 
79.47, 125.75, 135.52, 155.34, 166.16, 171.21, 172.03.   
MALDI-TOF-MS: m/e 437 (M+-H +Na); 438 (M+ + Na).  
Anal. Calc. for C20H33NO8: C, 57.82, H, 8.01, N, 3.37.  
Found: C, 58.33, H, 8.15, N, 3.65  
 
2.4.4 Polymerisation of Boc-Glu(OtBu)-ethyl methacrylate 
ATRP of the Glu-EMA monomer 1 was carried out in solution using ethyl-bromo-
isobutyrate (EBIB) as initiator. Glu-EMA (1), (831 mg, 2 mmol), 10.1 mg (0.1 mmol) 
CuCl and 32.4 mg (0.2 mmol) Bipy were weighed into a schlenk vessel. The vessel was 
evacuated and filled with N2. This procedure was repeated three times. DMSO-d6 (0.54 
mL) was added to dissolve the reactants and then purged with N2. The mixture was 
heated to 40 °C and 1.46 mL (0.07 mmol EBIB) initiator stock solution (containing 10 
mg/mL EBIB in DMSO-d6) was added. During the reaction samples were taken and 
conversion was determined by 1H NMR spectroscopy (comparing the amide resonance at 
7.2 ppm with the vinyl signal at 6.05 ppm). After polymerization, the mixture was poured 
in water/EDTA solution containing 2.5 g EDTA/100mL, while stirring vigorously. The 
precipitate formed was filtered and washed with cold water. The precipitate was then air 
dried and characterized by GPC in THF and with NMR in DMSO-d6.   
1H-NMR (SO(CD3)2): δ 1.4 (C(CH3)3); 1.7 (NHCH(CH2CH2R)COOR); 1.9 (C═CCH3); 
2.2 (NHCH(CH2CH2R)COOR); 3.8-4.3 (NHCHRCOOR, O(CH2)2O);  5,7 and 6.0 
(C=CH2);  7.2 (NH).  
GPC: Mn = 8.7 kg/mol , PDI=1.11 
 
2.4.5 Synthesis of Fmoc-Glu(OBzl)-Gly-Ala-Gly-ethyl methacrylate (2)  
- Synthesis of Fmoc-Glu(OBzl)-Gly-Ala-Gly-OH 
A suspension of Wang resin (30 g) in 300 mL DMF was cooled in an ice bath after 
which Fmoc Gly-OH (13.5 g, 45mmol), 9.20g (60mmol) HOBt and 4.30g (34.2 mmol) 
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DIPCDI was added. This mixture was shaken for 6 hours. The functionalised resin was 
filtered and washed repeatedly with DCM, DMF and isopropyl alcohol. Unfunctionalised 
groups on the resin were capped by adding 10.2 mL benzoylchloride and 8.4 mL pyridine 
to a suspension of the resin in 300mL of DCM at 0°C. This mixture was shaken for 30 
minutes, filtered and washed repeatedly with DCM, DMF and isopropyl alcohol. Then 
10g of the Fmoc Gly functionalised Wang resin (loading 0.9mmol per gram) was swollen 
and filtered three times in 90 mL DMF. Next 90 mL of DMF, containing 20% v/v 
piperidine was added to remove the Fmoc group. A positive Kaiser test indicated 
completeness of this reaction. The next amino acid was coupled by adding a mixture of 
8.40g (27 mmol) Fmoc Ala–OH, in 90 mL DMF, with 4.08g (32.4mmol) DIPCDI and 
4.60g (30mmol) of HOBt. The mixture was shaken for 30 minutes, after which it was 
washed with DMF and twice with DCM and isopropyl alcohol. A negative Kaiser test 
indicated the completeness of the reaction. After 15 minutes this mixture was washed 
with DMF. This procedure was repeated with the following two amino acids: Fmoc Gly-
OH (8.01 g, 27 mmol) and Fmoc Glu(OBzl)-OH (9.93 g 27 mmol). The obtained 
monomer was first freeze dried from acetic acid and subsequently from dioxane. From 
10g of Fmoc-Gly functionalized Wang resin, 4.2 g of peptide was obtained. 
1H-NMR (SO(CD3)2): δ 1.2 (NH-CH(CH3)-CO, 3H, d); 2.0  (NH-CH(CH2CH2COOH)-
CO, 2H, m); 2.4 (NH-CH(CH2CH2COOH)-CO, 2H, m); 3.7 (NH-CH2-CO, 4H, m); 4.1 
(C12H8-CH-CH2, 1H, m); 4.2-4.4 (NH-CH(CH3)-CO, NH-CH(CH2CH2COOH)-CO and 
C12H8-CH-CH2, 4H, m); 5.1 (C6H5-CH2, 2H, );7.1-8.2 (C12H8-CH-CH2, C6H5-CH2 , NH-
CH(CH2CH2COOH)-CO, NH-CH2-CO and NH-CH(CH3)-CO, 17H, m). 
 
- Synthesis of Fmoc-Glu(OBzl)-Gly-Ala-Gly-ethyl methacrylate (2) 
Fmoc-Glu(OBzl)-Gly-Ala-Gly-OH (750 mg , 1.19 mmol) was placed in 15 ml 
dioxane and stirred. To this solution 0.14 ml HEMA (1.19 mmol), 0.20 ml DiPEA (1.19 
mmol), and 245 mg DCC (1.19 mmol), a catalytic amount of DMAP was added. The 
solution was then stirred overnight. The dioxane was removed under vacuum and the 
resulting solid was washed three times with 10 ml EtOAc. The crude product was then 
purified using silica column chromatography with 10% MeOH in CH2Cl2. 450 mg of 
pure product was obtained (49% yield).  
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1H-NMR (SO(CD3)2): δ 1.2 (NH-CH(CH3)-CO, 3H, d); 1.85 (CO-CH(CH3)=CH2, 3H, s)  
2.0  (NH-CH(CH2CH2COOH)-CO, 2H, m); 2.4 (NH-CH(CH2CH2COOH)-CO, 2H, m); 
3.7 (NH-CH2-CO, 2H, m); 3.8 (NH-CH2-CO, 2H, m); 4.0 (C12H8-CH-CH2, 1H, m); 4.1-
4.4 (NH-CH(CH3)-CO, NH-CH(CH2CH2COOH)-CO, O-CH2CH2-O and C12H8-CH-CH2, 
8H, m); 5.1 (C6H5-CH2, 2H, ); 5.6 and 6.1 (CO-CH(CH3)=CH2, 2H, s) ; 7.1-8.2 (C12H8-
CH-CH2, C6H5-CH2 , NH-CH(CH2CH2COOH)-CO, NH-CH2-CO and NH-CH(CH3)-CO, 
17H, m). 
13C-NMR (SO(CD3)2): δ 17, 30, 47, 48, 54,  62, 65, 66, 120, 125, 126, 127,127.5, 128, 
135,136, 140, 143, 148, 166, 168, 169.5, 172, 173.  
 
2.4.6 Synthesis of Boc-Ala-Gly-Ala-Gly-ethyl methacrylate (3) 
- Synthesis of dipeptide Boc-Ala-Gly-OEt 
Boc-Ala-OH, 9.47g (50 mmol) was dissolved in 300 mL EtOAc in a 500 mL 
round bottom flask. To this HCl.NH2-Gly-OEt, (13.59 g, 50 mmol), DIPEA (17.4 mL, 
100 mmol), HOBt, (7.60g, 50 mmol) and DCC (10.32 g) were added. This mixture was 
then stirred overnight at room temperature. The precipitated dicyclohexyl urea (DCU) 
was filtered off and the EtOAc solution was washed, twice with 20 mL of a 1M solution 
of KHSO4, twice with 10 mL distilled water, once with 10 mL saturated NaCl solution, 
twice with 20 mL of a 1M solution of NaHCO3, twice with 10 mL distilled water and 
once with 10 mL saturated NaCl solution. The EtOAc layer was then dried with Na2SO4, 
filtered and after removal of EtOAc pure Boc Ala-Gly-OEt was obtained in 98% yield. 
1H-NMR (400 MHz) (SO(CD3)2): δ 1.1 (NH-CH(CH3)-C=O, and O-CH2-CH3, 6H, m); 
1.4 (OC(O)C(CH3)3, 9H, s); 3.7 (NH-CHaHb-C=O 1H, dd ); 3.85 (NH-CHaHb-C=O, 1H, 
dd); 3.9-4.1 (NH-(CH3-)CH-C=O and O-CH2-CH3, 3 H, m); 6.9 (NHCH-(CH3)-C=O, 1H, 
d); 8.1 (NH-CH2-C=O, 1H, t). 
 
- Synthesis of Boc-Ala-Gly-OH 
Boc-Ala-Gly-OEt, 6.5g (23.6 mmol) was placed in 91 mL of a 14:5:1 solution of 
dioxane: MeOH: NaOH (4M). This was stirred for 2 hours. Next 1M KHSO4 solution 
was added, and then the mixture was concentrated until all MeOH was removed. The 
product was freeze dried to yield 5.01g of Boc-Ala-Gly-OH (86 % yield). 
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1H-NMR (400 MHz) (SO(CD3)2): δ 1.1 (NH-CH(CH3)-C=O, 3H, d), 1.4 
(OC(O)C(CH3)3, 9H, s), 3.7 (NH-CHaHb-C=O 1H, d, d ), 3.85 (NH-CHaHb-C=O, 1H, d, 
d), 3.9-4.1 (NH-CH(CH3)-C=O, 1H, m), 6.9 (NH-(CH3-)CH-C=O, 1H, d), 8.1 (NH-CH-
C=O, 1H, t). 
 
- Synthesis of HCl.NH2-Ala-Gly-OEt 
Boc-Ala-Gly-OEt, 6.5 g (23.6 mmol) was dissolved in 90 mL 2 M HCl/EtOAc 
and stirred for 60 minutes. The EtOAc solution was concentrated to 20 mL and then 10 
mL tBuOH was added. After removal of the solvent the crude product was redissolved in 
50 mL CH2Cl2. This solution was extracted twice with 20 mL water. The water layer was 
freeze dried and 4.96g of the desired product was obtained quantitatively. 
1H-NMR (400 MHz) (SO(CD3)2): δ 1.1 (NH-CH(CH3)-C=O, and O-CH2-CH3, 6H, m), 
3.7 (NH-CHaHb-C=O 1H, dd ), 3.85 (NH-CHaHb-C=O, 1H, dd), 3.9-4.1 (NH-CH(CH3)-
C=O and O-CH2-CH3, 3 H, m), 8.3 (NH3+-(CH3-)CH-C=O, 3H, d), 8.9 (NH-CH2-C=O, 
1H, t). 
 
- Synthesis of Boc-Ala-Gly-Ala-Gly-OEt 
Boc Ala-Gly-OH, 5.01g (20.3 mmol) was dissolved in 200 mL of EtOAc. To this 
4.28 g of HCl.H2N-Ala-Gly-OEt (20.3 mmol), 3.12 g of HOBt (20.3 mmol), 7.06 mL 
DIPEA (40.6 mmol) and 4.20 g DCC (20.3 mmol) were added. The mixture was stirred 
over night. The DCU precipitate was filtered off after which the  EtOAc solution was 
washed, twice with 20 mL of a 1M solution of KHSO4, twice with distilled water, once 
with a saturated NaCl solution, twice with 20 mL of a 1M solution NaHCO3, twice with 
distilled water and once with saturated NaCl solution. The EtOAc layer was then dried 
with Na2SO4, filtered, followed by removal of the solvent. The crude product Boc-Ala-
Gly-Ala-Gly-OEt was purified by column chromatography in 10% MeOH/CH2Cl2, 
resulting in  4.6g of pure compound, 56% yield.  
1H-NMR (400 MHz) (SO(CD3)2): δ 1.1-1.2 (NH-CH(CH3)-C=O 6H, and O-CH2-CH3, 
3H, m), 1.4 (OC(O)C(CH3)3,9H, s), 3.65 (NH-CH2-C=O 2H, d ), 3.75 (NH-CH2-C=O, 
2H, d), 3.95 (NH-CH(CH3)-C=O, 1H, t), 4.1 (O-CH2-CH3, 2 H, q), 4.4 (NH-CH(CH3)-
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C=O, 1H, m), 7.0 (NH-CH(CH3)-C=O, 1H, d), 7.9 (NH-CH(CH3)-C=O, 1H, d), 8.0 (NH-
CH2-C=O, 1H, d), 8.3 (NH-CH2-C=O, 1H, s). 
 
- Synthesis of Boc-Ala-Gly-Ala-Gly-OH 
Boc-Ala-Gly-Ala-Gly-OEt 4.6 g (11.4 mmol) was placed in 62.7 mL of a 14:5:1 
solution of dioxane: MeOH: (4M)NaOH. The reaction mixture was stirred for 40 minutes 
and then quenched with 1M KHSO4. The solution was concentrated until all MeOH was 
removed. The pure product was obtained by freeze drying, in quantitative yield (4.2g). 
1H-NMR (400 MHz) (SO(CD3)2): δ 1.1-1.2 (NH-CH(CH3)-C=O 6H), 1.4 
(OC(O)C(CH3)3,9H, s), 3.65 (NH-CH2-C=O 2H, d ), 3.75 (NH-CH2-C=O, 2H, d), 3.95 
(NH-CH(CH3)-C=O, 1H, t), 4.4 (NH-CH(CH3)-C=O, 1H, m), 7.0 (NH-CH(CH3)-C=O, 
1H, d), 7.9 (NH-CH(CH3)-C=O, 1H, d), 8.0 (NH-CH2-C=O, 1H, d), 8.3 (NH-CH2-C=O, 
1H, s). 
 
- Synthesis of Boc-Ala-Gly-Ala-Gly-ethylmethacrylate (3) 
Boc-Ala-Gly-Ala-Gly-OH (11.4 mmol) was placed in 120 mL DMF. To this 1.43 
mL (11.4 mmol) hydroxy ethyl methacrylate (HEMA), 139 mg (1.14 mmol) DMAP, 
1.754 g (11.4 mmol) HOBt and 2.37 g (11.4 mmol) DCC were added. The reaction 
mixture was stirred over night after which the DCU precipitate was filtered off, and DMF 
was removed under reduced pressure. The product was then dissolved in EtOAc and 
washed twice with 20 mL of a 1M KHSO4 solution, twice with 10 mL of distilled water, 
once with 10 mL of a saturated NaCl solution, twice with 20 mL of a 1M NaHCO3 
solution, twice with 10 mL of distilled water and once with 10 mL of saturated NaCl 
solution. The EtOAc layer was then dried with Na2SO4, filtered, followed by evaporation 
of EtOAc. The crude product was purified by column chromatography in 10% 
MeOH/CH2Cl2 resulting in 2.22 g of pure 3, in 40 % yield.  
1H-NMR (400 MHz) (SO(CD3)2): δ 1.1 (NH-CH(CH3)-C=O 6H,), 1.4 (OC(O)C(CH3)3, 
9H, s), 1.85 (C(O)-C(CH3)=CH2, 3H, s), 3.65 (NH-CH2-C=O 2H, d), 3.75 (NH-CH2-
C=O, 2H, d), 3.95 (NH-CH(CH3)-C=O, 1H, t), 4.15-4.3 (NH-CH(CH3)-C=O and O-CH2-
CH2-O, 5H, m), 5.6 and 6.05 (C(O)-C(CH3)=CHaHb, 1H, s and 1H, s), 7.0 (NH-CH-C=O, 
1H, d), 7.9 (NH-CH-C=O, 1H, d), 8.0 (NH-CH2-C=O, 1H, d), 8.3 (NH-CH2-C=O, 1H, s). 
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13C-NMR (300 MHz) (SO(CD3)2), δ 172.5, 172.1, 171.8, 169.1, 167.8, 165.9, 135.1 
125.8, 77.9, 62.3, 62.2, 49.7, 47.8, 41.9, 28.2, 18.2, 18.08, 18.01  
IR: ν 3313 (N-H str.); 2979 (C-H str.); 1752 (C=O str. ester) 1658 (C=O str. amide I); 
1529 (N-H vib. amide II); 1452 (C-H vib)cm-1; 
MALDI-TOF-MS: m/e 429 (M+-tBu +Na); 476 (M+ -tBu + 2Na); 508 (M+ + 2Na). 
 
2.4.7 Synthesis of 1, 4-(2’-bromo-2’-methylpropionato) benzene (4) 
An excess of 2-bromoisobutyryl bromide (10.129 g, 44.06 mmol) was added 
dropwise to a round bottomed flask containing a solution of hydroquinone (2.174 g, 
19.75 mmol) and Et3N (4.390 g, 43.38 mmol) in THF (80 mL), which was purged with 
N2, and cooled in an ice bath. After complete addition of the acid bromide the reaction 
mixture was stirred for 4 hours at room temperature. With TLC (heptane / EtOAc 5:1) 
completion of the reaction was determined. The excess of acid bromide was quenched 
with MeOH. Triethyl ammonium bromide was removed by filtration over hiflo and the 
solvent removed in vacuo. The product was recovered as a yellowish oil that was 
recrystallized three times from MeOH, to give 5.36 g of a white crystalline product which 
was dried under vacuum, 67% yield. 
1H-NMR (300 MHz, CDCl3): δ 7.18 (arom. H, s, 4H,), 2.07 (O2C-C(CH3)2Br, s, 12H,) 
13C-NMR (75 MHz, CDCl3): δ 170.08 (O-C(=O)-C(CH3)2Br), 148.39 (arom. C-O), 
122.06 (arom. C), 55.19 (O2C-C(CH3)2Br), 30.60 (O2C-C(CH3)2Br) 
IR: 1747 (C=O, ester) cm-1 
  
2.4.8 Synthesis of Ac-AGAGK(EMA)GAGAG-OH (5) 
- Synthesis of Ac-AGAGKGAGAG-OH 
Ac-AGAGKGAGAG-OH was synthesized by standard solid phase methods using 
a “Wang” resin. A suspension of Wang resin (30 g) in 300 mL DMF was cooled in an ice 
bath after which Fmoc Gly-OH (13.5 g, 45mmol), 9.20g (60mmol) HOBt and 4.30g (34.2 
mmol) DIPCDI was added. This mixture was shaken for 6 hours. The functionalized resin 
was filtered and washed repeatedly with DCM, DMF and isopropyl alcohol. 
Unfunctionalized groups on the resin were capped by adding 10.2 mL benzoylchloride 
and 8.4 mL pyridine to a suspension of the resin in 300mL of DCM at 0°C. This mixture 
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was shaken for 30 minutes, filtered and washed repeatedly with DCM, DMF and 
isopropyl alcohol. 
Fmoc Gly functionalized Wang resin, 3 g, (loading 0.75mmol per gram) was 
swollen and filtered three times in 30 mL DMF. Next 30 mL of DMF, containing 20% 
v/v piperidine was added to remove the Fmoc group. A positive Kaiser test indicated 
completeness of this reaction. The next amino acid was coupled by adding a mixture of 
2.1g (2.25 mmol) Fmoc Ala-OH, in 90 mL DMF, with 297 mg (2.25mmol) DIPCDI and 
310 mg (2.25 mmol) of HOBt. The mixture was shaken for 30 minutes, after which it was 
washed with DMF and twice with DCM and isopropyl alcohol. A negative Kaiser test 
indicated the completeness of the reaction. This procedure was repeated with the 
following amino acids: Fmoc Gly-OH (2.07g, 2.25 mmol), Fmoc Ala-OH (2.10g, 2.25 
mmol), Fmoc Gly-OH (2.07g, 2.25 mmol), Fmoc Lys(Boc)-OH (3.16g, 2.25 mmol), 
Fmoc Gly-OH (2.07g, 2.25 mmol), Fmoc Ala-OH (2.10g, 2.25 mmol), Fmoc Gly-OH 
(2.07g, 2.25 mmol), Fmoc Ala-OH (2.10g, 2.25 mmol). While still on the resin the Fmoc 
protecting group on the terminal alanine was removed and the free amine was capped by 
adding 90 mL DMF containing 1 mL Ac2O and 2 mL DIPEA. The final peptide was then 
cleaved from the resin using 90% TFA/water solution and was precipitated in diethyl 
ether. Rom 3 g of resin 1.65 g of peptide was obtained.   
 
1H-NMR (SO(CD3)2): δ 1.2 (NH-CH(CH3)-CO, 12H, d); 1.3 (NH-
CH(CH2CH2CH2CH2NH3+)-CO, 2H, m); 1.5-1.7 (NH-CH(CH2CH2CH2CH2NH3+)-CO 
and NH-CH(CH2CH2CH2CH2NH3+)-CO, 4H, m); 1.9 (CH3-CO-O-NH, 3H, s); 2.7 (NH-
CH(CH2CH2CH2CH2NH3+)-CO, 2H, m); 3.5-3.7 (NH-CH2-CO, 10H, m); 4.0 (NH-CH2-
CH2-O, 2H, t); 4.1-4.3 (NH-CH(CH3)-CO and NH-CH2-CH2-O, 6H, m); 7.6 (NH-
CH(CH2CH2CH2CH2NH3+)-CO, 3H, m); 7.7-8.2 (NH-CH(R)-CO, 10H, m).  
 
- Functionalisation of Ac-AGAGKGAGAG-OH (5) 
Ac-AGAGKGAGAG-OH (808 mg , 1.05 mg) was placed in 30 ml distilled water. 
To this 532 mg (6.30 mmol) NaHCO3 was slowly added, followed by 297 µl (2.10 mmol) 
of 2-isocyanatoethyl-methacrylate which was added dropwise to the solution. This was 
stirred for 3 hours. Afterwards the solution was filtered to remove a white precipitate 
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which had formed and the solution was then washed with CH2Cl2 to remove any 
remaining isocyanate. The pH of the water was then lowered to 1 using 1M HCl and then 
washed with tBuOH to extract the final product. The tBuOH was the removed under 
vacuum. 310 mg of the final product was obtained (32 % yield). 
1H-NMR (SO(CD3)2): δ 1.2 (NH-CH(CH3)-CO, 12H, d); 1.3 (NH-
CH(CH2CH2CH2CH2NH3+)-CO, 2H, m); 1.5-1.7 (NH-CH(CH2CH2CH2CH2NH3+)-CO 
and NH-CH(CH2CH2CH2CH2NH3+)-CO, 4H, m); 1.9 (CH3-CO-O-NH, 3H, s); 2.0 
(C(CH3)=CH2, 3H, s); 2.7 (NH-CH(CH2CH2CH2CH2NH3+)-CO, 2H, m); 3.5-3.7 (NH-
CH2-CO, 10H, m); 4.0 (NH-CH2-CH2-O, 2H, t); 4.1-4.3 (NH-CH(CH3)-CO and NH-
CH2-CH2-O, 6H, m); 5.6 (C(CH3)=CHaHb, 1H, s);  6.0 (NH-
CH(CH2CH2CH2CH2NHONHR)-CO, 2H, m); 6.1 (C(CH3)=CHaHb, 1H, s); 7.7-8.2 (NH-
CH(R)-CO, 10H, m). 
MALDI-TOF-MS: m/e 936 (M++Na+), 958 (M++2Na+).   
 
2.4.9 Polymerisation of Fmoc-Glu(OBzl)-Gly-Ala-Gly-ethyl methacrylate (6) 
ATRP of monomer 2 was carried out in a solution of DMSO-d6. Fmoc-Glu(OBzl)-
Gly-Ala-Gly-ethyl methacrylate, 2, (150 mg, 0.2mmol) was placed in a schlenck vessel 
along with 4.1 mg 2-bromo ethyl isobutyrate (EBIB) (0.01mmol), 10 mg CuCl (0.1 
mmol) and 32.1 mg bipy (0.2 mmol). The vessel was evacuated and filled with N2. This 
procedure was repeated three times. Then 1 mL DMSO-d6 was added and the solution 
was purged with N2. The reaction mixture was placed into an oil bath preheated to 60 ºC. 
The polymerization was followed by 1H-NMR spectroscopy with samples taken every 30 
minutes. Conversion was measured comparing the NMR resonances of the Fmoc and 
amide signal between δ 7.9-8.2 ppm with the methacrylate vinylic proton signal at δ 5.6 
ppm. During the measurement of this polymerisation with NMR it was noticed that the 
Fmoc signals decreased with respect to the Alanine signal at 1.2 ppm, therefore the 
polymerisation was stopped after 3 hours.  
 
2.4.10 Polymerisation of Boc-Ala-Gly-Ala-Gly-ethyl methacrylate (7) 
The ATRP of monomer 3 was carried out using bi-functional initiator 4 in a 
solution of DMSO-d6. Boc-Ala-Gly-Ala-Gly-ethylmethacrylate (3), (486 mg, 1mmol) 
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was placed in a schlenck vessel along with 19.8 mg 1,4-(2’-bromo-2’-
methylpropionato)benzene (4) (0.05mmol), 20 mg CuCl (0.2 mmol) and 63.3 mg bipy 
(0.4 mmol). The vessel was evacuated and filled with N2. This procedure was repeated 
three times. Then 2mL DMSO-d6 was added and the solution was purged with N2. The 
reaction mixture was placed into an oil bath preheated to 40ºC. The polymerization was 
followed by 1H-NMR spectroscopy with samples taken every 30 minutes. Conversion 
was measured comparing the NMR resonances of the amide signal at δ 8.3 ppm with the 
methacrylate vinylic proton signal at δ 5.6 ppm. After 2.5 hours polymerization had 
reached 92% conversion. After polymerization the polymer was precipitated in an 
aqueous solution of EDTA (25 g /L). The solid was washed twice with 10 mL CH2Cl2 
dried, and redissolved in THF. The polymer was re-precipitated from THF in aqueous 
EDTA solution, filtered, and taken up in THF, which was subsequently removed under 
reduced pressure. Yields could not be determined due to the fact that samples were 
removed during polymerization, however 260 mg of polymer (3) was obtained.   
GPC: Mn = 6.3 kg/mol, PDI=1.13 
1H-NMR (400 MHz) (SO(CD3)2): δ 0.5-1 (-CH2-C(R)(CH3)-, m), 1.1-1.3 (NH-CH(CH3)-
C=O, m), 1.4 (OC(O)C(CH3)3, s), 1.75 (-CH2-(C(R)(CH3)-, m), 3.55-4.35 (NH-CH2-
C=O, (NH-CH(CH3)-C=O and O-CH2-CH2-O, m), 7.0 (NH-CH-C=O, s), 7.9 (NH-CH-
C=O, s), 8.0 (NH-CH2-C=O, s), 8.3 (NH-CH2-C=O, s). 
 
2.4.10 Typical polymerisation of Ac-AGAGK(EMA)GAGAG-OH (8) 
Ac-AGAGK(EMA)GAGAG-OH, (114 mg, 0.125 mmol) was placed in a schlenck 
vessel. To this EBiB (0.86 µl, 0.00625 mmol), CuCl, (0.618 mg, 0.00625 mmol) and 
PMDETA, (0.75 µl mg, 0.00625 mmol) were added. The vessel was evacuated and filled 
with Argon. This procedure was repeated three times. To this 1mL DMSO-d6 was added, 
followed by purging with Argon. The reaction mixture was then placed in a preheated oil 
bath at 50ºC. Samples were taken to follow the conversion by 1H-NMR spectroscopy; 
conversion was determined by comparing the signals of the amide at δ 7.7-8.2 ppm with 
the vinylic protons of the methacrylate at δ 5.6 ppm. After 4 hours no conversion was 
observed  
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2.4.11 Typical macro initiation of MMA from polyBoc-Ala-Gly-Ala-Gly-
ethylmethacrylate. 
PolyBoc-Ala-Gly-Ala-Gly-ethylmethacrylate (3), (35 mg, 5 µmol) was placed in a 
schlenck vessel. CuCl, (3.96 mg, 0.040 mmol) and bipy, (13 mg, 0.08 mmol) were added 
and the vessel was evacuated and filled with N2. This procedure was repeated three times. 
Then MMA, (0.47 mL 0.5 mmol) and 1 mL DMSO-d6 were added. This mixture was 
purged with N2 and then placed in an oil bath which had been preheated to 70ºC. The 
polymerization was followed using 1H-NMR spectroscopy, by comparing the signals of 
the amide protons from the macro initiator at δ 8.3 ppm with the vinylic protons of the 
methacrylate at δ 5.6 ppm. After 2 hours a conversion of 64% was reached. The polymer 
was worked up by precipitation in an aqueous EDTA solution (25g /L), followed by 
filtration and extraction of the desired product with CH2Cl2. The solvent was then 
removed under reduced pressure. No yield could be determined, as samples were 
removed during the polymerization, however 46 mg of polymer was obtained. 
GPC: Mn = 11.5 kg/mol , PDI=1.29 
1H-NMR (400 MHz) (SO(CD3)2): δ 0.5-1 (-CH2-C(R)(CH3), m), 1.1-2.0 (NH-CH(CH3)-
C=O, (OC(O)C(CH3)3, (-CH2-(C(R)(CH3)-, m), 3.55-4.35 (NH-CH2-C=O, (NH-
CH(CH3)-C=O, (O-CH3, and O-CH2-CH2-O, m), 7.0 (NH-CH(CH3)-C=O, s), 7.9 (NH-
CH(CH3)-C=O, s), 8.0 (NH-CH-C=O, s), 8.3 (NH-CH2-C=O, s)  
 
2.4.12 In situ formation of pMMA-p(Boc-Ala-Gly-Ala-Gly-EMA)-pMMA (9) 
Boc- Ala-Gly-Ala-Gly-ethylmethacrylate (3) (247 mg, 0.5 mmol) was placed in a 
schlenck vessel. To this 1,4-(2’-bromo-2’-methylpropionato)benzene (4), (10.8 mg, 0.025 
mmol), CuCl, (9.9 mg, 0.1 mmol) and bipy, (31.2 mg, 0.2 mmol) were added. The vessel 
was evacuated and filled with Argon. This procedure was repeated three times. To this 
1mL DMSO-d6 was added, followed by purging with Argon. The reaction mixture was 
then placed in a preheated oil bath at 40ºC and polymerized. Samples were taken to 
follow the conversion by 1H-NMR spectroscopy; conversion was determined by 
comparing the signals of the amide at δ 8.3 ppm with the vinylic protons of the 
methacrylate at δ 5.6 ppm. In a separate schlenck vessel, 220 µl of MMA (0.2 mmol) was 
placed in 1 mL DMSO-d6 and this solution was purged with Argon. Two hours after the 
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polymerization of 3 was initiated, and a 71% conversion  was reached, the MMA solution 
was added to the schlenck vessel, using a syphon. The polymerization was then continued 
for 3 hours until a MMA conversion of 56% had been achieved. The polymerization was 
then stopped and the polymer was worked up by precipitation in 50 mL of a solution of 
EDTA in water (25g/L), followed by filtration and re-dissolution of the polymer in 
CH2Cl2. The yield could not be determined due to the removal of samples during the 
polymerization, but 284 mg of polymer was obtained.  
GPC: Mn, macroinitiator = 4.6 kg/mol, PDI = 1.17, Mn, ABA block copolymer = 6.1 kg/mol, 
PDI=1.19 
1H-NMR (400 MHz) (SO(CD3)2): δ 0.5-1 (-CH2-C(R)(CH3)- m), 1.1-2.0 (NH-CH(CH3)-
C=O, (OC(O)C(CH3)3, (-CH2-(C(R)(CH3), m), 3.55-4.35 (NH-CH2-C=O, (NH-CH(CH3)-
C=O, O-CH3 and O-CH2-CH2-O, m), 7.0 (NH-CH-C=O, s), 7.9 (NH-CH-C=O, s), 8.0 
(NH-CH-C=O, s), 8.3 (NH-CH2-C=O, s). 
IR: ν 3284 (N-H str.); 2933 (C-H str.); 1725 (C=O str. ester); 1669 (C=O str. amide I); 
1524 (N-H vib. amide II); 1451 (C-H vib.) cm-1 
 
2.4.13 Synthesis of pMMA-p(NH2-Ala-Gly-Ala-Gly-ethylmethacrylate)-pMMA (10) 
The removal of the Boc groups from pMMA-p(Boc-Ala-Gly-Ala-Gly-
ethylmethacrylate)-pMMA was performed  by stirring 200 mg of the polymer in 10 mL 
of a 50:50 mixture of TFA and CH2Cl2 for 1 hour. The solvent was removed under 
reduced pressure. The yield was quantitative.  
To remove residual trifluoro acetic acid salts the polymer was dissolved in butanol 
and washed twice with a 1M NaHCO3 solution. The solvent was removed under reduced 
pressure.   
1H-NMR (400 MHz) (SO(CD3)2): δ 0.5-1 (-CH2-C(R)(CH3)- m), 1.1-2.0 (NH-CH(CH3)-
C=O, (-CH2-(C(R)(CH3), m), 3.45-4.35 (NH-CH2-C=O, (NH-CH(CH3)-C=O, O-CH2-
CH2-O and O-CH3, m), 7.0 (NH-CH-C=O, s), 7.9 (NH-CH-C=O, s), 8.0 (NH-CH-C=O, 
s), 8.3 (NH-CH2-C=O, s)  
IR before TFA removal: 3284 (N-H str.); 2953 (C-H str.); 1724 (C=O str. ester); 1669 (C=O str. 
amide I); 1542 (N-H vib. amide II); 1436 (C-H vib.) cm-1 
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IR after TFA removal: 3321 (N-H str.); 2917 (C-H str.); 1683 w and 1625 s (C=O str. amide I); 
1537 (N-H vib. amide II); 1468 (C-H vib.) cm-1 
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3.1 Introduction 
Elastin is one of the most important classes of naturally occurring structural 
proteins.1-5 It is commonly found in ligaments, arteries, skin, and lung tissue of mammals 
where it functions as an elastomeric material.6,7 There are many different types of 
elastin,8 but tropoelastin (the precursor protein of mammalian elastin) is one of the best 
studied. VPGVG (V = valine, P = proline and G = glycine) is its most prominent amino 
acid repeat.8-10 The aggregation, conformational and mechanical properties of both 
chemically synthesized4,11,12 and recombinantly prepared poly(VPGVG)13-16 have been 
extensively investigated. Poly(VPGVG) is soluble in water at room temperature, but as 
the temperature is increased the solubility of this polypeptide is decreased. This 
remarkable LCST behaviour is a result of a conformational change in elastin from 
random coil to β spiral (Figure 3.1) , which is caused by hydrophobic dehydration of the 
valine side chains.17,18 This means that as elastin is heated its bound water is expelled, 
leading to a more hydrophobic protein. The resulting β-spiral is formed because the 
hydrophobic side chains of the valines interact with each other, shielding themselves 
from the aqueous environment.19 The release of water compensates for the loss in 
conformational freedom of the protein.20 Optimisation of these hydrophobic interactions 
occurs when three of these long chain β spirals twist together into a larger aggregate.1 
This behaviour is completely reversible. The inverse transition temperature can also be 
fine tuned by replacing the second valine with any other amino acid (VPGXG), except 
proline.  By adding either acidic or basic amino acids in the 4th position, the LCST 
behaviour becomes both pH and temperature dependent.21,22 
 
 
Figure 3.1. A schematic drawing of a type II β-turn structure proposed for 
poly(VPGVG). 
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This LCST behaviour makes elastin like peptides, or ELP´s, of interest for a wide 
range of applications, for example as thermally responsive hydrogels with an inverse 
temperature transition.14,15,23 These peptide sequences are also biologically 
compatible,24,25 opening up the possibility of medical applications for ELP´s such as drug 
delivery.14,26-29 
All of the previous investigations have focused on linear polyVPGVG. However, 
it has been shown that this inverse temperature transition occurs not only in 
poly(VPGVG)n (where n > 10) but even in a single repeat of VPGVG.30 The aim of the 
research described in this chapter is to investigate the possibility of synthesizing 
polymers with similar LCST behaviour by introducing single repeats of VPGVG into the 
side chain. 
In chapter 2 we have already shown it to be possible to introduce silk based β-
sheet peptides into the side chain of a polymer without negatively affecting the 
conformational properties of the peptide.  However, the introduction of the VPGVG 
moiety in the side chain should lead to a macromolecular architecture with much more 
complex and dynamic properties. Two target architectures were chosen, a homopolymer, 
to demonstrate that the VPGVG sequences still undergo the transition from random coil 
to β-turn, and an ABA type block copolymer, in which the A blocks contain the VPGVG 
sequence. In nature, when elastin undergoes the transition from random coil to type II β-
turn a larger aggregate is formed to optimise the hydrophobic interactions. If the LCST 
behaviour is still present in the ABA architecture, a phase transition would be 
accompanied by a change in hydrophilicity of the A blocks, which could lead to the 
formation of a reversible network (Figure 3.2). 
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Figure 3.2. Schematic representation of an ABA block copolymer with single VPGVG 
repeats in the side chain of the A block. As the polymer is heated above the transition 
point of elastin, the side chains should begin to interact. 
 
In this chapter the synthesis of a VPGVG based monomer is outlined along with 
its successful polymerization via ATRP into both a homo and a triblock copolymer, using 
a polyethylene glycol (PEG) based bifunctional initiator in the latter case. The thermally 
responsive behaviour of these polymers is also investigated using CD spectroscopy and 
turbidity measurements. 
 
3.2 Results and discussion. 
3.2.1 Model ABA triblock copolymers 
In order to synthesise an ABA type block copolymer containing the elastin peptide 
sequence, a water soluble centre block is necessary, because the transition from random 
coil to β-spiral is only observed in an aqueous environment. With this in mind a 
bifunctional polyethylene glycol (PEG) based initiator was synthesised (Scheme 3.1). To 
investigate the optimal conditions for using the PEG based initiator in combination with a 
peptide based monomer the polymerization of a single amino acid was first explored. For 
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this purpose glutamic acid-based monomer 3, (Figure 3.3), as described in chapter 2, was 
polymerised using this initiator. 
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Scheme 3.1. Synthesis of PEG based bi-functional initiator 2. 
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Figure 3.3. Methacrylate-functionalized glutamic acid, 3. 
 
Polymerizations were performed using CuCl/Bipy as a catalytic system in DMSO-
d6 (1M conc.). The polymerisation was carried out at 50°C, and after 2 hours a conversion 
of 79 % was reached. The semi logarithmic plot of monomer concentration vs. time 
(Figure 3.4) was linear, indicating first order kinetics. 
 
Figure 3.4. Semi logarithmic plot of ln[M]0/[M]n vs. time for the polymerization of 
glutamic acid-ethyl methacrylate 3 with PEG initiator 2. Polymerization was performed 
in DMSO at 50°C 
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The GPC results for this polymerisation not only show a narrow molecular weight 
distribution, 1.22, but also a full shift from the Mn corresponding to the PEG initiator, 1.3 
kg/mol to 10.9 kg/mol, indicating complete initiation. There is a small discrepancy 
between the measured Mn and the theoretical Mn, 7.4 kg/mol, as the GPC results are 
based on polystyrene calibration standards which have a different hydrodynamic volume. 
These studies clearly show that this PEG bifunctional initiator is a suitable 
initiator for ATRP of amino acid-containing monomers. 
 
3.2.2 Synthesis and polymerisation of an elastin based monomer 
To synthesise an elastin-based side chain polymer it is necessary to synthesise a 
monomer containing the peptide sequence valine-proline-glycine-valine-proline 
(VPGVG). VPGVG based monomer 1 was prepared using solid phase peptide 
synthesis31,32. The peptide was synthesized on a Wang resin using standard Fmoc 
procedures.33 Then, while the peptide was still on the resin, the final valine was 
deprotected and the methacrylate moiety was introduced, using 2-isocyanatoethyl-
methacrylate (Scheme 3.2). The peptide was then cleaved from the resin resulting in a 
free carboxylic acid at the C terminus. The pure product was obtained by column 
chromatography. 
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Scheme 3.2. Synthesis of methacrylate-functionalized VPGVG (1) on the solid phase.  a) 
4 cycles of solid phase peptide chemistry i) Fmoc amino acid, HOBt, DiPCDI, DMF ii) 
piperidine DMF. b) 2-isocyanatoethyl-methacrylate, DMF, c) TFA: H2O 95:5 
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Monomer 1 was polymerised using ATRP with CuCl/Bipy as a catalyst and 
DMSO-d6 as solvent (Table 3.1). Both the standard initiator ethyl bromo isobutyrate 
(EBIB) and the bi-functional PEG initiator 2 were used resulting in the homopolymer 
(polyVPGVG, A), and the block copolymer, B, respectively. To prevent solubility 
problems during polymerization, a lower concentration (0.25M) than previously reported 
for the polymerisation of the glutamic acid based monomer 3 was used. The semi 
logarithmic plot of monomer concentration versus time for the polymerisation of 
monomer 1, initiated by EBIB (Figure 3.5), deviates from first order kinetics. This is 
probably due to the presence of oxygen during the reaction, as a result of non-optimal 
purging of the solvent at the beginning of the polymerisation. However, the GPC data 
shows a molecular weight distribution of 1.25, indicating that the polymerisation is still 
reasonably well controlled. 
For the second polymer B, polymerised using the PEG based initiator, the semi 
logarithmic plot was first order, and the GPC also shows a reasonably narrow molecular 
weight distribution (Figure 3.6) indicating control over the polymerisation. 
 
Table 3.1. ATRP results for monomer 1. The polymerisations were carried out at 35°C in 
DMSO with CuCl/Bipy in a 2:1ratio. 
 
Polym. Init. Time min 
Conv.
% 
Mn (GPC) 
kg/mol 
Mn(NMR) 
kg/mol 
Mn,th 
kg/mol PDI(GPC)
A EBIB 240 80 53.0 N/A 5.8 1.25 
B PEG 120 84 60.0 10.0 6.1 1.24 
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Figure 3.5. Semi logarithmic plot of ln[M]0/[M]n vs. time for the polymerization of 1 with 
EBIB initiator. Polymerization was performed at 36°C. 
 
 
Figure 3.6. Semi logarithmic plot of ln[M]0/[M]n vs. time for the polymerization of 1 with 
PEG initiator 2. Polymerization was performed at 35°C. 
 
The Mn values obtained by GPC for these polymers differ significantly from the 
theoretical Mn calculated from the initiator to monomer ratio. However, for polymer B it 
is possible to calculate the degree of polymerization, and thus Mn, from the NMR data by 
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comparing the integral value of the peak at 3.7 ppm originating from the initiator moiety 
with other peaks from the peptide block of the polymer, for example the urea group at 6.2 
ppm. This resulted in a value for Mn of 10.0 kg/mol (DPn = 14) which is closer to what 
we expected and shows that the Mn obtained by GPC is anomalous. This deviation can be 
partly attributed to the difference in the hydrodynamic volume of the polystyrene 
calibration standards and our polymers and partly attributed to interaction between the 
hydrophobic peptide (the temperature of the GPC was above the transition temperature of 
elastin, 70°C) and the column. There is also a slight deviation between the Mn obtained 
by NMR and the theoretical Mn. This is probably due to low initiator efficiency. Because 
the GPC of the resulting triblock copolymer does not show a bimodal distribution, any 
left over initiator is probably removed during the polymer work up. 
There is a clear difference in the level of control obtained over the polymerisation 
of the elastin based monomers in this chapter when compared to the polymerisation of 
AGAG monomers in chapter 2. Even in the case of polymer B which is polymerised with 
first order kinetics, the PDI is broader than that obtained for the AGAG based polymers. 
The reason for this difference in control could simply be the nature of the monomer; there 
are various functional groups present in the VPGVG based monomer which could 
interfere with the polymerisation, especially the urea group and the free carboxylic acid 
could have a negative effect because they are capable of forming complexes with the 
copper catalyst.34 In fact it is remarkable that ATRP of this peptide monomer can be 
performed with only a slight loss of control. A possible explanation for why no 
interaction occurs and the polymerisation proceeds, is that the solvent used for 
polymerisation, DMSO, breaks up any complexes these functional groups form with the 
catalyst, allowing the polymerization to progress. A second more likely, explanation is 
that during the polymerisation aggregation starts to occur, causing a slight loss of control 
and a broadening of the polydispersity. 
 
3.2.3 Physical properties of VPGVG based polymers 
CD spectroscopy was performed on Ac-VPGVG-OH and on polymers A and B, 
the results of which are depicted in Figure 3.7, 3.8 and 3.9, to investigate the folding 
behaviour of these two polymers at different temperatures. 
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Figure 3.7. CD spectra of Ac-VPGVG-OH. From 2°C to 80°Cat pH 1. Arrows represent 
increasing temperature. 
 
Figure 3.8. CD spectra of polymer A. From 2°C to  90°C at pH 1. Arrows represent 
increasing temperature. 
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Figure 3.9. CD spectra of block copolymer B, CD spectra taken from 2°C to 80°C at pH 
1. Arrows represent increasing temperature 
 
The folding properties of single repeats of VPGVG have been extensively studied 
by Reiersen and Rees30  using CD spectroscopy. They observed several changes in the 
spectra upon increasing temperature. Below the phase transition temperature the CD 
spectra have several characteristic features, a minimum at 200 nm, a maximum at 205-
210 nm and a shallow minimum at 220 nm. This is indicative of a random coil type of 
conformation. As the temperature is increased above the transition temperature several 
changes occur. The minimum at 200 nm becomes shallower; at 220 nm the minimum 
deepens, while at 205-210 nm the maximum remains unchanged. This type of shift in 
ellipticity is known to be due to a change in structure from random coil to type II β turn.1  
We observe a similar spectrum for Ac-VPGVG-OH (Figure 3.8), which shows the 
same pattern, a minimum at 190 nm, which becomes shallower upon heating, a maximum 
around 205-210 nm, and a minimum at 220 nm which deepens upon heating. The only 
difference between our spectra and that of Reiersen et al. is that our first minimum is at 
190 nm instead of 200 nm. This can be attributed to the fact that Reiersen et al used the 
eightmer Ac-GGVG(VPGVG)-OH and we used the fivemer Ac-VPGVG-OH. 
The CD spectrum of polymer A, the homopolymer (Figure 3.8), is very similar to 
that of the monomer (Figure 3.7) and that obtained by Reiersen and Rees, with only one 
minor difference which is that the maximum at 200-210 nm is above 0, instead of below. 
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However, the same characteristic increase at 195 nm and decrease at 220 nm are 
observed. 
The CD spectra of the triblock copolymer, B, at pH 1 (Figure 3.9) also shows this 
characteristic behaviour, but this time the maximum at 200-210 nm is around zero instead 
of below it. Therefore it appears that the incorporation of the peptide into the side chain 
of a polymer has not significantly affected its inverse phase transition behaviour. 
 
3.2.4 Turbidity measurements 
In order to determine whether the induced phase transition from random coil to β 
turn gives rise to aggregation, turbidity measurements were performed on polymers A 
and B at different temperatures and pH’s. Scattering was measured on an aqueous 
solution of each sample at 480 nm, while the temperature was increased from 2 to 80°C. 
For the homopolymer, A, there was no increase in turbidity as the temperature was 
increased. For the block copolymer, B, the turbidity increased significantly with 
increasing temperature (Figure 3.10A.). Also a change in the transition temperature was 
observed for B when the pH was raised from 1 to 6 (Figure 3.10A and B). Furthermore, 
the heating and cooling cycle shown in Figure 3.10B demonstrates that this phase 
transition is reversible. 
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Figure 3.10. Turbidity measurements of polymer B taken at two different pH’s, pH 1 (A) 
and pH 6 (B). B also shows a heating-cooling-heating cycle. 
 
The transition temperature for polymer B at pH 1 is  around 40°C, which is 
slightly higher than observed by Reiersen and Reese.30 This can be attributed to the fact 
that the peptide is incorporated in a side chain of a polymer. Interestingly this transition 
temperature can be increased to around 70°C by raising the pH. This dependence on pH 
is probably due to the free acid end groups of the peptide side chain. Deprotonation of the 
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carboxylic acid end groups at higher pH increases the hydrophilicity of the peptide side 
chain, making it necessary to go to a higher temperature to induce hydrophobic 
dehydration. 
The sharp increase in turbidity suggests that there is some form of block 
copolymer assembly taking place, possibly as a result of the increased hydrophobicity of 
the peptide blocks, leading to an amphiphilic block copolymer structure. The formation 
of amphiphilic block copolymers would explain why only the block copolymer B seems 
capable of a turbidity change. In the case of polymer A, there is no PEG chain present 
and no pronounced amphiphilic behaviour can therefore be introduced. 
 
3.3 Conclusion 
We have successfully shown that it is possible to prepare elastin based polymers 
via ATRP using both a standard initiator and a PEG based bifunctional initiator. We have 
again shown that ATRP in DMSO proves to be tolerant to a wide range of functional 
groups including urea groups and free carboxylic acids. We have also established a 
simple method for the functionalisation of a peptide on a resin, opening up the possibility 
of synthesizing a wider range of peptide based monomers. 
The physical properties of the elastin based polymers have been studied showing 
that the VPGVG side chains retain their characteristic transition from random coil to β-
spiral behaviour as shown by CD spectroscopy. Interestingly, when block copolymers 
were made from these materials, a turbidity change could be seen, which is thought to be 
caused by block copolymer assembly. This could be explained by the formation upon 
heating of amphiphilic block copolymers due to the hydrophilic to hydrophobic transition 
of the peptide side chains. 
 
3.4 Experimental 
3.4.1 General procedures 
1H and 13C-NMR spectra were measured on a 400 MHz Bruker Inova400 machine with a 
Varian probe. 
IR spectra were measured on an ATI Mattson Genesis Series FTIR. 
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Elemental analysis was performed on a Carlo-Erba Instruments EA1180 CHNO/S 
elemental analyzer 
CD spectra were measured on a Jasco J-810 spectropolarimeter, with a temperature 
control unit. Samples were dissolved in milli-Q water and sonicated for 1 hour in an ice 
bath. A polymer solution was diluted until maximum UV absorption of 1.5 was reached 
at 220 nm. The samples were measured using a 1 mm quartz cuvette at different 
temperatures. The same solution was also used for turbidity experiments using the same 
CD spectropolarimeter. They were carried out at a fixed wavelength of 480 nm. 
 
MALDI-TOF-MS spectra were measured on a Bruker Biflex III machine, with 
dihydroxybenzoic acid (DHB) as matrix. The sample was prepared by dissolving 2 mg of 
analyte in 1 mL THF after which this solution was mixed in a 1:1 ratio with a solution of 
10 mg DHB in 1mL H2O containing 0.1% trifluoro acetic acid. This was then placed on a 
MALDI plate. 
 
GPC measurements were performed using a Shimadzu GPC with Shimadzu RI and 
UV/Vis detection, fitted with a Polymer Laboratories Plgel 5 µm mixed-D column, and a 
PL 5 µm Guard column (separation range from 500 to 300,000 molecular weight) using 
THF or NMP as mobile phase at 35 and 70°C respectively. Polymer Laboratories 
polystyrene calibration kits were used. 
 
The dynamic light scattering (DLS) measurements were carried out using an intensity 
stabilized Helium-Neon laser (Spectra Physics, λ=632.8 nm, 4.5 mW). The incident beam 
of the laser was focused in the centre of the precision glass cylindrical cuvette (Helma), 
which was used as a scattering cell. The light, scattered at 90o with respect to the incident 
beam, was transferred to the single photon detector (ALV/SO-SIPD) through a single 
mode fibre to meet the spatial coherence conditions. The signals were processed with a 
320 channel Multiple Tau Digital Correlator (ALV-5000/E). The measurements were 
carried out in a temperature range of 20-90 °C (±0.05 °C) using a laboratory-made 
heating stage controlled by an active feedback temperature controller (LakeShore 340). 
The concentration of polymer in water was circa 1 mg per ml 
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3.4.2 Reagents 
p-Alkoxybenzyl alcohol “Wang” resin (Bachem, 1.14mmol/g), 9-fluorenylmethoxy 
carbonyl protected valine (Fmoc Val-OH) (Bachem > 99%), Fmoc glycine (Fmoc Gly-
OH) (Bachem > 99%) and Fmoc proline (Fmoc Pro-OH) (Bachem > 99%) were all used 
as received. CuCl (Aldrich, 97 %) was purified by washing with glacial acetic acid 3 
times and once with diethyl ether35. PEG 1000 (Fluka), ethyl-2 bromo isobutyrate (EBIB 
98% , Aldrich), hydroxyl ethyl methacrylate (HEMA Aldrich 97 %), 2-bromo-isobutyric 
acid, (Aldrich 98%), 2-isocyanatoethyl-methacrylate (Aldrich 98%), 2,2´-bipiridyl (Bipy) 
(Aldrich 99%), N, N-dicyclohexylcarbodiimide (DCC) (Fluka 99 %), 4-
dimethylaminopyridine (DMAP) (Across 99%), DMSO-d6  (Aldrich 99.9 %), N,N´-
diisopropyl ethylamine (DIPEA) (Fluka 99%), 1-hydroxybenzotriazole hydrate (HOBt) 
(Fluka ≥ 98%), N,N-diisopropyl carbodiimide (DIPCDI) (Fluka≥ 98%), trifluoro acetic 
acid (TFA)  (Aldrich 98%) and ethylene diamine tetra acetic acid tetrasodium salt hydrate 
(EDTA, Aldrich 98 %) were all used as received. 
Dichloromethane (DCM) and ethyl acetate (EtOAc) were distilled from calcium 
hydride, THF was distilled from sodium/benzophenone prior to use. Dimethylformamide 
(DMF) and isopropyl alcohol were used as received (J.T.Baker) 
 
3.4.3 Synthesis of methacrylate-functionalised VPGVG (1). 
Methacrylate-functionalised VPGVG 1 was synthesized by standard solid phase 
methods using a “Wang” resin.31,32 A suspension of Wang resin (30 g) in 300 mL DMF 
was cooled in an ice bath after which Fmoc Gly-OH (13.5 g, 45mmol), 9.20g (60mmol) 
HOBt and 4.30g (34.2 mmol) DIPCDI were added. This mixture was shaken for 6 hours. 
The functionalised resin was filtered and washed repeatedly with DCM, DMF and 
isopropyl alcohol. Unfunctionalised groups on the resin were capped by adding 10.2 mL 
benzoylchloride and 8.4 mL pyridine to a suspension of the resin in 300mL of DCM at 
0°C. This mixture was shaken for 30 minutes, filtered and washed repeatedly with DCM, 
DMF and isopropyl alcohol. Then 10g of the Fmoc Gly functionalised Wang resin 
(loading 0.9mmol per gram) was swollen and filtered three times in 90 mL DMF. Next 90 
mL of DMF, containing 20% v/v piperidine was added to remove the Fmoc group. A 
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positive Kaiser test33,36 indicated completeness of this reaction. The next amino acid was 
coupled by adding a mixture of 9.16g (27 mmol) Fmoc Val-OH, in 90 mL DMF, with 
4.08g (32.4mmol) DIPCDI and 4.60g (30mmol) of HOBt. The mixture was shaken for 30 
minutes, after which it was washed with DMF and twice with DCM and isopropyl 
alcohol. A negative Kaiser test indicated the completeness of the reaction. Free amines 
were capped by adding 90 mL DMF containing 1 mL Ac2O and 2 mL DIPEA. After 15 
minutes this mixture was washed with DMF. This procedure was repeated with the 
following three amino acids: Fmoc Gly-OH (8.02g, 32.4 mmol), Fmoc Pro-OH (9.11g, 
32.4 mmol) and Fmoc Val-OH (9.16g, 32.4 mmol). While still on the resin the Fmoc 
protecting group on the terminal valine was removed and the free amine was 
subsequently coupled with 3 equiv. 2-isocyanatoethyl-methacrylate in DMF. The 
methacrylate-functionalised VPGVG was cleaved from the resin using 90% TFA/water 
solution and was concentrated after cleavage. The obtained monomer was first freeze 
dried from acetic acid and subsequently from dioxane. The monomer was then purified 
by column chromatography using 60 H silica (Merck) and CHCl3/MeOH/water (65:25:4) 
as an eluent. From 10 g of Fmoc-Gly functionalised Wang resin, 3.5 g of peptide was 
obtained. 
1H-NMR (SO(CD3)2): δ 0.5-1.2 (NHC(C(CH3)2)COR, 12H); 1.7-2.2 
(NHC(CH(CH3)2)COR, NHCH2CH2CH2CHCOR, 6H and C═CCH3, 3H); 3.2-4.4 
(NHCHRCOR, NHCH2COR, NHCH2CH2CH2CHCOR, RO(CH2)2NHCONH,13 H); 5.6 
and 6.1 (C=CH2, 2H, s); 6.7-8.5 (NH amide and NH urea, 5H). 
13C-NMR (SO(CD3)2): δ 17.94, 18.30, 19.12, 24.52, 29.15, 30.77, 31.33, 55.92, 58.52, 
59.67, 64.12, 125.81, 135.80, 157.83, 166.50, 168.46, 170.52, 171.27, 171.63, 171.91. 
IR(KBr): ν 3318 (NH str); 2964 (CH str); 1718 (C=O str); 1644 (C=C str); 1555 (NH 
bend); 1173 (C-N str). 
MALDI-TOF-MS: m/e 605 (M+ -H +Na); 621 (M+ -H +K); 627 (M+ -2H + 2Na). 
 
3.4.4 Synthesis of bifunctional PEG ATRP macro initiator (di-α,ω-bromo-
isobutyrate-PEG) (2). 
PEG (Mn: 1000 g/mol, 5.00 g, 5 mmol) was melted and dissolved in 20 mL 
benzene. The mixture was heated under vacuum until all benzene was evaporated. This 
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procedure was repeated 3 times to remove all residual water from PEG. Dried PEG was 
redissolved in 20-30 mL dried THF and 3.34 g (20mmol) 2-bromo-isobutyric acid was 
added and stirred until dissolved. The reaction mixture was cooled to –20 °C and 4.13 g 
(20 mmol) DCC and 244.5 mg (2 mmol) DMAP were added in quick succession. The 
solution was allowed to come to room temperature and stirred for 72 h. The progress of 
the reaction was monitored by TLC. After completion precipitated DCU was removed by 
filtration and THF was removed by evaporation to obtain the crude product. The product 
was purified by column chromatography using 60 H silica, with 5% MeOH in CHCl3 as a 
mobile phase. Bifunctional PEG initiator was obtained in 91% yield. 
1H-NMR (SO(CD3)2): δ 1.8 (COC(CH3)2Br, 12H, s); 3.5 (O(CH2)2O backbone, mp); 3.6 
(ROCH2CH2OCO, 4H, t); 4.3 (ROCH2CH2OCO, 4H, t). 
13C-NMR (SO(CD3)2): δ 30.23, 57.06, 65.00, 67.90, 69.78, 69.90, 170.74. 
MALDI-TOF-MS: m/e 1307 (M+); 1351, 1395, 1439, 1483, 1527, 1571 (M+ + O(CH2)2); 
1263, 1219, 1175, 1139, 1095 (M+ - O(CH2)2). 
Anal. Calcd for C54H104O26Br2: C, 48.80, H, 7.89. Found: C, 48.20, H, 7.91. 
 
3.4.5 Polymerization of Glu-EMA, 3, with bifunctional PEG 2 as initiator. 
ATRP of Glu-EMA was carried out in solution using α,ω-di-bromo-isobutyrate-
PEG 2 as bifunctional initiator. Glu-EMA, (415 mg, 1 mmol), 10.0 mg (0.1 mmol) CuCl 
and 32.0 mg (0.2 mmol) bipy were weighed into a schlenk vessel. The vessel was 
evacuated and filled with N2. This procedure was repeated three times. DMSO-d6 (0.5 
mL) was added to dissolve reactants after which the vessel was purged again with N2. 
Then 31 mg (0.025 mmol) 2 was dissolved in 0.5 mL DMSO-d6 and added to the 
mixture. The reaction mixture was heated to 70 °C and the initiator solution was added. 
During the reaction samples were taken and conversion was determined by 1H NMR 
spectroscopy (comparing the amide resonance at 7.2 ppm with the vinyl signal at 6.05 
ppm). After polymerization, the mixture was poured in an aqueous solution of 25 g 
EDTA/L, while stirring vigorously. The precipitate was filtered off, washed with cold 
water, air dried and characterized by GPC in THF and NMR in DMSO-d6. 
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1H-NMR (SO(CD3)2): δ 0.5-2.3 (-CH2-CH(RCH3)-, C(CH3)3, -CH2-CH(RCH3), 
NHCH(CH2CH2R)COOR, and NHCH(CH2CH2R)COOR); 3.8-4.3 (NHCHRCOOR, 
O(CH2)2O); 6.7-7.2 (NH). 
GPC: Mn = 10.9 kg/mol, PDI = 1.22 
3.4.6 Polymerization of methacrylate-functionalized VPGVG to homopolymer (A) 
ATRP of VPGVG based monomer 1 was carried out in solution using EBIB as 
initiator. Monomer 1 (300 mg, 0.5 mmol), CuCl 10.1 mg (0.1 mmol) and bipy 34.0 mg 
(0.2 mmol) were weighed into a schlenk vessel. The vessel was evacuated and filled with 
N2. This procedure was repeated three times. DMSO-d6 (1.57 mL) was added to dissolve 
reactants and 45 µL (0.5 mmol) xylene was introduced as internal standard. The mixture 
was heated to 36 °C and 0.43 mL (0.022 mmol EBIB) of a 10µl/ml solution EBIB in 
DMSO-d6 was added. During the reaction samples were taken and conversion was 
determined by 1H NMR spectroscopy based on the ratio of the vinyl signals (5.61) ppm to 
the xylene aromatic signal (from 6.8-7.2 ppm). After polymerization, the mixture was 
precipitated in diethyl ether. The ether layer was decanted and the brown precipitate was 
subsequently re-dissolved in water (resulting solution pH 6.0). A 1M HCl solution was 
added until pH 1.0 was reached, causing the desired product to precipitate out as a white 
powder.  The resulting polymer was filtered off and rinsed with ice-cold water. The 
product was then taken up in a 1:1 water/THF mixture. After evaporation of THF the 
turbid water mixture was freeze dried. Characterization was performed by GPC with 
NMP as eluent and NMR in DMSO-d6. 
1H-NMR (SO(CD3)2): δ 0.5-2.1 (NHC(C(CH3)2)COR, 12H, NHC(CH(CH3)2)COR, 
NHCH2CH2CH2CHCOR, 6H, -CH2-CH(RCH3)-, 3H and -CH2-CH(RCH3)-, 4H); 3.0-5.5 
(NHCHRCOR, NHCH2COR, NHCH2CH2CH2CHCOR, RO(CH2)2NHCONH, 13H); 6.0-
8.5 (NH amide and NH urea, 5H) 
GPC: Mn = 53.0 kg/mol, PDI=1.25 
 
3.4.7 Polymerization of methacrylate-functionalized VPGVG to an ABA block 
copolymer (B) 
ATRP polymerization of VPGVG based monomer 1 was carried out in solution 
using α,ω-di-bromo-isobutyrate-PEG 2 as a bifunctional initiator. VPGVG-monomer 
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(154 mg, 0.25 mmol), 10.0 mg (0.1mmol) CuCl and 34.0 mg (0.2 mmol) bipy were 
weighed into a schlenk vessel. The vessel was evacuated and filled with N2. This 
procedure was repeated three times. DMSO-d6 (0.5 mL) was added to dissolve reactants 
and 45 µL (0.5 mmol) xylene was introduced as internal standard. This mixture was then 
purged with N2. The bifunctional initiator (31 mg, 0.025 mmol) was dissolved in 0.5 mL 
DMSO-d6. The reaction mixture was heated to 35 °C and the initiator solution was added. 
After polymerization, the mixture was poured in ether. After decantation of the ether 
layer, the brown polymer precipitate was re-dissolved in demineralised water (resulting 
solution pH 6.0). Acidification with a 1M HCl solution to pH 1 resulted in precipitation 
of the polymer as a white powder. The polymer was filtered off and rinsed with ice cold 
water. The product was then re-dissolved in a 1:1 water/THF mixture. After evaporation 
of THF the turbid water mixture was freeze dried yielding the desired ABA block 
copolymer. Characterization was performed by GPC with NMP as eluent and NMR in 
DMSO-d6. 
1H-NMR (SO(CD3)2): δ 0.5-2.1 (NHC(C(CH3)2)COR, NHC(CH(CH3)2)COR, 
NHCH2CH2CH2CHCOR, -CH2-CH(RCH3)- and -CH2-CH(RCH3)-); 3.0-5.5 
(NHCHRCOR, NHCH2COR, NHCH2CH2CH2CHCOR, RO(CH2)2NHCONH, and O-
CH2-CH2-O); 6.0-8.5 (NH amide and NH urea). 
Mn from NMR = 10.9 kg/mol 
GPC: Mn = 60.0 kg/mol, PDI=1.24 
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4.1 Introduction 
In chapter 3 we have described the preparation of a new class of elastin hybrid 
polymers.1 We investigated whether the transition found in linear VPGVG2,3 was also 
introduced into a triblock copolymer in which the pentapeptide units were incorporated in 
the polymer side chains. By polymerizing a methacrylate functionalized VPGVG 
monomer from a bifunctional poly(ethylene glycol) initiator via atom transfer radical 
polymerization (ATRP), the desired structure was prepared (Figure 4.1). We found that 
the VPGVG sequence in the side chain of the polymer underwent the transition from 
random coil to type II β-turn as observed for linear polyVPGVG.4-6 This transition is 
caused by hydrophobic dehydration which induces the VPGVG sequence to change from 
hydrophilic to hydrophobic as it is heated.7-9 We also observed that an aqueous solution 
of the triblock copolymer showed an increase in turbidity upon heating, indicating that 
there was some form of aggregation occurring, probably due to the transition of the block 
copolymer from a hydrophilic to an amphiphilic species as the VPGVG blocks became 
hydrophobic.10 
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Figure 4.1. Chemical structure of elastin based side chain block copolymers, n = 5, 7 
and 11 
 
Having investigated the synthesis and some of the physical properties of this 
elastin based block copolymer we decided to study the physical properties in more detail. 
One aspect that makes elastin a very versatile material is that the LCST can be fine tuned 
by changing the hydrophobicity of the pentapeptide repeat. By replacing the second 
valine by any other amino acid, except proline, the difference in polarity of the side 
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chains leads to different LCST’s. Pioneering work by Urry has shown that virtually any 
phase transition temperature can be obtained by the correct composition of elastin 11. 
Furthermore, the LCST behaviour of linear poly VPGVG can also be heavily influenced 
by other parameters, such as molecular weight3,12, concentration3,13 and, when amino 
acids with acidic or basic side chains are introduced, by pH.14,15 We decided to 
investigate whether the stimulus responsive character of our elastin side chain block 
copolymers is affected by the same parameters as linear poly VPGVG. For this purpose a 
series of polymers was made with varying degree of polymerization (DP) of the elastin 
fragments. We chose to look at the effects of DP, concentration and pH on the phase 
transition temperature of our block copolymers. 
In chapter 3 we also examined the aggregation behaviour of these polymers using 
turbidity measurements. In order to gain a clearer insight into this behaviour the 
aggregates were studied in more detail with dynamic light scattering and electron 
microscopy. With this investigation we hope to further demonstrate that by introducing a 
functional peptide into the side chain of a polymer, the functionality is transferred into the 
polymer itself, and is still dependent on the physical parameters which affect the original 
peptide sequence. 
 
4.2 Results and discussion. 
4.2.1 Elastin Based Monomer Synthesis 
To begin our investigation into the effects of molecular weight, concentration and 
pH on our elastin based block copolymers it was necessary to resynthesize the VPGVG 
based monomer 1. This time a solution based approach was used (Scheme 4.1) instead of 
the previously used solid phase approach1 as this allowed us to more easily produce a 
larger quantity of this short peptide. 
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Scheme 4.1. Synthesis of VPGVG based monomer 1, a) DCC, HOBt, DIPEA, EtOAc, 
98%, b) 2 M HCl/EtOAc, quantitative, c) DCC, HOBt, DIPEA, EtOAc, 61%, d) BOP, 
DIPEA, EtOAc, 88%, e) 70:10:2 dioxane: water: 4M NaOH, quantitative  f) 2 M 
HCl/EtOAc, g) DCC, HOBt, DIPEA, EtOAc, 54%, h) NaHCO3, water, 89% 
 
4.2.2 Block length 
It has been shown by Meyer and Chilkoti12 that as the molecular weight of linear 
polyVPGVG is increased, the transition temperature is decreased. To investigate whether 
our polymers were also affected in the same way, three polymers with different VPGVG 
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block lengths were synthesized via ATRP using the same PEG based initiator as used in 
chapter 3 (Figure 4.1). The polymerizations all had first order rate kinetics and the 
degrees of polymerization of each polymer could be determined using 1H-NMR 
spectroscopy, by comparing the peaks due to poly ethylene glycol at 3.5 ppm and the 
peaks due to urea at 6.2 ppm (Table 1.4). 
 
Table 4.1. Molecular weight data, determined by 1H NMR, and transition temperatures, 
measured at pH 1, for polymers A, B, and C. 
 
Sample DP of VPGVG 
Block 
Mn (kg/mol) Transition 
Temp. °C 
A ñ = 5.3 7.0 47 
B ñ = 7.2 9.4 44 
C ñ = 11.1 15.2 33 
 
The three polymers were dissolved in a phosphate buffer of pH 1 and the 
transition temperature was determined (Table 4.1). The turbidity measurements clearly 
showed a decrease in the transition temperature as the chain length was increased. This is 
in agreement with the results described by Meyer and Chilkoti12 for linear elastin. It was 
suggested that as the linear VPGVG polymers become shorter they become more ordered, 
increasing the energy required to change from one structure to the other.3 The changes in 
transition temperature which are observed with our block copolymers, however, are more 
pronounced than those observed for linear polyVPGVG.  When the number of VPGVG 
units on each side of the triblock copolymer is increased from 7 to 11, a change is 
observed in LCST from 44 to 33ºC. According to Meyer, to obtain a similar change in 
transition temperature from 50 to 35°C with linear VPGVG the chain length had to be 
increased from 30 to 60 units. This suggests that there is an additional reason for the 
relatively large change in transition temperature observed with our block copolymers. 
One difference between our side chain block copolymers and linear VPGVG is that as the 
molecular weight of our polymers is increased the polymethacrylate backbone is also 
extended. As the backbone becomes longer its influence on the properties of the triblock 
copolymer becomes more pronounced, as the hydrophobicity of the end block is 
increased.  The VPGVG side chains of the polymers with a higher degree of 
polymerization are in a more hydrophobic environment and can therefore more readily 
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undergo the inverted phase transition, lowering the transition temperature more than is 
observed with a similar molecular weight change in linear elastin. 
 
4.2.3 Concentration 
The second physical parameter of interest is concentration. It has been shown that 
as the concentration was increased the transition temperature decreased.12,13 To 
investigate the effect of concentration on our block copolymers, four different 
concentrations of the triblock copolymer C, in a buffer of pH 1, were made and their 
transition temperatures measured. 
From the turbidity measurements (Figure 4.2) we can clearly see that as the 
concentration increases the transition temperature decreases (Table 4.2), the same trend 
as is observed for linear VPGVG. For linear VPGVG Urry et al13 proposed that this 
change in transition temperature is caused by the fact that the transition from random coil 
to β-spiral is a cooperative process. This means that as the concentration is increased this 
cooperative effect plays a larger role in the transition process, decreasing the transition 
temperature. 
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Figure 4.2. Turbidity measurements of different concentrations of triblock copolymer C 
taken at pH 1. 
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Table 4.2. Transition temperatures for polymer C at different concentrations. 
 
Concentration 
(mg/mL) 
Transition 
temperature (°C) 
2.5 25.0 
1.3 36.5 
0.6 47.5 
0.3 56.0 
 
This explanation could also apply to our block copolymers. As the concentration 
of our block copolymer increases the cooperative effect becomes more pronounced, 
reducing the transition temperature in a similar manner as for linear polyVPGVG. 
 
4.2.4 pH dependence 
It has been shown that by replacing the second valine in linear poly VPGVG with 
an acidic or basic amino acid the properties of the polypeptide can be changed, allowing 
the transition temperature to be manipulated by varying the pH. For example, if valine is 
replaced by glutamic acid the transition temperature can be increased by increasing the 
pH.14-16 For our triblock copolymers there is already a free carboxylic acid group at the 
end of the peptide side chain, therefore it was not necessary to introduce a pH sensitive 
amino acid. 
The triblock copolymers A-C were dissolved in three phosphate buffers of pH 1, 2 
and 3. The turbidity measurements clearly showed that as the pH increased for each 
polymer the transition temperature also increased (Figure 4.3, Figure 4.4 and Figure 4.5) 
until there was no longer a transition point for triblock copolymer A at pH = 3. 
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Figure 4.3.Turbidity measurements of triblock copolymer A at pH =1, 2 and 3. 
 
0 10 20 30 40 50 60 70 80 90 100
5
10
15
20  pH 1
 pH 2 
 pH 3
LCST:
pH 1: 44 °C
pH 2: 50 °C
pH 3: 70 °CA
U
Temperature (°C)
 
Figure 4.4. Turbidity measurements of triblock copolymer B at pH =1, 2 and 3. 
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Figure 4.5. Turbidity measurements of triblock copolymer C at pH =1, 2 and 3. 
 
It is clear that the same trend is observed for our triblock copolymers as for linear 
polyVPGXG, in which X is an acidic residue (Table 4.3). For substituted linear 
polyVPGVG the change in transition temperature is thought to be due to a change in the 
hydrophobicity of the VPGXG sequence.15,17 As the pH is increased the acidic residue 
becomes deprotonated making the peptide sequence more hydrophilic, thus increasing the 
transition temperature. This explanation is also applicable to our triblock copolymer 
systems. As the acidic end groups become deprotonated the end blocks become more 
hydrophilic, increasing the temperature at which hydrophobic dehydration occurs. This 
results in our triblock copolymer systems having the same behaviour as linear 
polyVPGXG. 
Table 4.3. Transition temperatures for polymer A, B and C at different pH’s. 
 
 
 
 
pH buffer Transition temperature (°C) 
 polymer A (ñ =5) polymer B (ñ =7) polymer C (ñ =11) 
1 47 44 33 
2 60 50 40 
3 -- 70 49 
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4.2.5 Aggregation 
In the previous chapter it was suggested that the mechanism of aggregation is due 
to a change in the amphiphilicity of the block copolymers as they are heated. To 
investigate what sorts of aggregates are formed upon heating block copolymer C was 
analysed with dynamic light scattering measurements in a buffer solution of pH 1. Figure 
4.6 shows the changes in diffusion coefficient with temperature. The large deviation 
between the first, second and third cumulants at higher temperatures indicates that the 
measured particles are not spherical. This type of change is indicative of network 
formation. 
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Figure 4.6. Temperature dependence of the diffusion coefficient as determined by 
dynamic light scattering, for triblock copolymer C at pH =1, taken at a concentration of 
1mg/ml. 
 
The idea of network formation was furthermore supported by cryoSEM of the 
same solution (Figure 4.7). The solution was heated above the block copolymer transition 
temperature and then quenched in liquid N2. After freeze fracturing the morphology of 
the block copolymer above its LCST could be determined by cryoSEM. The cryoSEM 
pictures clearly indicated the presence of a network. 
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A      B 
 
Figure 4.7. CryoSEM images of a 1mg/ml solution of triblock copolymer C, at pH =1, 
frozen in above its LCST; A) 8.000 times enlargement, B) 20.000 times enlargement. 
 
4.3 Conclusion 
In this chapter we have shown that the LCST behaviour of a series of side chain 
elastin based block copolymers is influenced by the same parameters as linear 
polyVPGVG. By increasing polymer concentration or molecular weight the transition 
temperature is lowered, by increasing pH the transition temperature increases. This 
proves that it is possible to incorporate a structural peptide into a polymer and have it 
retain its functionality, resulting in functional synthetic polymers which behave in a 
similar way as the original peptide sequence or protein on which they are based. 
We have also found more evidence that the mechanism of aggregation for our 
peptides is due to a change in aggregation in our block copolymers. From cryoSEM and 
DLS measurements we can see that upon heating no defined structures are present but 
instead a network is clearly formed. 
 
4.4 Experimental 
4.4.1 General procedures 
1H and 13C-NMR spectra were measured on a 400 MHz Bruker Inova400 machine with a 
Varian probe. 
IR spectra were measured on an ATI Mattson Genesis Series FTIR. 
From Structural Proteins to Synthetic Polymers 
 
 98
Elemental analysis was performed on a Carlo-Erba Instruments EA1180 CHNO/S 
elemental analyzer 
Turbidity measurements were carried out on a Jasco J-810 spectropolarimeter, with a 
temperature control unit. Samples were dissolved in a phosphate buffer of pH of 1, 2 or 3, 
composed of sodium chloride, sodium dihydrogen phosphate monohydrate, di-sodium 
hydrogen phosphate dehydrate and ortho-phosphoric acid. The samples were measured 
using a 1 mm quartz cuvette at different temperatures. The measurements were carried 
out at a fixed wavelength of 480 nm. 
MALDI-TOF-MS spectra were measured on a Bruker Biflex III machine, with 
dihydroxybenzoic acid (DHB) as matrix. Samples were prepared by dissolving 2 mg of 
analyte in 1 mL THF after which this solution was mixed in a 1:1 ratio with a solution of 
10 mg DHB in 1mL H2O containing 0.1% trifluoro acetic acid. This was then placed on a 
MALDI plate. 
GPC measurements were performed using a Shimadzu GPC with Shimadzu RI and 
UV/Vis detection, fitted with a Polymer Laboratories Plgel 5 µm mixed-D column, and a 
PL 5 µm Guard column (separation range from 500 to 300,000 molecular weight) using 
THF or NMP as mobile phase at 35°C and 70°C respectively. Polymer Laboratories 
polystyrene calibration kits were used. 
Dynamic light scattering (DLS) measurements were carried out using an ALV/GmbH set 
up fitted with an ALV 125-laser light spectrometer, an ALV-5000 digital correlator and a 
Lexel 500 mW Ar-laser. The measurements were carried out a 514.5 nm, 200 mW and at 
an angle of incidence of 60, 90 and 120°. 
Cryo Scanning Electron Microscopy (Cryo-SEM) was performed on JEOL JSM T300 
operating at 30kV. The sample solution was heated above the LCST, and quenched in 
nitrogen slush. Afterwards, the sample was freeze-fractured using standard procedures, 
and transferred into the Cryo SEM. The sample was sublimed for 5 minutes before 
inserting into the sample chamber. 
 
4.4.2 Reagents 
CuCl (Aldrich, 97 %) was purified by washing with glacial acetic acid 3 times and 
once with diethyl etherREF. Boc-L-Valine (Fluka, ≥ 99%), Boc-L-Proline (Fluka, ≥ 
Chapter 4 Stimulus Responsive Behaviour of Elastin Based Polymers 
 
 99
99%), Glycine ethyl ester hydrochloride (HCl.H-Gly-OEt, Janssen, 99%), polyethylene 
glycol , Mn = 1000 g/mol (PEG 1000) (Fluka), hydroxyl ethyl methacrylate (HEMA 
Aldrich 97 %), 2-bromo-isobutyric acid, (Aldrich 98%), 2-isocyanatoethyl-methacrylate 
(Aldrich 98%), 2,2´-bipyridyl (Bipy) (Aldrich 99%), N, N-dicyclohexylcarbodiimide 
(DCC) (Fluka 99 %), 4-dimethylaminopyridine (DMAP) (Across 99%), DMSO-d6  
(Aldrich 99.9 %), N,N´-diisopropylethylamine (DIPEA) (Fluka 99%), 1-
hydroxybenzotriazole hydrate (HOBt) (Fluka ≥ 98%), potassium hydrogen sulfate 
(KHSO4) (Riedel-de Haën 99%), sodium hydrogen carbonate (NaHCO3) (Merck 99.5%)  
sodium sulfate anhydrous (Fluka 99%), were all used as received. 
Dichloromethane (DCM) and ethyl acetate (EtOAc) were distilled from calcium hydride 
prior to use. 
For the buffers sodium chloride (Merck, p.a), sodium dihydrogen monohydrate (Merck, 
p.a), di-sodium hydrogen phosphate dehydrate (Merck, p.a) and ortho-phosphoric acid 
(Merck, p.a., 85 wt. % in water) were all used as received. 
 
4.4.1 Synthesis of methacrylate functionalized Val-Pro-Gly-Val-Gly (1). 
Synthesis of Boc-Val-Gly-OEt. 
Boc-Val-OH, 5.64 g (0.26 mmol) was dissolved in EtOAc (80 mL). To this 
mixture HCl.H-Gly-OEt, 3.63 g (0.26 mmol), DIPEA, 8.9 mL (0.52 mmol) and BOP, 
11.49 g (0.26 mmol) were added. After stirring for 10 minutes another equivalent of 
DIPEA, 4.45 mL (0.26 mmol) was added drop wise to obtain a basic solution (pH > 9). 
The reaction was stirred at room temperature for 16 hours. The reaction mixture was 
washed 3 times with 10 ml of a 1M NaHCO3 solution, once with 10ml water, once with 
10 ml brine solution, 3 times with 10 ml of a 1M KHSO4 solution, twice with 10 ml water 
and finally with 10 ml brine. The ethyl acetate layer was dried with Na2SO4 and the 
solvent (ethyl acetate) was removed under reduced pressure yielding the crude product. 
The crude product was dissolved in DCM and then added to diethyl ether. The impurities 
were filtered off and discarded and the remaining diethyl ether was removed under 
reduced pressure. Pure Boc-Val-Gly-OEt (6.92 gram) was obtained in 88% yield. 
1H-NMR (400 MHz, DMSO-d6): δ 0.9 (CH(CH3)2, 6H, m); 1.2 (CH3-CH2, 3H, t); 1.35 
(C(CH3)3, 9H, s); 2.1 (CH(CH3)2, 1H, m); 3.9 (HN-CH-C=O), 1H, m); 3.8 (NH-CHaHb-
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C=O, 1H, m); 4.0 (NH-CHaHb-C=O, 1H, m); 4.1 (CH3-CH2, 2H, q); 6.9 (-HN-CH-C=O, 
1H, d); 8.1 (NH-CH2, 1H, t). 
 
Synthesis of the HCl salt of H-Val-Gly-OEt. 
Boc-Val-Gly-OEt, 6.92 gram (0.23 mmol) was dissolved in 2 M HCl/EtOAc (50 
mL) and stirred for 90 minutes at room temperature. The reaction mixture was 
concentrated under reduced pressure. The resulting product was extracted in DCM (50 
mL), which was removed under reduced pressure. Pure HCl.H-Val-Gly-OEt was obtained 
in quantitative yield, (5.49 g). 
1H-NMR (400 MHz, DMSO-d6): δ 0.9 (CH-CH(CH3)2, 6H, m); 1.2 (CH3-CH2, 3H, t); 
2.15 (CH-CH(CH3)2, 1H, m); 3.7 (CH-CH(CH3)2), 1H, m); 3.8 (NH-CHaHb-C=O, 1H, 
m); 4.0 (NH-CHaHb-C=O, 1H, m); 4.1 (CH3-CH2, 2H, q); 7.6 (NH-CH2, 1H, s); 8.3 
(H3N+-CH, 3H, s). 
 
-Synthesis of Boc- Pro-Gly-OEt. 
Boc-Pro-OH, 10.02 g (46.6 mmol), HCl.H-Gly-OEt, 6.49 g (46.6 mmol), HOBt, 
7.13 g (46.6 mmol) and DIPEA, 16.0 mL (93 mmol) were dissolved in EtOAc (40 mL).  
To this solution, DCC (9.59 g, 46.6 mmol) was added. The reaction mixture was stirred 
for 16 h at room temperature, during which time a white precipitate (dicyclohexylurea 
(DCU)) was formed, which was filtered off. The reaction mixture was washed three times 
with 10 mL 1M KHSO4, 10 mL water, 10 mL brine, three times 10 mL 1M NaHCO3,  
twice with 10 mL water and finally with 10 mL brine. The mixture was then dried over 
Na2SO4 and solvent was removed under reduced pressure to obtain Boc-Pro-Gly-OEt 
(13.6 g) in 98 % yield. 
1H-NMR (400 MHz, DMSO-d6): δ 1.2 (CH3-CH2, 3H, t); 1.4 (C(CH3)3, 9H, s); 1.7-2.0 
(N-CH2-CH2-CH2, 4H, m); 3.3 (N-CH2-CH2-CH2, 2H, m); 3.8 (NH-CH2-CO, 2H, m); 4.1 
(CH3-CH2, 2H, q); 4.15 (N-CH-CO, 1H, m); 8.2 (NH-CH2-CO,1H, t). 
 
-Synthesis of the HCl salt of H- Pro-Gly-OEt. 
Boc-Pro-Gly-OEt, 13.6 g (45.5 mmol) was dissolved in 2M HCl/EtOAc (150 ml) 
and stirred for 90 minutes at room temperature. The excess HCl/EtOAc was removed 
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under reduced pressure. The resulting product was extracted in DCM (50 mL), which was 
removed under reduced pressure, yielding 10.7 gram of HCl.H-Pro-Gly-OEt (quantitative 
yield). 
1H-NMR (400 MHz, DMSO-d6): δ 1.2 (CH3-CH2, 3H, t); 1.9-2.1 (N-CH2-CH2-CH2, 4H, 
m); 3.3 (N-CH2-CH2-CH2, 2H, m); 4.0 (NH-CH2-CO, 2H, m); 4.2 (CH3-CH2, 2H, q); 4.4 
(N-CH-CO, 1H, m); 8.2 (NH-CH2-CO,1H, t). 
 
- Synthesis of Boc-Val-Pro-Gly-OEt. 
HCl.H-Pro-Gly-OEt, 10.7 g (45.5 mmol) was dissolved in EtOAc (200 ml). To 
this solution Boc-Val-OH, 9.89 g (45.5 mmol), HOBt, 6.99 g (45.5 mmol) and three 
equivalents DIPEA (23.7 ml) were added. Finally, 9.39 g DCC (45.5 mmol) was added. 
The reaction was stirred at room temperature for 22 h, during which time a white 
precipitate (DCU) was formed. This was filtered off and the reaction mixture was washed 
three times with 10 mL 1M KHSO4, 10 mL water, 10 mL brine, three times 10 mL 1M 
NaHCO3,  twice with 10 mL water and finally with 10 mL brine. The reaction mixture 
was then dried over Na2SO4 which was filtered off. The solvent was removed under 
reduced pressure and the remaining solid was extracted with DCM (150 mL), which was 
removed under reduced pressure (15.27 g). The crude product was then purified by 
column chromatography using 5% MeOH in DCM as a mobile phase. Boc-Val-Pro-Gly-
OEt was obtained in 61% yield (11.1g). 
1H-NMR (400 MHz, DMSO-d6): δ 0.8 (CH-(CH3)2, 6H, m); 1.2 (CH3-CH2, 3H, t); 1.4 
(C(CH3)3, 9H, s); 1.9-2.1 (N-CH2-CH2-CH2 and CH-(CH3)2, 5H, m); 3.3 (N-CH2-CH2-
CH2, 2H, m); 3.8 (NH-CH2-CO and NH-CH(CH-(CH3)2)-CO, 3H, m); 4.2 (CH3-CH2, 2H, 
q); 4.4 (N-CH-CO, 1H, m); 6.6 (NH-CH(CH-(CH3)2)-CO, 1H, d); 8.2 (NH-CH2-CO,1H, 
t). 
 
- Synthesis of Boc-Val-Pro-Gly-OH. 
Boc-Val-Pro-Gly-OEt, 11.1 g (27.8 mmol) was dissolved in 153 ml of a mixture 
containing 70% dioxane, 10% water and 20% 4M NaOH. This was stirred for 1 h. The 
solution was then neutralized by adding 1M KHSO4 until a pH of 7 was obtained; the 
solvent was removed under reduced pressure. The crude product was redissolved in 100 
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mL EtOAc, and washed three times with 10 mL 1M KHSO4 and twice with 10 mL water. 
After drying over Na2SO4, EtOAc was removed and the solid was extracted with 50 mL 
DCM. The solvent was removed under reduced pressure, yielding 10.0 g of pure Boc-
Val-Pro-Gly-OH (quantitative yield). 
1H-NMR (400 MHz, DMSO-d6): δ 0.8 (CH-(CH3)2, 6H, m); 1.4 (C(CH3)3, 9H, s); 1.9-2.1 
(N-CH2-CH2-CH2 and CH-(CH3)2 5H, m); 3.3 (N-CH2-CH2-CH2, 2H, m); 3.8 (NH-CH2-
CO and NH-CH(CH-(CH3)2)-CO, 3H, m); 4.4 (N-CH-CO, 1H, m); 6.6 (NH-CH(CH-
(CH3)2)-CO, 1H, d); 8.2 (NH-CH2-CO,1H, t). 
 
- Synthesis of Boc-Val-Pro-Gly-Val-Gly-OEt. 
Boc-Val-Pro-Gly-OH, 5.00 g (13.46 mmol) was dissolved in 80 mL EtOAc. To 
this mixture 6.9 mL of DIPEA (40.38 mmol) and 3.21 g of HCl-Val-Gly-OEt (13.46 
mmol) were added. Next 2.78 g of DCC (13.46 mmol) was added, the reaction was then 
stirred for 30 h during which time a white precipitate (DCU) was formed. This precipitate 
was filtered off and the reaction mixture was washed three times with 10 mL 1M KHSO4, 
10 mL water, 10 mL brine, three times with 10 mL 1M NaHCO3,  twice with 10 mL 
water and finally with 10 mL brine. After drying over Na2SO4, the solvent was removed 
and the crude product was redissolved in 50 mL DCM, which was subsequently removed 
under reduced pressure. After purifying by column chromatography using 60H silica and 
5% MeOH/DCM as mobile phase, 4.02 gram of pure Boc-Val-Pro-Gly-Val-Gly-OEt was 
obtained (yield 54%). 
1H-NMR (400 MHz, DMSO-d6): δ 0.8 (CH-(CH3)2, 12H, m); 1.2 (CH3-CH2, 3H, t); 1.4 
(C(CH3)3, 9H, s); 1.9-2.1 (N-CH2-CH2-CH2, CH-(CH3)2, 6H, m); 3.4 (N-CH2-CH2-CH2, 
2H, m); 3.6-4.2 (NH-CH2-CO, NH-CH(CH-(CH3)2)-CO and CH3-CH2, 8H, m); 4.3 (N-
CH-CO, 1H, m); 6.6 (NH-CH(CH-(CH3)2)-CO, 1H, d); 7.6 (NH-CH(CH-(CH3)2)-CO, 
1H, d); 8.2 (NH-CH2-CO,1H, t); 8.35 (NH-CH2-CO,1H, t). 
 
- Synthesis of Boc-Val-Pro-Gly-Val-Gly-OH. 
Boc-Val-Pro-Gly-Val-Gly-OEt, 3.01 g (5.42 mmol) was dissolved in 29.8 mL of a 
mixture containing 70% dioxane, 10% water and 20% 4M NaOH. This was then stirred 
for 1 h at room temperature. After neutralizing to pH 7 with 1M HCl, the solvent was 
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removed under reduced pressure. 4.1g (7.57 mmol) of Boc-Val-Pro-Gly-Val-Gly-OH was 
obtained (quantitative yield) 
1H-NMR (400 MHz, DMSO-d6): δ 0.8 (CH-(CH3)2, 12H, m); 1.4 (C(CH3)3, 9H, s); 1.7-
2.1 (N-CH2-CH2-CH2 and CH-(CH3)2, 6H, m); 3.4 (N-CH2-CH2-CH2, 2H, m); 3.6-4.2 
(NH-CH2-CO, NH-CH(CH-(CH3)2)-CO, 6H, m); 4.3 (N-CH-CO, 1H, m); 6.6 (NH-
CH(CH-(CH3)2)-CO, 1H, d); 7.6 (NH-CH(CH-(CH3)2)-CO, 1H, d); 8.35 (NH-CH2-
CO,2H, t). 
 
- Synthesis of HCl.H-Val-Pro-Gly-Val-Gly-OH. 
Boc-Val-Pro-Gly-Val-Gly-OEt, 4.1g (7.57 mmol) was dissolved in 50 mL of 2M 
HCl/EtOAc and stirred for 1h. The excess of HCl and solvent was removed under 
reduced pressure. The product was redissolved in 50 ml DCM, which was subsequently 
removed under reduced pressure. 3.7g (7.57 mmol) of HCl.H-Val-Pro-Gly-Val-Gly-OH 
was obtained (quantitative yield). 
1H-NMR (400 MHz, DMSO-d6): δ 0.8 (CH-(CH3)2, 12H, m); 1.7-2.1 (N-CH2-CH2-CH2 
and CH-(CH3)2, 6H, m); 3.4 (N-CH2-CH2-CH2, 2H, m); 3.6-4.2 (NH-CH2-CO, NH-
CH(CH-(CH3)2)-CO, 6H, m); 4.3 (N-CH-CO, 1H, m); 7.6 (NH-CH(CH-(CH3)2)-CO, 1H, 
d); 8.1 (NH3+-CH(CH-(CH3)2)-CO, 3H, d); 8.2 (NH-CH2-CO, 1H, m); 8.3 (NH-CH2-CO, 
1H, m). 
 
- Synthesis of methacrylate functionalized Val-Pro-Gly-Val-Gly (1). 
HCl.H-Val-Pro-Gly-Val-Gly-OH , 1.3g (2.71 mmol) was dissolved in 30 mL of 
Milli-Q water. To this solution 0.57 g of NaHCO3 (6.8 mmol) was added to obtain a basic 
reaction mixture of pH = 8. Next 767 µL of 2-isocyano ethyl methacrylate (5.42 mmol) 
was added dropwise while stirring vigorously. The reaction mixture was stirred for 150 
min. After washing twice with 5 mL DCM, the pH was lowered to 1 with 1M HCl. 
Finally, the product was extracted from the water layer with butanol which was 
subsequently removed under reduced pressure. The product was redissolved in water and 
after freeze drying, 1.4 gram (yield 89 %) of pure product was obtained. 
1H-NMR (400 MHz, DMSO-d6): δ 0.8 (CH-(CH3)2, 12H, m); 1.7-2.1 (N-CH2-CH2-CH2, 
CH-(CH3)2 and  CO-CH(CH3)=CH2,9H, m); 3.4-3.8 (N-CH2-CH2-CH2, and NH-CH2-CO, 
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6H, m); 4.0 (O-CH2-CH2-O, 2H, s); 4.2 (NH-CH(CH-(CH3)2)-CO, 2H, m); 4.3 (N-CH-
CO, 1H, m), 5.6 and 6.0 (C=CH2, 2H, s); 6.2 (NH-CH2-COOH 1H, m); 7.6 (NH-CH(CH-
(CH3)2)-CO, 1H, d);  8.2 (NH-CH2-CO, 1H, m); 8.3 (NH-CO-NH, 2H, m). 
13C-NMR (SO(CD3)2): δ 17.94, 18.30, 19.12, 24.52, 29.15, 30.77, 31.33, 55.92, 58.52, 
59.67, 64.12, 125.81, 135.80, 157.83, 166.50, 168.46, 170.52, 171.27, 171.63, 171.91. 
MALDI-TOF-MS: m/e 605 (M+ -H +Na); 621 (M+ -H +K); 627 (M+ -2H + 2Na). 
 
4.4.2 Polymerization of monomer 1, to an ABA block co-polymer 
The polymerization of methacrylate functionalized Val-Pro-Gly-Val-Pro 1 was 
carried out according to the previously published procedure.1 The polymerizations were 
performed at 60°C until the desired conversion was achieved. After polymerization, the 
mixture was poured in diethyl ether. After decantation of the ether layer, the brown 
polymer precipitate was redissolved in demineralised water (resulting solution pH 6.0). 
After acidifying the solution to pH 1 with 1M HCl, the solution was heated to 70-80°C 
and centrifuged. The water layer was decanted and the resulting crude product was 
redissolved in water. After freeze drying the pure product was obtained. 
The number of units of monomer 1 added to the PEG bifunctional initiator and 
subsequently the number average molecular weight Mn were determined by 1H-NMR 
spectroscopy in DMSO-d6, using the resonances of  the CH2-O groups of poly ethylene 
glycol at 3.5 and the signal of the urea group at 6.2. 
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5.1 Introduction 
Block copolymers have been studied extensively in the past decades because of 
their interesting assembly and phase separation behaviour in both solid state and solution. 
Well defined nano-structured materials have been prepared for a wide variety of 
applications, from electronics,1,2 to drug delivery.3 Recently there has been a growing 
interest in a specific class of hybrid block copolymers, in which well-defined peptide 
sequences are combined with synthetic polymers to create materials with novel secondary 
architectures.4   
There are many examples of the use of peptide-polymer hybrids to create phase 
separated nano structures on surfaces.5-8 Gallot and co-workers produced one of the first 
examples by preparing diblock copolymers of polystyrene or polybutadiene with poly(γ-
benzyl-L-glutamate) and poly(ε-benzyloxycarbonyl-L-lysine). It was found that these 
block copolymers formed lamellar structures in solution and in the dry state the peptide 
chains folded and arranged in a hexagonal array on a surface. Recently the development 
of controlled NCA polymerization methodologies has enabled researchers to investigate 
in more detail the effects of polydispersity on phase separation and polymer assembly. 9,10 
 Sogah and co-workers prepared block copolymers of β-sheet folding peptides, 
consisting of alanine or alanyl-glycine repeats, and polyethylene glycol. These structures 
gave rise to a phase separated material with a secondary structure similar to that of spider 
silk, consisting of crystalline β-sheet domains surrounded by an amorphous PEG matrix. 
Smeenk et al.11 recently prepared a similar material using protein engineering techniques. 
They produced a β-sheet forming polypeptide, which was subsequently coupled to a 
synthetic polymer. This triblock copolymer assembled into well defined fibres on a 
surface.   
 Amphiphilic peptide-polymer hybrid materials have also been used to form 
aggregates in solution.12  One interesting series of block copolymers was prepared by 
Cornelissen et al., by combining polystyrene with polyisocyanides containing peptides in 
the side chain.13-15 These so-called super-amphiphiles formed a variety of assemblies in 
solution, such as helical ribbons and vesicular aggregates, known as polymersomes. In a 
different approach by Velonia et al., polystyrene was linked to the lipase B enzyme of 
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candida antarctica, (CAL-B), via a maleimide-mediated coupling with a free cysteine. 
These giant-amphiphiles were shown to form micellar rods in solution.   
Klok et al. reported the synthesis of water-soluble stimuli responsive vesicles from 
peptide-based diblock copolymers. They prepared a block copolymer of polybutadiene 
and poly(glutamic acid) (PB-b-PGA) by using an amine functionalized polybutadiene as 
a macro initiator for the polymerisation of the N-carboxyanhydride of glutamic acid. 
They showed that these block copolymers formed vesicles whose size could be altered by 
varying the pH.16  
In a slightly different approach the same group17,18 used solid phase peptide 
chemistry to produce a coiled coil peptide motif with the sequence G(EAKLAEI)3Y, 
which was subsequently coupled to a PEG chain. They demonstrated that these block 
copolymers formed discrete supramolecular aggregates of two, three or four block 
copolymers instead of the unspecific self organisation normally associated with 
amphiphilic block copolymers. This is due to the fact that the driving force behind the 
formation of these supramolecular aggregates is not hydrophobic interaction as with 
conventional phase separation in normal block copolymers, but instead the propensity of 
the peptide blocks to form well organised tertiary structures.     
Recent advances in controlled radical polymerisation have given materials 
scientists an alternative approach with which to synthesise peptide-polymer hybrid 
materials. The attachment of initiator moieties to the end of a peptide has made it possible 
to perform controlled radical polymerisations from a peptide. The first example of this 
approach was published by Wooley and co workers19, who functionalised a peptide with 
an alkoxyamine group. While still on the resin, this peptide could then be used to initiate 
a nitroxide-mediated polymerisation (NMP). Mei et al. 20 used a similar approach to 
synthesise a polymer using the peptide GRGDS as an initiator. After functionalisation of 
the free N-terminus with 2-bromopropionyl bromide, to give an α-bromo amide initiator 
they were able to use this peptide to initiate the atom transfer radical polymerisation 
(ATRP) of hydroxy ethyl methacrylate. The cell binding efficiency of the polymer-
peptide hybrid was furthermore investigated. Both of these polymerisations were initiated 
by a peptide on the resin, the polymerisations themselves were not that well controlled.  
From Structural Proteins to Synthetic Polymers 
 110
Rettig et al. showed that it was possible to use a peptide based initiator in solution. 
They synthesised a peptide with the sequence GDGFD and, while still on the resin, 
converted the free amine to an α-bromo amide. This modified peptide was then cleaved 
from the resin and used to initiate the ATRP of n-butyl methacrylate, yielding a well 
defined polymer with a molecular weight distribution of 1.19. 
 In a recent article Wooley et al21 prepared two initiators based on Tritrpticin, a 13 
residue antimicrobial peptide, one for NMP and one for ATRP.  These functionalized 
peptides were used to initiate the polymerization of t-butyl acrylate, followed by styrene 
to produce a triblock copolymer. After cleavage from the resin and hydrolysis of the t-
butyl esters with trifluoro acetic acid (TFA), the ABC type tri block copolymers formed 
micellar aggregates in solution. Interestingly the anti microbial activity of the peptide was 
enhanced relative to the free peptide and the detrimental side effects normally associated 
with antimicrobial peptides, such as a high hemolytic activity, were reduced.  
The aim of this chapter is to prepare, in a controlled fashion, a peptide based 
amphiphilic triblock copolymer which can form aggregates in solution. We have chosen 
to use an approach similar to both Wooley21 and Rettig22 in which a peptide is 
synthesised on the resin and functionalised with an α-bromo ester group, which can be 
used to initiate the ATRP of MMA. Our approach differs from this previous work in that 
the peptide is used as a bifunctional initiator, in order to prepare ABA type block 
copolymers. The use of an alcohol as a functional handle in the side chain of the peptide 
allows the introduction of an α-bromo ester instead of an α-bromo amide, which should 
be beneficial for obtaining control over polymerisation.  
The peptide sequence we have chosen is a hydrophilic sequence known to form β-
hairpins.11 This should give rise to an amphiphilic polymer containing a peptide-based 
hydrophilic block with two amorphous synthetic blocks. The purpose of using a β-hairpin 
peptide sequence as the middle block of an ABA block copolymer is to facilitate the self 
assembly process. As the peptide folds into a β-hairpin, the two hydrophobic tails should 
be brought into closer proximity of each other, thus aiding the hydrophobic association of 
the polymer chains.        
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5.2 Results and discussion.  
To synthesise an ABA triblock copolymer, of which the B block is a peptide, it is 
necessary to prepare a peptide based bifunctional initiator. The approach we have chosen 
is to include serines in the peptide sequence which, when deprotected, contain alcohols in 
the side chain. These alcohols can then be modified into α-bromo esters to give the 
desired peptide based ATRP initiator. This peptide can then be used to initiate the 
polymerisation of a monomer such as methyl methacrylate (MMA), to give an ABA type 
block copolymer with a hydrophilic, peptide-based B block, and hydrophobic, pMMA A 
blocks. We have chosen to use ATRP as it is a straightforward polymerisation technique 
for which functional initiators can be easily synthesised.     
The sequence Ac-Ser-Gly-Ala-Gly-Ala-Glu-Gly-Ala-Gly-Ala-Ser-Gly-OH  (Ser = 
serine, Ala = alanine, Gly = glycine  and Glu = Glutamic acid) was synthesised using 
conventional solid phase peptide synthesis. This sequence is based on the crystalline β-
sheet region of silk worm silk, and represents a full β-hairpin.23 After the synthesis of the 
peptide the serines were deprotected and functionalised with 2-bromo-isobutyric acid 
(Scheme 5.1). Finally, the peptide was cleaved from the resin using TFA to yield the 
desired bifunctional initiator. The synthesis of this peptide was not as straight forward as 
can usually be expected for solid phase chemistry. During initial experiments mass 
spectrometry revealed that some of the couplings did not go to completion, giving rise to 
missing amino acids. In order to ensure complete couplings the reaction times were 
extended and this problem was resolved. In addition the coupling of the α-bromo ester to 
the free OH only went to 80 % completion the first time, therefore the product was 
washed and the coupling was repeated, until 100 % conversion was reached. The final 
product was characterised fully by NMR, Mass spectrometry and IR, and from 1 gram of 
resin 550 mg of peptide was obtained.   
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Scheme 5.1. Functionalisation of Ac-Ser-Gly-Ala-Gly-Ala-Glu-Gly-Ala-Gly-Ala-Ser-Gly-
OH on the resin; a)20 ml of a mixture of 3% TFA, 5% tri isopropyl silane (TIS), in DCM; 
b)DIPCDI, DIPEA, 2-bromo isobutyric acid, in DCM; c) 95%TFA in water. 
 
5.2.1 ATRP of MMA from bifunctional initiator 1. 
The polymerisation of methyl methacrylate from initiator 1 was performed using 
ATRP. MMA was chosen as it is a commonly used monomer for ATRP and because of 
its hydrophobic character. The polymerisation was carried out in DMSO-d6 using 
CuCl/PMDETA as a catalyst. After 75 minutes at 900C the polymerization reached 55 % 
conversion. Although there is a slight jump at the beginning of the polymerisation, the 
semi logarithmic plot of conversion against time shows first order kinetics, indicating that 
the polymerisation was controlled (Figure 5.1). Unfortunately, the resulting polymer was 
only soluble in water and DMSO and GPC in either of these solvents was not possible to 
obtain accurate molecular weight data for this polymer. To overcome this problem the 
pMMA blocks were cleaved from the peptide using a mixture of NaOH (4M): dioxane: 
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methanol (1:14:5). GPC analysis of the cleaved pMMA block showed a Mn of 610 g/mol 
and a polydispersity of 1.15. There is a discrepancy between the theoretical Mn of 1120 
g/mol and the Mn observed by GPC. This can be attributed to a mass loss caused by the 
removal of some of the methyl groups from the side chain of MMA, which can occur 
under these strongly basic conditions. This was confirmed by 1H-NMR. However, from 
the first order kinetics and the polydispersity of 1.15 we can conclude that the 
polymerisation was reasonably well controlled.      
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Figure 5.1. Semi logarithmic plot of conversion against time for the polymerisation of 
MMA from bifunctional peptide based initiator 1. 
 
5.2.2 Block Copolymer Assembly 
The assembly behaviour of the obtained peptide-based amphiphilic block 
copolymer was studied more closely, using transmission electron microscopy (TEM), 
cryogenic scanning electron microscopy (cryoSEM) and dynamic light scattering (DLS). 
Several different sample preparation methods were used. First, an aqueous solution of 1 
mg/ml of the block copolymer was prepared. In a second approach the commonly used 
method of applying an organic cosolvent for the formation of amphiphilic block 
copolymer assemblies was investigated .The polymer was added to two different organic 
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solvents, THF and methanol. As the block copolymer was not soluble in either of these 
solvents a suspension was obtained. Upon adding water to this suspension the block 
copolymer dissolved and the organic solvent was subsequently removed under vacuum.  
 
TEM measurements were performed of the three polymer solutions by placing the 
solutions onto a carbon grid, and, after removal of the solvent, shadowing the remaining 
aggregates with platinum. The TEM results of the three preparation methods are depicted 
in Figure 5.3 (aqueous solution), 5.4 (MeOH/water combination) and 5.5 (THF/water 
combination).  From the images obtained it is clear that no defined aggregates could be 
observed when pure water was used (Figure 5.3) or when the block copolymer was first 
suspended in MeOH (Figure 5.3). 
 
 
Figure 5.2. TEM images of pMMA-1-pMMA from an aqueous solution. 
 
 
Figure 5.3. TEM image of pMMA-1-pMMA, prepared by suspending the triblock 
copolymer in MeOH, adding water and subsequently removing MeOH.  
Chapter 5 Peptide-Polymer based vesicles by ATRP 
 115
 
However, when the samples were first suspended in THF, aggregates were clearly visible 
(Figure 5.4). The assemblies formed were spherical in nature and from the areas around 
the aggregates that were not shadowed it appears they collapsed under the vacuum used 
during TEM. This type of disruption is commonly seen with vesicular types of 
aggregates.  
 
 
 
Figure 5.4. TEM images of pMMA-1-pMMA, prepared by suspending the triblock 
copolymer in THF, adding water and subsequently removing the THF.  
 
With cryogenic scanning electron microscopy (cryoSEM) aggregates are frozen 
into a water droplet before introduction into the microscope, which stops the aggregates 
from collapsing under the low vacuum necessary for electron microscopy. The first 
sample that was measured as a control experiment was again the block copolymer in 
water. No structures could be observed in the SEM image (Figure 5.5). 
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Figure 5.5. CryoSEM images of pMMA-1-pMMA in water 
 
The SEM image of the second sample, which was again prepared by suspending 
the triblock copolymer in THF, adding water and subsequently removing the THF, 
clearly showed the presence of spherical aggregates (Figure 5.6). 
 
 
 
Figure 5.6. CryoSEM image of pMMA-1-pMMA, prepared by suspending the triblock 
copolymer in THF, adding water and subsequently removing THF. 
 
To investigate the size and shape of these assemblies they were studied using 
dynamic light scattering. These measurements were performed on two samples, one 
control sample prepared in water and one prepared using THF as cosolvent. For the 
control sample no scattering was observed, indicating that no aggregates were present. 
The second sample, containing the aggregated polymer, showed particles with a mean 
radius of 606 nm ± 132 nm, demonstrating they are not particularly uniform in size. 
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However, the three mean diffusion coefficients are similar to each other (Table 5.1), 
which is a strong indication that the particles are spherical. 
Table 5.1. The mean diffusion coefficient for the 1st, 2nd and 3rd diffusion coefficients.  
 
Coefficient number Mean diffusion coefficient 
1 2.95 
2 3.19 
3 3.21 
 
The formation of aggregates only occurs when the triblock copolymers are first 
suspended in THF. It is thought that this is due to the pMMA block of the polymer. In 
water these pMMA blocks are not soluble and therefore are too rigid to associate and 
cause phase separation. When placed in a THF/water mixture they are more soluble and 
therefore have an improved ability to aggregate, causing phase separation. If they are 
placed in a methanol/water mixture it is possible that the solubility of the pMMA parts is 
still too low and therefore no well-defined aggregation was observed.   
 The spherical aggregates that are observed could be either micelles or vesicles. In 
this case there is strong evidence to suggest that these particles are polymersomes. The 
spheres are larger than expected for micelles (600nm, based on DLS),21 and they collapse 
under the vacuum applied by the TEM measurements, proving that they are hollow. 
Micellar aggregates are solid and, therefore, should not collapse in vacuum.    
 
5.2.3 β-sheet Characterisation of Vesicles 
To investigate the secondary structure of our peptide based-block copolymer IR 
spectroscopy was used. This technique was chosen since it can reveal detailed 
information about the conformation of the peptide structure under investigation. From the 
amide I and amide II peaks it was observed that neither the initiator nor the tri block 
copolymer form β-sheets before assembly into vesicles. It was also clear from the IR 
spectra of the triblock polymer after assembly into vesicles that the peptide remains 
(partly) in a random coil type of structure (Figure 5.7 and Table 5.2). 
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Table 5.2. A comparison of standard amide I and Amide II values24 for anti parallel β-
sheets to amide I and II values for 1,  pMMA -1-pMMA, and pMMA -1-pMMA in vesicles. 
 
 
 
 
Figure 5.7. Amide I and II region in infrared for A) 1, B)  pMMA-1-pMMA and C) 
pMMA-1-pMMA in vesicles. 
 
Compound Amide I ( cm-1) Amide II (cm-1) 
Random coil 1656  1535  
Antiparallel β-sheet 1632-1613(s)/1685(w)  1530  
1 1640  1519 
pMMA-1-pMMA 1648  1527  
pMMA-1-pMMA in vesicle 1644(s) 1531  
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It was not expected that a β-sheet conformation would be observed for compound 
1, or for the triblock copolymer, pMMA-1-pMMA, as they were not exposed to 
conditions in which folding could occur. It is surprising, however, that no β-sheet 
formation is observed for this peptide sequence when assembled into a vesicular 
structure. It can be supposed that the peptide must fold in some manner to allow the 
pMMA tails to aggregate within the vesicle wall. IR clearly shows that during this folding 
process the peptides do not aggregate into β-sheets. This could be a result of the steric 
hindrance introduced by the pMMA chains causing the peptide to twist during the 
aggregation process, preventing the creation of hydrogen bonds within the loop. It could 
also be that aggregation occurs too rapidly, trapping the peptide in a random coil structure 
before it has enough time to form β-hairpins.   
 
5.3 Conclusion 
 In this chapter a new synthetic method for the preparation of peptide containing 
triblock copolymers has been demonstrated. The synthesis of a β-sheet containing, 
bifunctional ATRP initiator, is shown. The inclusion of two serines in the peptide 
sequence allows the introduction of an α-bromo ester, in place of the α-bromo amide 
used by Rettig et al.22 This bifunctional initiator was then used to initiate the ATRP of 
MMA.  
Having created a peptide-based amphiphilic polymer we investigated the 
structures formed in solution. It was shown that in water no aggregation takes place and 
therefore no structures are discerned, however, upon first suspending the polymer in THF 
and then adding water we observed the formation of vesicles or polymersomes. These 
structures were studied with TEM, cryoSEM and DLS to confirm the shape and average 
particle size. IR spectroscopy revealed that the peptide assumed a random coil structure 
within the wall of the vesicle.  
 This work highlights the possibilities which exist when using peptide based 
polymers to create nano structured materials. Altering the peptide which is used, the 
length of the polymer which is made, or even the monomer which is polymerised, could 
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lead to a wide range of fascinating nanometer sized structures, with interesting 
functionalities on the surface.   
 
5.4 Experimental 
5.4.1 General procedures 
1H and 13C-NMR spectra were measured on a 400 MHz Bruker Inova400 machine with a 
Varian probe.  
IR spectra were measured on an ATI Mattson Genesis Series FTIR.  
CD spectra were measured on a Jasco J-810 spectropolarimeter, with a temperature 
control unit. Samples were dissolved in a phosphate buffer of pH 1, 2 or 3 at varying 
concentrations. The polymer solution was diluted until maximum UV absorption of 1.5 
was reached at 220 nm. The samples were measured using a 1 mm quartz cuvette at 
different temperatures.  
MALDI-TOF-MS spectra were measured on a Bruker Biflex III machine, with 
dihydroxybenzoic acid (DHB) as matrix. The samples were prepared by dissolving 2 mg 
of analyte in 1 mL THF, after which this solution was mixed in a 1:1 ratio with a solution 
of 10 mg DHB in 1mL H2O containing 0.1% trifluoro acetic acid. This was then placed 
on a MALDI plate. 
GPC measurements were attempted using a Shimadzu GPC with Shimadzu RI and 
UV/Vis detection, fitted with a Polymer Laboratories Plgel 5 µm mixed-D column, and a 
PL 5 µm Guard column (separation range from 500 to 300,000 molecular weight) using 
THF or DMSO as mobile phase at 35 and 70°C respectively. Polymer Laboratories 
polystyrene calibration kits were used.  
The dynamic light scattering (DLS) measurements were carried out using an intensity 
stabilized Helium-Neon laser (Spectra Physics, λ=632.8 nm, 4.5 mW). The incident beam 
of the laser was focused in the center of the precision glass cylindrical cuvette (Helma), 
which was used as a scattering cell. The light, scattered at 60, 90 and 1200 with respect to 
the incident beam, was transferred to the single photon detector (ALV/SO-SIPD) through 
a single mode fiber to meet the spatial coherence conditions. The signals were processed 
with a 320 channel Multiple Tau Digital Correlator (ALV-5000/E). The measurements 
were carried out in a temperature range of 20-90 °C (±0.05 °C) using a laboratory-made 
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heating stage driven by an active feedback temperature controller (LakeShore 340). The 
raw data was fitted using Origin 6.1 computer software. 
For the TEM studies a JEOL JEM-1010 instrument was used. Samples were prepared by 
drying a drop of the dispersion on a carbon-coated copper grid. When grids of aqueous 
samples were prepared the excess of water was blotted away with a filter paper after 2 
min. For Pt shadowing the grids were placed in an Edwards coater Model 306 under an 
angle of 45° with respect to the Pt source. The samples were left to dry for a day in the 
fume hood before study.  
Cryo Scanning Electron Microscopy (Cryo-SEM) was performed on a JEOL JSM T300 
operating at 30kV. The sample solution was quenched in nitrogen slush. Afterwards, the 
sample was freeze-fractured using standard procedures, and transferred into the Cryo 
SEM. The sample was sublimed for 5 minutes before inserting into the sample chamber. 
 
5.4.2 Reagents 
CuCl (Aldrich, 97 %) was purified by washing with glacial acetic acid 3 times and once 
with diethyl ether25. 
p-Alkoxybenzyl alcohol “Wang” resin (Bachem, 1.14mmol/g), 9-fluorenylmethoxy 
carbamate and trityl protected Serine (Fmoc Ser (Trt)-OH) (Bachem, ≥ 99%), Fmoc-
Glycine (Fmoc Gly-OH) (Bachem, ≥ 99%), Fmoc-tert. butyl protected-Glutamic acid 
(Fmoc Glu(OtBu)-OH) (Bachem, ≥ 99%) Fmoc-Alanine (Fmoc Ala) (Bachem ≥ 99%), 2-
bromo-isobutyric acid, (Aldrich 98%), 2,2´-bipiridyl (Bipy) (Aldrich 99%), N, N-
dicyclohexylcarbodiimide (DCC) (Fluka 99 %), 4-dimethylaminopyridine (DMAP) 
(Acros 99%), DMSO-d6  (Aldrich 99.9 %), N,N´-diisopropylethylamine (DIPEA) (Fluka 
99%), 1-hydroxybenzotriazole hydrate (HOBt) (Fluka ≥ 98%), N,N-
diisopropylcarbodiimide (DIPCDI) (Fluka≥ 98%), trifluoro acetic acid (TFA)  (Aldrich 
98%), tri isopropyl silane (TIS) (Acros 99%) pentamethyl diethylene triamine 
(PMDETA) (Aldrich 98%),  Potassium hydrogen sulfate (KHSO4) (Riedel-de Haën 
99%), Sodium hydrogen carbonate (NaHCO3) (Merck 99.5%)  sodium sulfate anhydrous 
(Fluka 99%), were all used as received.  
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Dichloromethane (DCM) and ethyl acetate (EtOAc) were distilled from calcium hydride 
and THF was distilled from sodium/benzophenone prior to use.  
Dimethylformamide (DMF) and isopropyl alcohol were used as received (J.T.Baker). 
  
5.4.3 Synthesis of 2-bromo-isobutyric acid functionalised Ac-Ser-Gly-Ala-Gly-Ala-
Glu-Gly-Ala-Gly-Ala-Ser-Gly-OH, 1. 
2-bromo-isobutyric acid functionalized Ac-Ser-Gly-Ala-Gly-Ala-Glu-Gly-Ala-
Gly-Ala-Ser-Gly-OH, 1 was synthesized by standard solid phase methods using a 
“Wang” resin. A suspension of Wang resin (30 g) in 300 mL DMF was cooled in an ice 
bath, after which Fmoc Gly-OH (13.5 g, 45mmol), 9.20g (60mmol) HOBt and 4.30g 
(34.2 mmol) DIPCDI were added. This mixture was shaken for 6 hours. The 
functionalized resin was filtered and washed repeatedly with DCM, DMF and isopropyl 
alcohol. Unfunctionalised groups on the resin were capped by adding 10.2 mL 
benzoylchloride and 8.4 mL pyridine to a suspension of the resin in 300mL of DCM at 
0°C. This mixture was shaken for 30 minutes, filtered and washed repeatedly with DCM, 
DMF and isopropyl alcohol. Then 1.5g of the Fmoc Gly functionalized Wang resin 
(loading 0.65 mmol per gram) was swollen and filtered three times in 20 mL DMF. Next 
20 mL of DMF, containing 20% v/v piperidine was added to remove the Fmoc group. A 
positive Kaiser test indicated completeness of this reaction. The next amino acid was 
coupled by adding a mixture of 1.66g (2.01mmol) Fmoc Ser(Trt)-OH, in 30 mL DMF, 
with 3.51 mL of a 1M solution of HOBt in DMF and 3.22 mL of a 1M solution of 
DIPCDI in DMF. The mixture was shaken for 16 hours, after which it was washed with 
DMF and twice with DCM and isopropyl alcohol. A negative Kaiser test indicated the 
completeness of the reaction. The Fmoc group was then removed using the same 
procedure as above. This was repeated with the following eleven amino acids: Fmoc Gly-
OH (0.87 g, 2.01 mmol), Fmoc Ala-OH (0.91g, 2.01 mmol), Fmoc Gly-OH (0.87 g, 2.01 
mmol), Fmoc Ala-OH (0.91g, 2.01 mmol), Fmoc Gly-OH (0.87 g, 2.01 mmol), Fmoc 
Glu(OtBu)-OH (1.24 g, 2.01 mmol), Fmoc Gly-OH (0.87 g, 2.01 mmol), Fmoc Ala-OH 
(0.91g, 2.01 mmol), Fmoc Gly-OH (0.87 g, 2.01 mmol), Fmoc Ala-OH (0.91g, 2.01 
mmol), Fmoc Gly-OH (0.87 g, 2.01 mmol), and finally, Fmoc Ser(Trt)-OH (1.66g, 2.01 
mmol), except each one was only shaken for 4 hours. While still on the resin the Fmoc 
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protecting group on the terminal serine was removed and the free amine was capped by 
adding 90 mL DMF containing 1 mL Ac2O and 2 mL DIPEA. The Trityl protecting 
groups were then removed from the serine side chains by using 20 mL of  a mixture 
containing 3% TFA and 5% TIS in DCM. This was shaken for 5 mins and then the 
mixture was removed and replaced with another 20 mLs of the same mixture. After 15 
mins it was removed and the resin was rinsed with 20 ml of a solution containing 5% 
DIPEA in DCM. The free OH groups of the serines were then coupled with 2-bromo-
isobutyric acid, 0.97g (3.9 mmol) using DMAP 0.71g (3.9 mmol) and DIPCDI 0.60 mL 
(3.9 mmol) in 20 ml DCM. The resin was then washed repeatedly with DCM, DMF and 
isopropyl alcohol, and this coupling was repeated in order to obtain 100% conversion. 
The final bifunctional peptide based initiator was cleaved from the resin using 90% 
TFA/water solution and was precipitated in diethyl ether.  
550 mg of peptide was obtained. 
MALDI- TOF before α-bromo ester formation: m/e 954 (M- 2 H2O + H+), 990 (M+H+), 1012 (M 
+Na+), 1028 (M+ K+) 
MALDI- TOF: m/e 1230 (100%), 1232 (50%), 1233 (48%), 1228 (48%), 1229 (25%), 
1234 (19%),  (M- Br + Na+), 1310 (100.0%), 1312 (65%), 1311 (50%), 1308 (45%), 1309 
(25%), 1313 (25%), 1314 (10%), (M+Na+). 
1H-NMR (SO(CD3)2): δ 1.2  (CH(CH3), 12H, d); 1.7 (CH2CH2COOH, 2H, m); 1.8 
(H3CC(=O)-NH, and (C(CH3)2Br, 15H, m); 2.2 (CH2CH2COOH, 2H, t); 3.7 
(NHCH2C=O, 12H, m); 4.1-4.3 (NHCH(CH3)C=O, NHCH(CH2CH2COOH)C=O and 
NHCH(CH2-OR)C=O, 9H, m); 4.7  (NHCH(CH2-OR)C=O, 2H, m); 7.8-8.2 
(NHC(R)C=O, 13H, m); 8.4 (Ac-NHC=O, 1H, t). 
13C-NMR (SO(CD3)2): δ 17.96, 18.33, 18.57, 22.74, 26.81, 31.34, 40.79, 42.27, 48.13, 
48.54, 48.58, 48.84, 52.54, 157.84, 168.03, 168.30, 168.52, 168.60, 169.39, 170.77, 
171.49, 172.20, 172.21, 172.29, 172.68.  
IR: 3277 (N-H str.); 2926 (C-H str.); 1731 (C=O str. α-bromo ester): 1640 (C=O str. 
amide I); 1519 (N-H vib. amide II); 1445 (C-H vib.) cm-1.  
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5.4.4 ATRP Polymerization of MMA from initiator 1 
Initiator 1, 30.9mg (0.025 mmol), and CuCl 10.1 mg (0.1 mmol) were placed in a 
schlenck vessel. The vessel was then evacuated and purged with Ar three times to remove 
any air present in the system. 106 µl MMA (1 mmol) and 11 µl PMDETA (0.1mmol) 
were added to the vessel, along with 1 ml DMSO-d6. This solution was purged for 10 
minutes with Ar at room temperature and then the polymerization mixture was heated to 
900C. The conversion of the polymerization was followed using 1H-NMR spectroscopy, 
by comparing the integrals of the protons of the methacrylate double bond at δ 6.0 ppm 
with the peak due to the α-protons of the alanines and glutamic acids at δ 4.25 ppm. After 
1 hour and 5 minutes the polymerization reached 55 % conversion and was stopped. The 
blue polymer solution was precipitated into diethyl ether and stirred for 10 minutes. The 
ether was then decanted off and the remaining polymer was left to air dry. The yield was 
not determined due to the fact that samples were taken throughout the polymerisation, 
however 55 mg of polymer was obtained. For GPC analysis 5 mg of the polymer was 
placed in a mixture of Dioxane/water/NaOH (4M) 15:4:1 and stirred for 1 hour. The 
solvent was then removed and the resulting crude product was dissolved in 30 ml DCM. 
This was then washed three times with 10 ml of demi-water. The DCM layer was then 
evaporated and the sample was redissolved in THF. 
1H-NMR (SO(CD3)2): δ 0.6-1.3 (-CH2–C(CH3)R- and (CH(CH3), m); 1.5-2.0 (-CH2–
C(CH3)R- -CH2CH2COOH, H3CC(=O)-NH, and C(CH3)2Br m); 2.2 (CH2CH2COOH, 
m); 3.0-3.8 (C(O)OCH3 and NHCH2C=O, m); 4.1-4.3 (NHCH(CH3)C=O, 
NHCH(CH2CH2COOH)C=O and NHCH(CH2-OR)C=O, m); 4.7  (NHCH(CH2-OR)C=O, 
m); 7.8-8.2 (NHC(R)C=O, m). 
IR: 3277 (N-H str.); 2927 (C-H str.); 1726 (C=O methacrylate); 1648 (C=O str. amide I); 
1527 (N-H vib. amide II); 1458 (C-H vib.) cm-1.  
1H-NMR (CDCl3) pMMA block after cleavage: δ 0.6-0.9 (-CH2–C(CH3)R- ); 1.2 (-CH2–
C(CH3)R-); 3.6 (C(O)OCH3,).  
GPC: Mn = 629 g/mol, PDI =1.15  
1H-NMR Mn = 1120 g/mol 
 
 
Chapter 5 Peptide-Polymer based vesicles by ATRP 
 125
5.5 References 
(1) Kim, H. C.; Wilds, J. B.; Kreller, C. R.; Volksen, W.; Brock, P. J.; Lee, V. Y.; Magbitang, T.; 
Hedrick, J. L.; Hawker, C. J.; Miller, R. D. Advanced Materials 2002, 14, 1637-1639. 
(2) Shin, K.; Leach, K. A.; Goldbach, J. T.; Kim, D. H.; Jho, J. Y.; Tuominen, M.; Hawker, C. J.; 
Russell, T. P. Nano Letters 2002, 2, 933-936. 
(3) Kopecek, J. European Journal of Pharmaceutical Sciences 2003, 20, 1-16. 
(4) Klok, H. A.; Lecommandoux, S. Advanced Materials 2001, 13, 1217 - 1229. 
(5) Billot, J. P.; Douy, A.; Gallot, B. Makromolekulare Chemie-Macromolecular Chemistry And Physics 
1976, 177, 1889-1893. 
(6) Billot, J. P.; Douy, A.; Gallot, B. Makromolekulare Chemie-Macromolecular Chemistry And Physics 
1977, 178, 1641-1650. 
(7) Douy, A.; Gallot, B. Polymer Engineering and Science 1977, 17, 523-526. 
(8) Gallot, B. Progress In Polymer Science 1996, 21, 1035-1088. 
(9) Schlaad, H.; Kukula, H.; Smarsly, B.; Antonietti, M.; Pakula, T. Polymer 2002, 43, 5321-5328. 
(10) Deming, T. J. Advanced Drug Delivery Reviews 2002, 54, 1145-1155. 
(11) Smeenk, J. M.; Otten, M. B. J.; Thies, J.; Tirrell, D. A.; Stunnenberg, H. G.; van Hest, J. C. M. 
Angewandte Chemie-International Edition 2004, In Press. 
(12) Lowik, D.; van Hest, J. C. M. Chemical Society Reviews 2004, 33, 234-245. 
(13) Cornelissen, J. J. L. M.; Fischer, M.; Sommerdijk, N. A. J. M.; Nolte, R. J. M. Science 1998, 280, 
1427-1430. 
(14) Vriezema, D. M.; Hoogboom, J.; Velonia, K.; Takazawa, K.; Christianen, P. C. M.; Maan, J. C.; 
Rowan, A. E.; Nolte, R. J. M. Angewandte Chemie-International Edition 2003, 42, 772-776. 
(15) Vriezema, D. M.; Kros, A.; de Gelder, R.; Cornelissen, J.; Rowan, A. E.; Nolte, R. J. M. 
Macromolecules 2004, 37, 4736-4739. 
(16) Checot, F.; Lecommandoux, S.; Gnanou, Y.; Klok, H. A. Angewandte Chemie-International Edition 
2002, 41, 1339-1343. 
(17) Klok, H. A.; Langenwalter, J. F.; Lecommandoux, S. Macromolecules 2000, 33, 7819-7826. 
(18) Vandermeulen, G. W. M.; Tziatzios, C.; Klok, H. A. Macromolecules 2003, 36, 4107-4114. 
(19) Becker, M. L.; Liu, J. Q.; Wooley, K. L. Chem. Commun. 2003, 180-181. 
(20) Mei, Y.; Beers, K. L.; Byrd, H. C. M.; Vanderhart, D. L.; Washburn, N. R. Journal of the American 
Chemical Society 2004, 126, 3472-3476. 
(21) Becker, M. L.; Liu, J. Q.; Wooley, K. L. Biomacromolecules 2005, 6, 220-228. 
(22) Rettig, H.; Krause, E.; Borner, H. G. Macromolecular Rapid Communications 2004, 25, 1251-1256. 
(23) Simmons, A., H; Michal, C., A; Jelinski, L., W Science 1996, 271, 84-87. 
(24) Krimm, S.; Bandekar, J. In Advances in Protein Chemistry; Academic Press, Inc., 1986; Vol. 38, pp 
282-361. 
(25) Keller, R. N.; Wycoff, H. D. Inorganic Synthesis 1946, 2, 1-4. 
 
 
  
Chapter 6 
Well Defined Polymers 
Containing Antimicrobial 
Peptides
The Synthesis of Peptide based polymers via ATRP 
 
 128
6.1 Introduction 
With the increased resistance of bacteria to currently used antibiotics there has 
been an extensive search for new antibacterial agents.1 Antibacterial peptides, and more 
specifically cationic antimicrobial peptides, offer exciting possibilities as alternatives for 
conventional antibiotics. Currently, more than 500 different antimicrobial sequences have 
either been isolated from a wide range of organisms, or designed and synthesised in  
laboratories.2 These anti microbial peptides can be classified based on their secondary 
structure. Four major classes have been identified: β-sheet, α-helical, loop and random 
coil, with the first two classes being the most prevalent in nature.3 
The mechanism of action of antimicrobial peptides is being actively studied and 
available information continues to grow. Although the mechanism is still widely under 
contention, it is well established that these peptides interact with the cell membrane 
causing it to become leaky.4  It has been shown that the peptide associates with the 
anionic lipopolysaccharide (LPS) layer on the outside of the cell wall, displacing the 
Mg2+ and Ca2+ counter ions normally found there.5 This causes a local disturbance in the 
outer membrane, allowing the peptide access to the cytoplasmic membrane. The 
antimicrobial peptide then compromises the integrity of the cytoplasmic membrane, by 
either forming a supramolecular aggregate and creating channels, or by binding to the 
lipid head groups within the membrane, disturbing its stability, and thus causing cracks to 
appear on the surface.6,7 
Antimicrobial peptides have some advantages over conventional antibiotics. They 
can kill target cells exceptionally rapidly, they have a large activity spectrum and are 
therefore useful against a wide range of bacteria. Due to the physical nature of their 
mechanism of activity there are few known mechanisms of resistance.4 
There are several disadvantages which have limited the use of these peptides as 
antibiotics. The most obvious, which applies to all peptide based therapeutics, is that they 
are easily degraded within the body by proteases. Another disadvantage is that they cause 
membrane disruption not only in bacterial cells, but any cell they come into contact with, 
therefore they can be cytotoxic.8 One method which has been suggested to overcome 
these drawbacks is the synthesis of a peptide-polymer hybrid material based on 
antimicrobial peptides.9,10  
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There are some examples of peptide-polymer hybrids made with antimicrobial 
proteins. Imura et al9 coupled poly ethylene glycol (PEG) to tachyplesin I. Wooley et al 
11 constructed polymer peptide hybrids with antibiotic activity via controlled radical 
polymerisation. For this purpose they prepared two initiators based on Tritrpticin, a 13 
residue antimicrobial peptide, one for nitroxide mediated polymerisation (NMP) and one 
for atom transfer radical polymerisation (ATRP).  They were both used to initiate the 
polymerization of t-butyl acrylate, followed by styrene to produce a triblock copolymer 
on the solid phase. After removal from the resin and hydrolysis of the t-butyl esters, using 
TFA, this tri block copolymer clearly formed micellar aggregates in solution. 
Interestingly, the anti microbial activity of the peptide was enhanced relative to the free 
peptide and the high hemolytic activity normally associated with this peptide, was 
reduced 
In the previous chapters we have looked constructing well defined polymers 
containing at short peptide sequences, taken from well known structural proteins, in the 
side chain. Our aim in this chapter is to show that we can use ATRP to include 
antimicrobial peptides in the side chain of a polymer. Two antimicrobial peptides were 
chosen, one based on gramicidin S (Figure 6.1), a naturally occurring peptide from the β-
sheet class of antimicrobial peptides, and a synthetic peptide from the α-helical 
class.12Gramicidin S is a large cyclic decapeptide which is well known for its antibiotic 
properties.13,14It also is well known to form both inter- and intra-molecular β-sheets.15-17 
This β-sheet secondary structure is integral to the activity of gramicidin S. It is proposed 
that when gramicidin S enters the membrane of the cell wall it aggregates into an 
amphiphilic antiparallel β-sheet type structure with a polar and non polar surface. This 
then disrupts the liposomal packing, causing the cell wall to become permeable. 
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Figure 6.1. The anti microbial peptide gramicidin S. 
 
The second peptide has the sequence KFFKFFKFFK, (K = Lysine, F = 
Phenylalanine) and is a synthetic α-helical peptide which is known as a cell-
permeabilising peptide.18 The α-helix that is formed has a polar and apolar side which 
allows it to penetrate and disrupt the cell membrane.19 Both compounds were chosen as 
target compounds to show it is possible to include a variety of secondary structures into 
synthetic polymers. For both of these peptides the secondary structure is integral to their 
activity,12 therefore their conformation was investigated using IR spectroscopy after 
incorporation into the side chain of a polymer. 
The peptides that we have chosen are bulkier than any other peptide monomer 
which has been polymerised in a controlled fashion, therefore it is a challenge to 
polymerise them using ATRP. The sequence KFFKFFKFFK also contains a large 
quantity of free amines in the side chain which can affect ATRP, making this monomer 
especially challenging to polymerise. 
 
6.2 Results and discussion. 
6.2.1 Monomer synthesis. 
The target peptide monomers based on gramicidin S20-22 and on KFFKFFKFFK. 
were synthesised and kindly provided by Gijs Grotenbreg at the University of Leiden,23 
and Daan Noort of TNO-PML Zeist respectively24 (Figure 6.2). In short, both compounds 
were made using solid phase peptide chemistry.25,26 In the case of gramicidin S one of the 
naturally occurring prolines in the turn was replaced with a hydroxy proline. The hydroxy 
group could then be used to introduce the monomer handle by reaction with ethyl 
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isocyanato methacrylate, to give monomer 1. The KFFKFFKFFK monomer was also 
functionalised on the resin first with a small ethylene glycol spacer, which was again 
coupled with the same ethyl isocyanato methacrylate to give monomer 2. 
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Figure 6.2. Gramicidin S based monomer 1 and KFFKFFKFFK based monomer 2. 
 
6.2.2 ATRP of antimicrobial peptide based monomers. 
 Gramicidin S based monomer 1 was polymerised using ATRP (Figure 6.3). The 
polymerization was performed in an NMR tube under Argon, using the standard ATRP 
initiator ethyl bromo isobutyrate (EBIB), CuCl/PMDETA as catalyst, and DMSO-d6 as 
solvent. The NMR tube was placed in an NMR spectrometer, at a temperature of 55°C 
and 1H NMR spectra were taken at regular intervals. From these spectra the conversion 
was calculated by comparing the amide signals around 7.2 ppm with the methacrylate 
signal at 6.1 ppm. After 15½ hours the polymerisation had reached a conversion of 65% 
and was stopped. From the semi logarithmic plot of conversion against time (Figure 6.4) 
we can clearly see the polymerisation is first order. This indicates good control over the 
polymerisation. This was further confirmed by the GPC data which showed a PDI of 
1.09. There was again a discrepancy between the Mn according to GPC, 9.03 kg/mol and 
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the theoretical Mn 19.6 kg/mol, (corresponding to 13 units). This is ascribed to the 
difference in hydrodynamic volume of the poly(gramicidin S) derivative and the poly 
styrene calibrants used. However, from the linear kinetics and the narrow molecular 
weight distribution it can be concluded that monomer 1 was polymerised in a controlled 
manner. 
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Figure 6.3. Polymerisation of gramicidin S based monomer 1. 
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Figure 6.4. A semi logarithmic plot of conversion versus time for the ATRP 
polymerisation of monomer 1. 
 
Monomer 2 was also polymerised using similar conditions (Figure 6.5). The 
polymerisation was performed in a 400 MHz NMR at 55°C in DMSO-d6, using EBIB as 
initiator and CuCl/PMDETA as a catalyst system. Again the polymerisation was followed 
using 1H NMR spectroscopy, and the conversion was calculated by comparing the amide 
signals around 7.2 ppm with the methacrylate signals at 6.1 ppm. After 7 hours and 45 
minutes the conversion had reached 75 % and was stopped. The semi logarithmic plot 
shows a large spread of data points which makes it difficult to assess whether the 
polymerisation proceeds with first order kinetics. (Figure 6.6). It is unclear why there is 
such a large spread of data points. 
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Figure 6.5. Polymerisation of KFFKFFKFFK based monomer 2. 
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Figure 6.6. Semi logarithmic plot for the polymerisation of monomer 2. 
 
The GPC trace showed two main peaks, one with a retention time of 11.32 
minutes peak and one with a retention time of 12.22 minutes (Figure 6.7). These peaks 
appear after the inclusion limit of the GPC column and after the smallest polystyrene 
calibration standard that was used. This means that it is not possible to determine the 
molecular weight from this GPC spectrum. This anomalous elution behaviour is 
attributed to a combination of the difference in hydrodynamic volume between our 
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polymer and the polystyrene calibrants used, and interaction between the column and the 
polymer. Although it is not possible to get any useful molecular weight data, the presence 
of two peaks, one with a shorter elution time, possibly due to the polymer, and another 
peak a with a longer elution time, possible due to the monomer, provides us with some 
evidence that polymerisation has taken place. This is supported by the fact that 
conversion was observed using NMR. Unfortunately the PDI could not be determined 
from this GPC spectrum, which prevented a more detailed analysis of the level of control 
over polymerisation. 
 
 
 
Figure 6.7. GPC Trace of poly(KFFKFFKFFK). Although both peaks are outside the 
inclusion limit of the column it is probable that peak A is due to the polymer and peak B 
is due to the remaining monomer. The shape of peak A indicates that the polymerisation 
was not totally controlled. 
 
It is possible that by varying the conditions of polymerisation, control over the 
polymerisation could be improved. Unfortunately, due to the limited quantities which 
were available, the polymerisation could be attempted only once and therefore a detailed 
exploration of the conditions required for a living polymerisation process was not 
possible. 
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6.2.3. IR Analysis of Secondary structure. 
To investigate whether by introducing the gramicidin S derivative, 1, into the side 
chain of this polymer there is an adverse effect on its conformation we examined the 
polymer using IR spectroscopy. The amide I and amide II peaks were compared to known 
references for β-sheet amide I and amide II shifts27-29 (Table 6.1) to see if the peptide still 
retained its ability to form β-sheets. 
 
Table 6.1. A comparison of the amide I and II peaks of poly(gramicidin S) with reference 
peaks27,28 for a random coil and antiparallel β-sheet conformation. 
 
Compound Random coil Antiparallel β-sheet gramicidin S 
Poly(gramicidin 
S) 
Amide I 1656 cm-1 1632  cm-1 1632  cm-1 1636  cm-1 
Amide II 1535  cm-1 1530  cm-1 1525  cm-1 1529  cm-1 
 
From these IR measurements we can clearly see that there is still evidence of β-
sheet formation by the gramicidin S analogue in the polymer side chains. This indicates 
that the gramicidin S derivative has not been adversely affected by introduction into the 
polymeric structure. 
The secondary structure of the poly(KFFKFFKFFK) was also investigated using 
IR spectroscopy. The amide I and II peaks were compared to known α-helix amide I and 
II  signals (Table 6.2).30 From the IR results it is clear that the peptide adopts a random 
coil conformation. It would appear that this time the conformation of the peptide is not 
retained during polymerisation. 
 
Table 6.2. A comparison of the amide I and II peaks of poly(O-KFFKFFKFFK) with 
reference peaks30 for an α-helix conformation. 
 
Compound Random coil α-helix Poly(o-KFFKFFKFFK) 
Amide I 1656 cm-1 1658  cm-1 1656  cm-1 
Amide II 1535  cm-1 1545  cm-1 1528  cm-1 
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CD spectroscopy was also performed on both polymers but neither was 
completely soluble in water, therefore scattering was observed. The anti bacterial activity 
of both the gramicidin S and the KFFKFFKFFK based polymers was assessed by TNO 
Zeist, however the results were inconclusive. 
 
6.3 Conclusion 
In this chapter we have shown that it is possible to synthesise and polymerise two 
monomers based on two different antimicrobial peptides. A gramicidin based monomer 
was synthesised and polymerised successfully and IR showed that its secondary structure 
was retained. The polymerisation of the second monomer was less controlled although a 
polymer was still successfully produced. With variations in the polymerisation 
conditions, possibly a reduction in the polymerisation temperature to reduce the speed of 
polymerisation slightly, control over this polymerisation could be improved. IR 
spectroscopy indicated that the secondary structure of this peptide was not retained, and 
more work is necessary to investigate conditions under which an α-helix structure is 
induced. Although the polymerisation of the second peptide is not well controlled, we 
have clearly demonstrated that it is possible to polymerise these two monomers, despite 
their bulk and the fact that there are numerous amines and amides present which could 
have a negative influence on the polymerisation process. 
In this thesis the focus of the work had been on the use of structural proteins as 
inspiration for our polymers. This Chapter clearly demonstrates that there are a wide 
variety of peptides which can be introduced into the side chain of a polymer using ATRP. 
The work described in this thesis could therefore be the beginning of a new research area 
which has much potential. 
In the field of antimicrobial peptide containing polymers there is still a lot of 
research left to be done. The current polymers require more extensive testing to 
investigate if inclusion of these peptides in the side chain of a polymer reduces their 
cytotoxicity without affecting their antimicrobial activity. A wide selection of anti 
microbial peptides should be introduced into the side chain of polymers to discover which 
ones give rise to the best antimicrobial coatings, and to increase the range of antibacterial 
agents available. 
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There are peptides with other properties whose inclusion in synthetic polymer may 
give rise to some very interesting materials.31 A well known possibility is to create 
polymeric drug delivery systems. Inclusion of, for example anti tumour drugs in 
polymers is known to improve their selectivity for the tumour, through the EPR effect 
described in the introduction. An alternative possibility is to use catalytically active 
peptide sequences, based on sequences commonly found in enzymes such as the catalytic 
triad found in proteases and lipases, to create synthetic polymers which are able to 
catalyse organic chemistry reactions. Clearly there is a vast potential for peptide polymer 
hybrid materials, and by preparing them in a controlled manner more complex 
architectures are accessible, expanding this potential even further. 
 
6.4 Experimental 
6.4.1 General procedures 
1H and 13C-NMR spectra were measured on a 400 MHz Bruker Inova400 machine with a 
Varian probe. 
IR spectra were measured on an ATI Mattson Genesis Series FTIR. 
Turbidity measurements were carried out on a Jasco J-810 spectropolarimeter, with a 
temperature control unit. Samples were dissolved in a phosphate buffer of pH of 1, 2 or 3, 
composed of sodium chloride, sodium dihydrogen phosphate monohydrate, di-sodium 
hydrogen phosphate dehydrate and ortho-phosphoric acid. The samples were measured 
using a 1 mm quartz cuvette at different temperatures. The measurements were carried 
out at a fixed wavelength of 480 nm. 
MALDI-TOF-MS spectra were measured on a Bruker Biflex III machine, with 
dihydroxybenzoic acid (DHB) as matrix. Samples were prepared by dissolving 2 mg of 
analyte in 1 mL THF after which this solution was mixed in a 1:1 ratio with a solution of 
10 mg DHB in 1mL H2O containing 0.1% trifluoro acetic acid. This was then placed on a 
MALDI plate. 
LC-Mass spectrometry was performed on a Q-TOF hybrid instrument equipped with a 
standard Z-spray interface (Micromass, Altrincham, UK) and an Alliance, type 2690 
liquid chromatograph (Waters, Milford, MA, USA). 
Chapter 6 Well Defined Polymers containing Antimicrobial Peptides 
 139
GPC measurements were performed using a Shimadzu GPC with Shimadzu RI and 
UV/Vis detection, fitted with a Polymer Laboratories Plgel 5 µm mixed-D column, and a 
PL 5 µm Guard column (separation range from 500 to 300,000 molecular weight) using 
THF as mobile phase at 35°C. Polymer Laboratories polystyrene calibration kits were 
used. 
Reverse HPLC was performed on a Amersham Biosciences AKTA chromatography 
system fitted with a Alltech Alltime C18 5 µ column. Detection was performed at 214 
nm. The following chromatographic conditions were used: eluent A 5% CH3CN/H2O, 
containing 0.1% TFA. Eluent B: 80% CH3CN/H2O, containing 0.1% TFA. Flow rate: 1 
ml/min. Gradient: 0 – 100% B in 20 min. 
 
6.4.2 Reagents 
CuCl (Aldrich, 97 %) was purified by washing with glacial acetic acid 3 times and 
once with diethyl ether.32 Ethyl-2 bromo isobutyrate (EBIB 98%, Aldrich), 2,2´-bipiridyl 
(Bipy) (Aldrich 99%), DMSO-d6  (Aldrich 99.9 %) were all used as recived. 
Dichloromethane (DCM) and ethyl acetate (EtOAc) were distilled from calcium hydride 
and DMF was simply distilled prior to use. 
 
Monomer 1 was synthesised and kindly provided by Gijs Grotenbreg of the University of 
Leiden.23 
Monomer 2 was kindly provided by Daan Noort of TNO Zeist. 
 
6.4.3 Polymerisation of gramicidin S based monomer 1 
Gramicidin S based monomer 1, 167 mg (0.125  mmol), was dissolved in 0.5 ml 
DMSO-d6 along with 1.27 mg CuCl (0.0125 mmol) and 0.75 µl penta methyl diethylene 
triamine (PMDETA) (0.0125 mmol). Next 0.86 µl (0.00625 mmol) ethyl 2-
bromoisobutyrate (EBIB) was added. This mixture was then placed into an NMR tube, 
which was purged with argon for 10 minutes. The NMR tube was placed in a 400 MHz 
Bruker Inova400 NMR with a Varian probe with the temperature set to 55°C. Every 30 
minutes for the first 2 hours and then every hour for the next 13½ hours a 1H-NMR 
spectrum was taken. From these spectra the conversion was determined by comparing the 
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amide peak at 7.2 ppm with the peak due to the methacrylate group at 6.1 ppm. After 15½ 
hours the conversion had reached 65 % and the polymerisation was stopped. The polymer 
was then precipitated in a water/EDTA (2.5g per 100ml) solution to remove DMSO and 
CuCl/PMDETA. 
1H-NMR (400 MHz, DMSO-d6): δ 0.5-0.8 (CHCH2CH(CH3)2, CHCH(CH3)2, m), 1.1-2.0 
(-C(CH3)3, CHCH2CH(CH3)2,  -CH2-C(R)(CH3), and CH-CH2-CH2-CH2 –NH-Boc, CH-
CH2-CH2-CH2-NH-, m), 2.6-3.1 (CH-CH2-Ar, O-CH2-CH2-NH-R, CHCH(CH3)2, CH-
CH2-CH2-CH2 –NH-Boc, -CH-CH2-CH(R)-CH2-NH-, CH-CH2-CH2-CH2-NH-, -CH2-
C(R)(CH3), and O-CH3, m), 3.6-4.9 CH-CH2-CH(R)-CH2-NH-, CH-CH2-Ar, -
CHCH2CH(CH3)2, -CHCH(CH3)2, O-CH2-CH2-NH-R, CH-CH2-CH2-CH2-NH-, m), 6.9-
8.2 amides and aryrl groups 
GPC: Mn = 9.03 kg/mol, Mn, theoretical = 19.6 kg/mol, PDI = 1.09 
IR: ν 3277 (N-H str.); 2958 (C-H str.); 1709 (C=O str. ester); 1636 (C=O str. amide I); 
1529 (N-H vib. amide II); 1447 (C-H vib.) cm-1 
 
6.4.4 Polymerisation of O-KFFKFFKFFK based monomer 2 
Monomer 2, (214 mg, 0.125 mmol), was dissolved in 0.5 ml DMSO-d6. To this 
solution, 0.86 µl EBIB (0.00625 mmol), 1.23 mg CuCl (0.00625 mmol), and 1.51 µl 
PMDETA (0.00625) were added. This mixture was then placed in an NMR tube and 
flushed with argon for 10 minutes. Next the NMR tube was placed in a 400 MHz Bruker 
Inova400 NMR with a Varian probe with the temperature set to 55°C. From the 1H-NMR 
spectra taken during the polymerisation the conversion was determined by comparing the 
amide peaks around 7.2 ppm with the peak due to the methacrylate group at 6.1 ppm. 
After 7.5 hours the conversion had reached 75 %. The resulting polymer was then 
dissolved in water and basified with 4 M NaOH until a white precipitate was formed. 
This was centrifuged and the remaining water was decanted off, leaving the purified 
polymer. 
1H-NMR (400 MHz, DMSO-d6): δ 0.9 (CH-CH2-CH2-CH2-CH2-NH2), m), 1-1.9 (CH-
CH2-CH2-CH2-CH2-NH2, and -CH2-C(R)(CH3), m), 2.4-3.6 (CH-CH2-Ar, CH-CH2-CH2-
CH2-CH2-NH2, O-CH2-CH2-O, O-CH2-CH2-NH-R, -CH2-C(R)(CH3), and O-CH3, m), 
3.7- 5.2 (CH-CH2-Ar and -CH2-CH2-CH2-CH2-NH2, m) 6.9-8.2 amides and aryrl groups. 
Chapter 6 Well Defined Polymers containing Antimicrobial Peptides 
 141
GPC: two peaks at elution time 11.32 minutes and 12.22 minutes 
IR: ν 3282 (N-H str.); 2936 (C-H str.); 1648 (C=O str. amide I); 1553 (N-H vib. amide 
II); 1454 (C-H vib.) cm-1 
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Samenvatting 
Structurele eiwitten zijn, net als polysacchariden, zoals cellulose en chitine, zeer 
belangrijk voor de mechanische eigenschappen van planten en dieren. Natuurlijke 
bouwmaterialen, gebaseerd op peptiden, hebben vaak unieke combinaties van 
eigenschappen. Een voorbeeld hiervan is spinzijde. Spinzijde heeft een unieke en 
ongebruikelijke combinatie van elasticiteit en sterkte, en wordt daarom weleens de “high 
performance” vezel uit de natuur genoemd. Deze mechanische eigenschappen van 
eiwitten worden bepaald door de secundaire structuur, die op zijn beurt weer wordt 
gedicteerd door frequente herhalingen een korte aminozuursequenties. Het introduceren 
van deze peptide-opeenvolgingen in een synthetisch polymeer is één manier om nieuwe 
materialen te maken. Deze materialen bootsen de secundaire structuur na van het eiwit 
waarop het gebaseerd is, en daarmee de mechanische eigenschappen. Dit proefschrift 
beschrijft de synthese van een reeks van hybride materialen gebaseerd op peptiden en 
polymeren, die gesynthetiseerd worden via atom transfer radical polymerization (ATRP).  
De voorwaarden om ATRP toe te kunnen passen op monomeren die gebaseerd 
zijn op peptiden, werden onderzocht in hoofdstuk 2. Eerst werd een enkel aminozuur, nl. 
glutaminezuur, gefunctionaliseerd met een methacrylaat groep, en vervolgens werd dit 
product gepolymeriseerd. De polymerisatie verliep op een gecontroleerde wijze en volgde 
een eerste orde kinetiek. De polymerisatie gaf een goed gedefineerd polymeer met een 
polydispersiteit (PDI) van 1,11. Dit is de eerste keer dat een gecontroleerde radicaal 
polymerisatie van een aminozuur monomeer is uitgevoerd. 
Zijde heeft een secundaire structuur die bestaat uit twee belangrijke elementen, 
een kristallijn β-sheet domein in een  amorfe matrix. Om deze structuur na te bootsen 
werden drie verschillende peptidesequenties van drie verschillende delen van de β-sheet, 
gefunctionaliseerd met een methacrylaat groep, waarna deze monomeren werden 
gepolymeriseerd via ATRP. Alleen het monomeer dat op het streng-element van de β-
sheet was gebaseerd kon op een gecontroleerde manier worden gepolymeriseerd. Een 
triblok-copolymeer werd bereid, waarin dit monomeer in een centraal kristallijn blok 
tussen twee amorfe blokken pMMA werd opgenomen. De β-sheet structuur van het 
kristallijne centrumblok werd bevestigd door IR spectroscopie, wat aangaf dat de 
structuur zoals gevonden wordt in zijde was verkregen.  
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De hoofdstukken 3 en 4 beschrijven de synthese van een zijketenpolymeer dat 
gebaseerd is op elastine, dat, naast zijde, een ander zeer bekend structureel eiwit is. 
VPGVG (V = valine, P = proline en G = glycine) is een aminozuursequentie die 
veelvuldig voorkomt in tropoelastine, een precursor voor elastine. Aan het eind van de 
VPGVG sequentie werd een methacrylaat gekoppeld en, via ATRP, gepolymeriseerd. 
Hierdoor ontstond een goed gedefinieerd polymeer met VPGVG in de zijketens. CD 
spectroscopie toonde aan dat de karakteristieke overgang van de VPGVG zijketens van 
een amorfe structuur naar een β-spiraalvorm behouden bleef, wanneer het polymeer werd 
verwarmd. Door gebruik te maken van een PEG gebaseerde ATRP initiator als centraal 
blok werd vervolgens een ABA type blokcopolymeer bereid, waarbij de elastine 
fragmenten zich in de zijketens van de A blokken bevonden. Bij verwarming vertoonde 
een oplossing van dit materiaal in water een turbiditeitstoename. Dit effect kan verklaard 
worden door de vorming van amfifiele blokcopolymeren ten gevolge van de  overgang 
van hydrofiele naar hydrofobe peptide-zijketens. Dit zogenaamd “lower critical solution 
temperature” (LCST) gedrag gaf aanleiding tot de vorming van grotere complexen. 
CryoSEM en DLS metingen bevestigden dat tijdens het verwarmen het blokcopolymeer 
assembleert in een netwerk structuur.  
Via turbiditeitsmetingen werd bepaald dat de LCST van een reeks 
triblokcopolymeren, met zijketens gebaseerd op elastine, door dezelfde parameters als het 
lineaire polyVPGVG werd beïnvloed. Het verhogen van de polymeerconcentratie of het 
molecuulgewicht verminderde de overgangstemperatuur en het verhogen van de pH 
verhoogde de overgangstemperatuur.  
 In hoofdstuk 5 werd het aggregatiegedrag van een goed gedefinieerd amfifiel 
triblokcopolymeer met peptiden in de hoofdketen onderzocht. Een initiator werd 
gesynthetiseerd die gebaseerd was op een bifunctioneel peptide met de sequentie 
SAGAGEGAGAGSG, een bekende β-hairpin sequentie. De twee eindstandige  serines 
konden daarna worden gefunctionaliseerd met behulp van een α-bromo ester om de 
gewenste ATRP initiator te geven. Deze werd gebruikt voor ATRP van MMA om een 
triblokcopolymeer te creëren dat een hydrofiel centrumblok met twee hydrofobe 
buitenblokken bevat. Onderzoek met lichtverstrooiing en elektronenmicroscopie liet zien 
dat het amfifiele triblokcopolymeer aggregeerde tot polymere vesicles (polymersomes). 
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Tot slot werd in hoofdstuk 6 de ontwikkelde methodologie voor de bereiding van 
peptide gebaseerde materialen uitgebreid van sequenties die afkomstig waren van 
structurele eiwitten naar functionele peptiden. Twee monomeren die op twee 
antimicrobiële peptiden zijn gebaseerd, gramicidine S en KFFKFFKFFK, werden eerst 
gesynthetiseerd en daarna gepolymeriseerd (via ATRP). Op deze wijze was het mogelijk 
om twee goed gedefinieerde polymeren te bereiden die antimicrobiële peptiden bevatten. 
Dit toont de veelzijdigheid aan van het gebruik van ATRP om op peptide gebaseerde 
monomeren te polymeriseren. Het laat verder zien dat een grote verscheidenheid aan 
peptiden in de zijketen van een polymeer kan worden geïntroduceerd met ATRP, 
waarmee hybride materialen met een scala aan toepassingen kunnen worden gemaakt. 
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Summary 
 
Structural proteins, together with polysaccharides such as cellulose and chitin, are 
responsible for the introduction of mechanical properties into plants and animals. Protein 
based natural building materials often have unique combinations of properties. For 
instance spider silk, often described as nature’s high performance fibre, has an unusual 
combination of elasticity and strength. These properties are usually controlled by the 
secondary structure of the protein, which is in turn often dictated by a short repeating 
amino acid sequence. Introducing these peptide sequences into a synthetic polymer is one 
way to prepare novel materials with secondary architectures mimicking that of the 
proteins they are based on. This thesis describes the synthesis of a series of peptide based 
hybrid materials via atom transfer radical polymerization (ATRP). 
The conditions for the ATRP of peptide based monomers were investigated in 
chapter 2. A single amino acid, glutamic acid, was functionalised with a methacrylate 
handle and was polymerised. The polymerisation proceeded in a controlled manner, 
showing first order kinetics and resulting in a well-defined polymer with a polydispersity 
(PDI) of 1.11. This is the first example of the controlled radical polymerisation of an 
amino acid based monomer.  
The secondary structure of silk consists of two main regions, a crystalline β-sheet 
domain within a less well defined amorphous matrix. In order to mimic this structure 
three different peptide sequences, from three different parts of a β-sheet were 
functionalised with a methacrylate handle and then polymerised using ATRP. Of the 
three monomers it was only possible to polymerise the monomer based on the strand part 
of a β-sheet in a controlled manner. A triblock copolymer was prepared containing this 
monomer in a central crystalline block incorporated between two amorphous pMMA 
blocks. The β-sheet nature of the peptide based centre block was confirmed using IR 
spectroscopy, indicating that a silk like structure had been obtained.   
In chapters 3 and 4 a side chain polymer based on elastin, another widely studied 
structural protein, was prepared. The most prominent amino acid repeat found in 
tropoelastin, an elastin precursor, is VPGVG (V = valine, P = proline and G = glycine). 
The addition of a methacrylate handle onto the end of VPGVG allowed its introduction 
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into the side chain of a well defined polymer using ATRP. CD spectroscopy revealed that 
upon heating the VPGVG side chains retained their characteristic transition from random 
coil to β-spiral behaviour. When this elastin based monomer was introduced into an ABA 
type block copolymer, using a PEG based ATRP initiator as the central block, a turbidity 
change was observed. This could be explained by the formation upon heating of 
amphiphilic block copolymers due to the hydrophilic to hydrophobic transition of the 
peptide side chains. This so-called lower critical solution temperature (LCST) behaviour 
gave rise to the formation of larger aggregates. CryoSEM and DLS measurements 
indicated that upon heating the block copolymer assembles into a network structure. 
It was furthermore demonstrated via turbidity measurements that the LCST of a 
series of side chain elastin based triblock copolymers was influenced by the same 
parameters as linear polyVPGVG. Increasing the polymer concentration or molecular 
weight lowered the transition temperature and increasing the pH increased the transition 
temperature.    
In chapter 5, the aggregation behaviour of a well defined peptide based 
amphiphilic triblock copolymer with the peptide in the main chain, was investigated. A 
bifunctional peptide based initiator was synthesised based on the sequence 
SAGAGEGAGAGSG, a well known β-hairpin forming sequence. The two serines on 
each end could then be functionalised with an α-bromo ester to give the desired ATRP 
initiator. This was used to initiate ATRP of MMA in order to create a triblock copolymer 
containing a hydrophilic centre block with two hydrophobic outer blocks. Investigations 
with light scattering and electron microscopy revealed that this amphiphilic triblock 
copolymer formed vesicles, or polymersomes, in solution. 
Finally in chapter 6 the developed methodology for the construction of peptide-
based materials was extended from sequences originating from structural proteins, to 
functional peptides. Two monomers based on two antimicrobial peptides, gramicidin S 
and KFFKFFKFFK were synthesised and polymerised via ATRP. In this way it was 
possible to prepare two well defined polymers containing antimicrobial peptides. This 
demonstrates the versatility of using ATRP to polymerise peptide based monomers, and 
the wide variety of different peptides which can be efficiently introduced into the side 
chain of a polymer, to create hybrid materials with a range of applications. 
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